Clinical Trials
Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Non-fasting (Fed) ConditionsCondition: HealthyIntervention: Drug: Amlodipine Besylate / Benazepril Hydrochloride Sponsor: Dr. Reddy's Laboratories Limited Completed Fri, 02 Jul 2010 12:00:00 EDT Pharmacokinetics of Amlodipine Besylate at Delivery and During LactationCondition: Chronic Hypertension in PregnancyIntervention: Drug: Amlodipine besylate Sponsors: University of Texas Southwestern Medical Center; National Center for Advancing Translational Science (NCATS) Completed Tue, 03 Feb 2015 12:00:00 EST Bioequivalence Study of 10 mg Amlodipine Besylate/ 20 mg Benazepril Hydrochloride Capsules of Dr.Reddys Laboratories Limited Under Fasting ConditionsCondition: HealthyIntervention: Drug: Amlodipine Besylate / Benazepril Hydrochloride Sponsor: Dr. Reddy's Laboratories Limited Completed Fri, 02 Jul 2010 12:00:00 EDT Nifedipine GITS and Amlodipine Besylate on Recovery of Blood Pressure Rhythm and Arterial StiffnessCondition: HypertensionInterventions: Drug: Nifedipine GITS; Drug: Amlodipine besylate Sponsors: Jing Liu; Bayer Unknown status Fri, 21 Oct 2016 12:00:00 EDT Bioequivalency Study of Amlodipine Besylate Tablets, 10 mg of Dr. Reddy's Under Fed ConditionsCondition: HealthyIntervention: Drug: Amlodipine Sponsor: Dr. Reddy's Laboratories Limited Completed Thu, 27 May 2010 12:00:00 EDT Bioequivalency Study of Amlodipine Besylate Tablets, 10 mg of Dr. Reddy's Under Fasting ConditionsCondition: HealthyIntervention: Drug: Amlodipine Sponsor: Dr. Reddy's Laboratories Limited Completed Thu, 27 May 2010 12:00:00 EDT Bioequivalence Study of Amlodipine and Norvasc Under Fasting and FED Conditions in Chinese Healthy VolunteersCondition: BioequivalenceInterventions: Drug: LANDI-Amlodipine Besylate Tablet 5mg; Drug: Norvasc Tablets 5mg Sponsor: Shanghai Haini Pharmaceutical Co., Ltd. Completed Mon, 28 Nov 2016 12:00:00 EST Fimasartan Plus Amlodipine on Hemodynamic Parameters and Arterial Stiffness in Patients With HypertensionCondition: Arterial HypertensionIntervention: Combination Product: Fimasartan plus amlodipine besylate Sponsor: Centro Universitario de Ciencias de la Salud, Mexico Unknown status Tue, 26 Sep 2017 12:00:00 EDT Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fed ConditionsCondition: FedIntervention: Drug: Amlodipine Besylate/Benazepril HCl Sponsor: Dr. Reddy's Laboratories Limited Completed Mon, 09 Jan 2012 12:00:00 EST Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fasting ConditionsCondition: FastingIntervention: Drug: Amlodipine Besylate/Benazepril HCl Sponsor: Dr. Reddy's Laboratories Limited Completed Mon, 09 Jan 2012 12:00:00 EST 
Bioavailability of 5 mg of Levamlodipine Maleate Tablets Versus 10 mg of Amlodipine Besylate Tablet in Healthy SubjectsCondition: HypertensionInterventions: Drug: Levamlodipine, Amlodipine; Drug: Amlodipine, Levamlodipine Sponsors: Conjupro Biotherapeutics, Inc.; CSPC Ouyi Pharmaceutical Co., Ltd. Completed Wed, 05 Sep 2018 12:00:00 EDT Amlodipine 10mg Drug Use InvestigationCondition: HypertensionIntervention: Drug: Amlodipine Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. Completed Fri, 03 Dec 2010 12:00:00 EST Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fed ConditionCondition: HealthyIntervention: Drug: Amlodipine besylate/Atorvastatin calcium Sponsor: Dr. Reddy's Laboratories Limited Completed Mon, 17 Nov 2014 12:00:00 EST Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fasting ConditionCondition: HealthyIntervention: Drug: Amlodipine besylate/Atorvastatin calcium Sponsor: Dr. Reddy's Laboratories Limited Completed Wed, 19 Nov 2014 12:00:00 EST Clinical Bioequivalence Study on Two Amlodipine Tablet 10mg FormulationsCondition: HealthyInterventions: Drug: BF-Amlodipine Tablet 10mg; Drug: Norvasc Tablet 10mg Sponsors: Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited; Chinese University of Hong Kong Completed Mon, 14 Mar 2016 12:00:00 EDT A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Under Fasting ConditionsCondition: HealthyInterventions: Drug: AMLODIPINE (as BESILATE) TABLETS 10 mg , single dose; Drug: Norvasc® 10 mg Tablets Sponsor: Actavis Inc. Completed Fri, 27 Mar 2009 12:00:00 EDT A Relative Bioavailability Study of Amlodipine Besylate 10 mg Tablets Tablets Under Fed ConditionsCondition: HealthyInterventions: Drug: AMLODIPINE (as BESILATE) TABLETS 10 mg , single dose; Drug: NorvasC® 10 mg Tablets Sponsor: Actavis Inc. Completed Fri, 27 Mar 2009 12:00:00 EDT Long Term Study of Valsartan and Amlodipine in Patients With Essential Hypertension (Extension to Study CVAA489A1301)Condition: HypertensionIntervention: Drug: Valsartan + Amlodipine besilate Sponsor: Novartis Completed Tue, 13 Mar 2007 12:00:00 EDT CKD-330 Drug-Drug Interaction Study (Amlodipine)Condition: HypertensionInterventions: Drug: Amlodipine 10mg; Drug: Amlodipine 10mg/Candesartan 32mg Sponsor: Chong Kun Dang Pharmaceutical Completed Mon, 17 Feb 2014 12:00:00 EST Benefit of Amlodipine in HRT Cycle for Frozen Embryo Transfer in the Correction of Uterine Pulsatility IndexCondition: Frozen Embryo TransferInterventions: Drug: Amlodipine 5mg; Drug: Placebo Sponsor: University Hospital, Montpellier Not yet recruiting Thu, 08 Jul 2021 12:00:00 EDT
Amlodipine in the Prevention and Treatment of Iron Overload in Patients With Thalassemia MajorConditions: Thalassemia; Iron OverloadIntervention: Drug: Amlodipine Sponsors: University of Campinas, Brazil; Fundação de Amparo à Pesquisa do Estado de São Paulo Completed Fri, 15 Jul 2011 12:00:00 EDT Pharmacokinetic Interactions of Candesartan Cilexetil and Amlodipine BesylateCondition: HealthyIntervention: Drug: candesartan cilexetil 32mg, amlodipine 10mg Sponsor: HK inno.N Corporation Unknown status Fri, 03 May 2013 12:00:00 EDT Effect of Amlodipine on Anti-platelet Drug Effect in Patients With Coronary Artery DiseaseCondition: Ischemic Heart DiseaseIntervention: Drug: Amlodipine Sponsor: Ruttonjee Hospital Completed Thu, 16 Sep 2010 12:00:00 EDT Bedtime Administration of Amlodipine Versus LisinoprilCondition: HypertensionIntervention: Drug: Amlodipine Sponsor: Allina Health System Unknown status Fri, 19 Apr 2013 12:00:00 EDT Safety and Pharmacokinetics Study of Amlodipine 10mg and Candesartan 32mgCondition: HealthyIntervention: Drug: candesartan cilexetil 32mg, amlodipine 10mg Sponsor: Shin Poong Pharmaceutical Co. Ltd. Completed Wed, 21 Aug 2013 12:00:00 EDT Amlodipine 10 mg Tablets Under Fed ConditionsCondition: HealthyInterventions: Drug: Amlodipine Besylate; Drug: Norvasc® Sponsor: Teva Pharmaceuticals USA Completed Wed, 11 Feb 2009 12:00:00 EST Amlodipine 10 mg Tablets Under Fasting ConditionsCondition: HealthyInterventions: Drug: Amlodipine Besylate; Drug: Norvasc® Sponsor: Teva Pharmaceuticals USA Completed Wed, 11 Feb 2009 12:00:00 EST Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 HypertensionCondition: HypertensionInterventions: Drug: amlodipine/losartan; Drug: amlodipine Sponsor: Hanmi Pharmaceutical Company Limited Completed Thu, 20 May 2010 12:00:00 EDT Comparing Safety and Efficacy of Amlodipine Verses S Amlodipine in Patients With Essential HypertensionCondition: Essential HypertensionInterventions: Drug: S-amlodipine 2.5mg; Drug: Amlodipine 5mg Sponsors: Ahn-Gook Pharmaceuticals Co.,Ltd; Korea University Guro Hospital; Dt&Sanomedics Recruiting Fri, 18 Sep 2020 12:00:00 EDT Amlodipine on Blood Flow of Preovulatory Follicle in Polycystic Ovarian PatientsCondition: Female Infertility Associated With AnovulationInterventions: Drug: Clomifene citrate ( clomid 50 mg ); Drug: Amlodipine Sponsor: Ahmed Fathy Ali Mohamed Ghanem Completed Wed, 09 Sep 2015 12:00:00 EDT
Comparision of Blood Pressure Variability Between Amlodipine and LosartanCondition: HypertensionInterventions: Drug: Amlodipine; Drug: Losartan Sponsors: Wonju Severance Christian Hospital; Pfizer Completed Thu, 17 Oct 2013 12:00:00 EDT Evaluate Efficacy and Safety of Ezetimibe/Rosuvastatin and Candesartan Cilexetil/Amlodipine Besylate Combination TabletsCondition: Hypertension, HyperlipidemiaInterventions: Drug: Ezetimibe/Rosuvastatin; Drug: Candesartan cilexetil/Amlodipine besylate; Drug: Candesartan cilexetil Sponsor: HK inno.N Corporation Active, not recruiting Wed, 20 Feb 2019 12:00:00 EST BR1010 in Patients With Essential Hypertension Patients Who do Not Adequately Respond to Fimasartan/Amlodipine CombinationCondition: Essential HypertensionIntervention: Drug: Fimasartan/Amlodipine Sponsor: Boryung Pharmaceutical Co., Ltd Completed Wed, 19 Jun 2019 12:00:00 EDT Efficacy and Safety of Aliskiren Administered in Combination With Amlodipine Versus Amlodipine Alone in African American Patients With Stage 2 HypertensionCondition: HypertensionInterventions: Drug: Aliskiren/Amlodipine; Drug: Amlodipine Sponsor: Novartis Completed Mon, 02 Mar 2009 12:00:00 EST Manidipine Versus Amlodipine in Patients With HypertensionCondition: HypertensionInterventions: Drug: Manidipine 20mg; Drug: Amlodipine 10mg Sponsors: Korea University Guro Hospital; Takeda Pharmaceuticals International, Inc. Terminated Mon, 10 Apr 2017 12:00:00 EDT A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and LosartanCondition: HealthyInterventions: Drug: Amlodipine plus Losartan; Drug: Amlodipine, Losartan Sponsor: Hanmi Pharmaceutical Company Limited Completed Thu, 09 Sep 2010 12:00:00 EDT A Bioequivalence Study of Amlodipine Plus Losartan Versus Amlodipine and LosartanCondition: HealthyInterventions: Drug: Amlodipine plus Losartan; Drug: Amlodipine, Losartan Sponsor: Hanmi Pharmaceutical Company Limited Completed Thu, 09 Sep 2010 12:00:00 EDT Aliskiren in Combination With Amlodipine in Hypertensive Patients Not Responding to Angiotensin Receptor Blocker (ARB) Plus AmlodipineCondition: Essential HypertensionIntervention: Drug: Aliskiren/Amlodipine and Aliskiren/Amlodipine/HCTZ Sponsor: Novartis Completed Thu, 29 Apr 2010 12:00:00 EDT CKD-330 Phase 3 Trial in Amlodipine Non-responderCondition: HypertensionInterventions: Drug: CKD-330 16/5mg; Drug: Amlodipine 5mg Placebo; Drug: CKD-330 16/5mg Placebo; Drug: Amlodipine 5mg Sponsor: Chong Kun Dang Pharmaceutical Completed Mon, 26 Oct 2015 12:00:00 EDT Valsartan Versus Amlodipine Effect on Left Ventricular Multidirectional Deformation and Adipocytokines LevelCondition: HypertensionInterventions: Drug: valsartan (160 mg/d); Drug: amlodipine (10 mg/d). Sponsors: Damanhour University; Tanta University Completed Wed, 19 Jun 2019 12:00:00 EDT
Comparison of Amlodipine and Aliskiren in Diabetic Hypertensive Patient With Blood Pressure Not Controlled by LosartanConditions: Hypertension; Diabetes MellitusInterventions: Drug: Aliskiren; Drug: Amlodipine Sponsors: Hospital Universitario Pedro Ernesto; Novartis Withdrawn Thu, 04 Aug 2011 12:00:00 EDT Compare the Pharmacokinetics of TAH(80/10/12.5) Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male VolunteersCondition: HealthyInterventions: Drug: TAH Tablet (Telmisartan80/Amlodipine besylate10/Hydrochlorothiazide12.5); Drug: TWYNSTA(Telmisartan+Amlodipine besylate); Drug: Hydrochlorothiazide Sponsor: IlDong Pharmaceutical Co Ltd Completed Thu, 26 Jan 2017 12:00:00 EST Clinical Trial to Compare the Pharmacokinetics of TAH Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male VolunteersCondition: HealthyInterventions: Drug: TAH Tablet (Telmisartan/Amlodipine besylate/Hydrochlorothiazide); Drug: TWYNSTA(Telmisartan+Amlodipine besylate); Drug: Hydrochlorothiazide Sponsor: IlDong Pharmaceutical Co Ltd Completed Fri, 15 Apr 2016 12:00:00 EDT Aliskiren/Amlodipine/Hydrochlorothiazide (HCTZ) Versus Aliskiren/Amlodipine in US Minority Patients With Stage II Systolic HypertensionCondition: HypertensionInterventions: Drug: Aliskiren/Amlodipine; Drug: Aliskiren/Amlodipine and Hydrochlorothiazide (HCTZ) Sponsor: Novartis Completed Tue, 21 Jul 2009 12:00:00 EDT Azilsartan/Amlodipine Combination Tablets LD & HD Specified Drug-use Survey "Long-term Use Survey"Condition: HypertensionIntervention: Drug: Azilsartan/Amlodipine Sponsor: Takeda Completed Fri, 04 Jul 2014 12:00:00 EDT Efficacy of Amlodipine-Folic Acid Tablets on Reduction of Blood Pressure and Plasma HomocysteineCondition: Essential HypertensionInterventions: Drug: Amlodipine-FA tablet,low dose group; Drug: Amlodipine-FA tablet,high dose group; Drug: Amlodipine Sponsors: Shenzhen Ausa Pharmed Co.,Ltd; Ruijin Hospital; Second Affiliated Hospital of Nanchang University; Xuzhou Medical University Unknown status Tue, 08 Oct 2013 12:00:00 EDT Fixed Dose Combination of Bisoprolol and Amlodipine in the Treatment of HypertensionCondition: HypertensionInterventions: Drug: Bisoprolol/Amlodipine (Bisoprolol failed group); Drug: Bisoprolol/Amlodipine (Amlodipine failed group) Sponsor: Merck KGaA, Darmstadt, Germany Completed Thu, 07 Nov 2013 12:00:00 EST Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential HypertensionCondition: HypertensionInterventions: Drug: Amlodipine plus Losartan; Drug: Amlodipine Sponsor: Hanmi Pharmaceutical Company Limited Completed Thu, 16 Jul 2009 12:00:00 EDT China Stroke Primary Prevention Trial for Subjects With H-type Hypertension and MTHFR 677 CC/CT GenotypeCondition: HypertensionInterventions: Drug: Amlodipine besylate tablets; Drug: Amlodipine besylate and folic acid tablets Sponsors: Shenzhen Ausa Pharmed Co.,Ltd; Shenzhen CCHRPP Biomedical Institute; Peking University First Hospital; Second Affiliated Hospital of Nanchang University; The First People's Hospital of Lianyungang; First Affiliated Hospital of Harbin Medical University; The First Affiliated Hospital of Shanxi Medical University Not yet recruiting Fri, 23 Jul 2021 12:00:00 EDT Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients With Hypertension Not Adequately Responding to Amlodipine AloneCondition: HypertensionInterventions: Drug: Amlodipine 10 mg; Drug: Aliskiren 150; Drug: Amlodipine 300 Sponsor: Novartis Completed Fri, 24 Oct 2008 12:00:00 EDT
Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With HypertensionCondition: HypertensionInterventions: Drug: Valsartan/amlodipine 80/5 mg; Drug: Amlodipine 5 mg Sponsor: Novartis Completed Tue, 19 Dec 2006 12:00:00 EST Efficacy of Amlodipine-folic Acid Tablets on Reduction of Blood Pressure and Plasma HomocysteineCondition: Essential HypertensionInterventions: Drug: Amlodipine; Drug: amlodipine-FA tablet, low dose group; Drug: amlodipine-FA tablet ,high dose group Sponsors: Shenzhen Ausa Pharmed Co.,Ltd; Peking University First Hospital; Chinese PLA General Hospital; Capital Medical University; Fudan University; Ruijin Hospital; Nanchang University; First Affiliated Hospital of Fujian Medical University; First Affiliated Hospital of Harbin Medical University; China Medical University, China; Health Science Center of Xi'an Jiaotong University; Xuzhou Medical University; Anhui Medical University; Huazhong University of Science and Technology; West China Hospital; Guangdong Provincial People's Hospital; Second Affiliated Hospital, School of Medicine, Zhejiang University Unknown status Wed, 08 May 2013 12:00:00 EDT Effect of Amlodipine Versus Amlodipine Combined With Atorvastatin on the Coronary Vasospastic AnginaCondition: Quality of LifeInterventions: Drug: Caduet 10Mg-20Mg Tablet; Drug: NorvasC® 10 mg Tablets Sponsor: Kosin University Gospel Hospital Unknown status Wed, 15 Feb 2017 12:00:00 EST Aliskiren and the Calcium Channel Blocker Amlodipine Combination as an Initial Treatment Strategy for HypertensionCondition: HypertensionInterventions: Drug: Amlodipine; Drug: hydrochlorothiazide; Drug: Aliskiren Sponsor: Novartis Completed Tue, 25 Nov 2008 12:00:00 EST Pharmacodynamic Effects of Ranolazine Versus Amlodipine on Platelet ReactivityCondition: Coronary Artery DiseaseInterventions: Drug: Ranolazine; Drug: Amlodipine Sponsor: University of Roma La Sapienza Unknown status Mon, 12 Dec 2011 12:00:00 EST A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential HypertensionCondition: HypertensionIntervention: Drug: Fimasartan , Amlodipine, Placebo Sponsors: Boryung Pharmaceutical Co., Ltd; Gachon University Gil Medical Center; The Catholic University of Korea; Kyungpook National University Hospital; Daegu Catholic University Medical Center; Wonkwang University Hospital; Wonju Severance Christian Hospital; Korea University Guro Hospital; DongGuk University; Yeungnam University Hospital; Chonnam National University Hospital; Cheil General Hospital and Women's Healthcare Center; Chungnam National University; Asan Medical Center; Seoul National University Bundang Hospital; Inha University Hospital; Seoul National University Hospital; Inje University; Samsung Medical Center; Busan National University Yangsan Hospital; Soon Chun Hyang University; Catholic University of Korea Saint Paul's Hospital; Hallym University Kangnam Sacred Heart Hospital; Jeju National University Hospital; Hanyang University Seoul Hospital; Kangbuk Samsung Hospital Completed Thu, 26 Jan 2012 12:00:00 EST Bioavailability Study Comparing 10 mg Amlodipine Besylate Orally Disintegrating Tablets (ODT) And 10 mg Amlodipine Besylate CapsulesCondition: Healthy VolunteersInterventions: Drug: Amlodipine - reference; Drug: Amlodipine ODT - test Sponsors: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Aurobindo Pharma Ltd; Trident Life Sciences Ltd. Completed Fri, 06 Aug 2010 12:00:00 EDT S-amlodipine+Chlorthalidone vs S-amlodipine+Telmisartan in HypertensionCondition: Essential HypertensionInterventions: Drug: S-amlodipine 2.5mg + Chlorthalidone 25mg; Drug: S-amlodipine 2.5mg + Telmisartan 40mg Sponsors: Seoul National University Bundang Hospital; Hanlim Pharm. Co., Ltd. Unknown status Fri, 21 Jul 2017 12:00:00 EDT A Two Way Cross Over Pharmacokinetic Interaction Study Between Raltegravir and Amlodipine in Healthy VolunteersCondition: HIVInterventions: Drug: Raltegravir; Drug: Amlodipine Sponsor: St Stephens Aids Trust Completed Fri, 26 Apr 2013 12:00:00 EDT Drug-drug Interaction Study(CKD-501, Amlodipine)Condition: Type 2 Diabetes MellitusInterventions: Drug: CKD-501; Drug: amlodiopine; Drug: CKD-501 amlodipine Sponsors: Chong Kun Dang Pharmaceutical; Severance Hospital Completed Mon, 25 Apr 2011 12:00:00 EDT
Evaluation of Amlodipine Pharmacokinetics in Patients Receiving Hi Flux HemodialysisConditions: Hemodialysis; PharmacokineticsIntervention: Drug: Amlodipine Besylate Sponsor: University of Michigan Withdrawn Fri, 26 Oct 2018 12:00:00 EDT Telmisartan, Amlodipine and Combination in Healthy SubjectsCondition: HealthyIntervention: Drug: amlodipine/telmisartan/combination Sponsor: Boehringer Ingelheim Completed Fri, 13 Aug 2010 12:00:00 EDT Efficacy and Safety of the Combination of Aliskiren (300 mg) and Amlodipine (10 mg) Compared to Amlodipine (10 mg) Monotherapy in Patients With Moderate to Severe HypertensionCondition: Moderate to Severe HypertensionInterventions: Drug: Aliskiren/amlodipine 300/10 mg tablet; Drug: Amlodipine 10 mg capsule Sponsor: Novartis Completed Wed, 11 Feb 2009 12:00:00 EST CKD-828 Drug Interaction Study (S-amlodipine)Condition: Healthy Male VolunteersInterventions: Drug: S-amlodipine 5mg,Telmisartan 80mg; Drug: S-amlodipine 5mg Sponsors: Chong Kun Dang Pharmaceutical; Asan Medical Center Completed Thu, 19 May 2011 12:00:00 EDT The Pharmacokinetic Interaction Between Amlodipine and LosartanCondition: HealthyInterventions: Drug: Amlodipine10mg; Drug: Losartan potassium 100mg; Drug: Amlodipine plus Losartan Sponsors: Korea University Anam Hospital; Hanmi Pharmaceutical co., ltd. Completed Thu, 11 Apr 2019 12:00:00 EDT Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential HypertensionCondition: HypertensionInterventions: Drug: Azilsartan Medoxomil and amlodipine; Drug: Amlodipine Sponsor: Takeda Completed Fri, 11 Jan 2008 12:00:00 EST A Comparative Study Between Amlodipine 10mg And 5mg With Hypertension For Whom 5mg Is InsufficientCondition: HypertensionIntervention: Drug: Amlodipine Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. Completed Mon, 25 Dec 2006 12:00:00 EST A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Candesartan Cilexetil MonotherapyCondition: Essential HypertensionInterventions: Drug: Candesartan cilexetil 16mg; Drug: Amlodipine 10mg, Candesartan cilexetil 16mg Sponsor: HK inno.N Corporation Unknown status Mon, 23 Feb 2015 12:00:00 EST Evaluation of Celecoxib Effects on Amlodipine in Subjects With Existing Hypertension Requiring AntihypertensivesCondition: HypertensionInterventions: Drug: OE 10 mg amlodipine besylate tablet; Drug: OE 200 mg celecoxib capsule; Drug: Matched placebo for OE amlodipine besylate tablet; Drug: Matched placebo for OE celecoxib capsule Sponsor: Kitov Pharma Ltd Completed Thu, 01 Dec 2016 12:00:00 EST Amlodipine Plus/Minus Atorvastatin for Protection of ArteriesCondition: Arterial and Arteriolar DisordersInterventions: Drug: amlodipine plus atorvastatin (Caduet); Drug: amlodipine (Norvasc) Sponsor: Shanghai Institute of Hypertension Unknown status Wed, 14 Aug 2013 12:00:00 EDT
Effects of Aliskiren/Amlodipine Versus Amlodipine Monotherapy on Ankle-foot Volume in Hypertensive PatientsCondition: HypertensionIntervention: Drug: aliskiren/amlodipine Sponsor: University of Pavia Unknown status Wed, 13 Jan 2010 12:00:00 EST Amlodipine Use in the Prevention and Treatment of Iron Overload in Patients With Thalassemia MajorCondition: Thalassemia MajorIntervention: Drug: Amlodipine Sponsors: University of Campinas, Brazil; Fundação de Amparo à Pesquisa do Estado de São Paulo Completed Tue, 18 May 2010 12:00:00 EDT The Effect of Losartan Versus Amlodipine-based Therapy in Ischemic Stroke (0954-338)(COMPLETED)Condition: Ischemic StrokeInterventions: Drug: losartan; Drug: amlodipine Sponsor: Taipei Veterans General Hospital, Taiwan Completed Thu, 18 Sep 2008 12:00:00 EDT A Pilot Study Exploring Efficacy and Safety of Amlodipine in the Stented Angina PatientsCondition: Coronary Artery DiseaseInterventions: Drug: Placebo; Drug: Amlodipine Sponsor: Seoul National University Hospital Unknown status Mon, 10 May 2010 12:00:00 EDT Perindopril Amlodipine for the Treatment of HypertensionCondition: Essential HypertensionInterventions: Drug: XOMA 985; Drug: Amlodipine Besylate; Drug: Perindopril Erbumine Sponsor: Symplmed Pharmaceuticals LLC Completed Mon, 19 Mar 2012 12:00:00 EDT Assessment of Aliskiren/Amlodipine and Amlodipine on Ankle Foot Volume (AFV) in Patients With HypertensionConditions: Hypertension; Ankle EdemaInterventions: Drug: Aliskiren/amlodipine; Drug: Amlodipine; Drug: Placebo to Aliskiren/amlodipine; Drug: Placebo to Amlodipine Sponsor: Novartis Pharmaceuticals Terminated Thu, 04 Mar 2010 12:00:00 EST Bioequivalence Study of Amlodipine Tablets Under Fasting ConditionsCondition: HealthyIntervention: Drug: amlodipine 10 mg tablet Sponsor: Ranbaxy Laboratories Limited Completed Mon, 20 Oct 2008 12:00:00 EDT Study on Anti-inflammatory Effect of Anti-hypertensive Treatment in Patients With Small AAA's and Mild HypertensionConditions: Hypertension; Abdominal Aortic AneurysmInterventions: Drug: Aliskiren; Drug: Amlodipine Sponsors: VU University Medical Center; Novartis Terminated Mon, 29 Aug 2011 12:00:00 EDT Bioequivalence Study of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female VolunteersCondition: HealthyInterventions: Drug: Telmisartan/Amlodipine; Drug: Telmisartan; Drug: Amlodipine Sponsor: Boehringer Ingelheim Completed Thu, 09 Oct 2014 12:00:00 EDT Pharmacokinetics of Telmisartan Alone and in Combination With Amlodipine in Healthy VolunteersCondition: HealthyInterventions: Drug: Telmisartan; Drug: Amlodipine Sponsor: Boehringer Ingelheim Completed Thu, 09 Oct 2014 12:00:00 EDT
Bioequivalence Study of Amlodipine 10mg Tablets Under Fed ConditionsCondition: HealthyIntervention: Drug: amlodipine 10 mg tablet Sponsor: Ranbaxy Laboratories Limited Completed Mon, 20 Oct 2008 12:00:00 EDT Sacubitril/Valsartan Versus Amlodipine in Hypertension and Left Ventricular Hypertrophy.Conditions: Hypertension; Left Ventricular HypertrophyInterventions: Drug: sacubitril/valsartan; Drug: Amlodipine Sponsor: Shanghai Jiao Tong University School of Medicine Not yet recruiting Fri, 18 Jun 2021 12:00:00 EDT Amlodipine VaLsartan Efficacy in Hypertensive Patients.A Real World TrialCondition: Essential HypertensionIntervention: Drug: Valsartan, Amlodipine - Sponsor: PharmEvo Pvt Ltd Completed Wed, 13 Dec 2017 12:00:00 EST Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Amlodipine 5 mg MonotherapyCondition: HypertensionInterventions: Drug: irbesartan/amlodipine; Drug: amlodipine Sponsor: Sanofi Completed Tue, 11 Aug 2009 12:00:00 EDT Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine in Subjects With Hypertension Requiring Antihypertensive TherapyCondition: HypertensionInterventions: Drug: Over-encapsulated 10 mg amlodipine besylate tablet; Drug: Matched placebo capsule for over-encapsulated celecoxib capsule; Drug: Over-encapsulated 200 mg celecoxib capsule; Drug: Matched placebo capsule for over-encapsulated amlodipine besylate tablet Sponsor: Kitov Pharmaceuticals, Ltd. Completed Tue, 24 Jun 2014 12:00:00 EDT The Effects of Systolic Blood Pressure Lowering on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic DysfunctionConditions: Hypertension; Diastolic DysfunctionInterventions: Drug: valsartan; Drug: amlodipine Sponsor: Novartis Pharmaceuticals Completed Fri, 31 Aug 2007 12:00:00 EDT Fimasartan/Amlodipine Combination Phase IIICondition: Essential HypertensionInterventions: Drug: Fimasartan and Amlodipine; Drug: Fimasartan Sponsors: Boryung Pharmaceutical Co., Ltd; Gachon University Gil Medical Center; The Catholic University of Korea; Kangbuk Samsung Hospital; Kyungpook National University Hospital; Keimyung University Dongsan Medical Center; Korea University Guro Hospital; Korea University Anam Hospital; DongGuk University; Dong-A University Hospital; Pusan National University Hospital; Seoul National University Bundang Hospital; Seoul National University Hospital; Asan Medical Center; Pusan National University Yangsan Hospital; Wonju Severance Christian Hospital; Gangnam Severance Hospital; Severance Hospital; Ulsan University Hospital; Inje University; Inje University Haeundai Paik Hospital; Chonnam National University Hospital; Jeju National University Hospital; Chungnam National University; Hanyang University Seoul Hospital Completed Mon, 02 Jun 2014 12:00:00 EDT Effect of Amlodipine Versus Bisoprolol on Hypertensive Patients With End-stage Renal Disease on Maintenance Hemodialysis.Condition: Hypertension, RenalInterventions: Drug: Bisoprolol Fumarate 5-10 mg; Drug: Amlodipine 5-10 mg Sponsors: Alexandria University; Damanhour University Completed Wed, 11 Sep 2019 12:00:00 EDT Telmisartan and Amlodipine Versus Monocomponent TabletsCondition: HypertensionInterventions: Drug: Telmisartan/Amlodipine Combination Tablet; Drug: Amlodipine Monocomponent Sponsor: Boehringer Ingelheim Completed Wed, 19 Jan 2011 12:00:00 EST Efficacy and Safety of TAH Combination in Comparison With Telmisartan/Amlodipine Combination for Essential Hypertension PatientsCondition: Essential HypertensionInterventions: Drug: Telmisartan/Amlodipine+Hydrochlorothiazide; Drug: Telmisartan/Amlodipine; Drug: Placebo for Hydrochlorothiazide Sponsor: IlDong Pharmaceutical Co Ltd Completed Thu, 14 Apr 2016 12:00:00 EDT
Bariatric Surgery and Pharmacokinetics of AmlodipineCondition: Obesity, MorbidIntervention: Drug: Amlodipine Sponsors: Norwegian University of Science and Technology; St. Olavs Hospital; Volvat Medisinsk Senter Stokkan; Namsos Hospital; Alesund Hospital Recruiting Fri, 16 Sep 2016 12:00:00 EDT Study Comparing the Efficacy of Amlodipine Besylate/Benazepril Versus Amlodipine in the Treatment of Severe HypertensionCondition: HypertensionIntervention: Drug: amlodipine besylate/benazepril hydrochloride Sponsor: Novartis Pharmaceuticals Completed Mon, 29 Aug 2005 12:00:00 EDT Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes MellitusConditions: Hypertension; Diabetes MellitusInterventions: Drug: Amlodipine; Drug: Hydrochlorothiazide (HCTZ); Drug: Aliskiren Sponsor: Novartis Completed Fri, 07 Nov 2008 12:00:00 EST Amlodipine as Adjuvant Treatment to Iron Chelation for Prevention of Cardiac Iron Overload in Thalassemia PatientsConditions: Beta-Thalassemia; Iron OverloadInterventions: Drug: Amlodipine; Drug: Deferasirox Sponsor: Kevin H.M. Kuo, MD, MSc, FRCPC Unknown status Wed, 17 Jun 2015 12:00:00 EDT Treatment of Early Hypertension Among Persons Living With HIV in HaitiConditions: HIV/AIDS; Pre HypertensionIntervention: Drug: Amlodipine 5mg Sponsors: Weill Medical College of Cornell University; Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic; Fogarty International Center of the National Institute of Health Recruiting Thu, 31 Dec 2020 12:00:00 EST Bioequivalence Study (Candesartan 16 mg and Amlodipine 10 mg)Condition: HypertensionInterventions: Drug: HL068 16/10mg; Drug: Candesartan 16mg and Amlodipine 10mg Sponsor: HanAll BioPharma Co., Ltd. Unknown status Fri, 09 Dec 2016 12:00:00 EST Efficacy and Safety of S-amlodipine 2,5 mg and 5 mg in Hypertension PatientsCondition: HypertensionIntervention: Drug: S-NOR (s-amlodipine) 2,5 mg & 5 mg tablet Sponsor: Neutec Ar-Ge San ve Tic A.Ş Completed Tue, 31 Jan 2017 12:00:00 EST Aliskiren or Amlodipine in Hypertensive Hemodialysed PatientsConditions: Hypertension; DialysisIntervention: Drug: Aliskiren Sponsors: University of Campania "Luigi Vanvitelli"; IRCCS San Raffaele Unknown status Thu, 14 Jul 2011 12:00:00 EDT Telmisartan Fixed Dose Combination vs Amlodipine in Hypertensive Patients With Type 2 Diabetes MellitusCondition: HypertensionInterventions: Drug: Telmisartan 80; Drug: Amlodipine 10 Sponsor: Boehringer Ingelheim Completed Wed, 08 Apr 2009 12:00:00 EDT A National Multicentre Study to Assess the Efficacy of the Fixed Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled by MonotherapyCondition: Primary HypertensionIntervention: Drug: valsartan/amlodipine Sponsor: Novartis Completed Tue, 16 Nov 2010 12:00:00 EST
Losartan/Amlodipine on Hemodynamics Parameters and Arterial Stiffness in Arterial HypertensionCondition: HypertensionInterventions: Drug: Losartan and Amlodipine; Drug: Losartan Sponsor: Centro Universitario de Ciencias de la Salud, Mexico Unknown status Fri, 10 Aug 2018 12:00:00 EDT 18 Week Study Evaluating Safety and Efficacy of Olmesartan, Amlodipine, and Hydrochlorothiazide, in Type 2 DiabeticsConditions: Type 2 Diabetes; HypertensionInterventions: Drug: Amlodipine; Drug: amlodipine / olmesartan medoxomil combination; Drug: Hydrochlorothiazide Sponsor: Daiichi Sankyo, Inc. Completed Wed, 09 Apr 2008 12:00:00 EDT PMS Study of Amlodipine/Valsartan for the Treatment of HypertensionCondition: Essential HypertensionIntervention: Drug: Amlodipine/Valsartan Sponsor: TSH Biopharm Corporation Limited Completed Mon, 10 Feb 2014 12:00:00 EST A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate MonotherapyCondition: Essential HypertensionInterventions: Drug: Amlodipine 5mg; Drug: Amlodipine 5mg, Candesartan cilexetil 16mg; Drug: Amlodipine 10mg, Candesartan cilexetil 16mg Sponsor: HK inno.N Corporation Unknown status Mon, 23 Feb 2015 12:00:00 EST Amlodipine Versus Nifedipine ER for the Management of Postpartum HypertensionCondition: Hypertension in PregnancyInterventions: Drug: Amlodipine; Drug: NIFEdipine ER Sponsor: Prisma Health-Upstate Recruiting Wed, 10 Mar 2021 12:00:00 EST Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic HypertensionCondition: Stage 2 Systolic HypertensionInterventions: Drug: valsartan, amlodipine, HCTZ; Drug: Losartan, HCTZ followed by valsartan, amlodipine, HCTZ Sponsor: Novartis Completed Thu, 02 Jul 2009 12:00:00 EDT Bioequivalence Trial of Concor AM® vs Bisoprolol and Amlodipine in Chinese ParticipantsCondition: HealthyInterventions: Drug: Bisoprolol-Amlodipine FDC; Drug: Bisoprolol; Drug: Amlodipine Sponsor: Merck KGaA, Darmstadt, Germany Completed Fri, 21 Jul 2017 12:00:00 EDT A Bioequivalence Study of Valsartan / Amlodipine From Valsartan and Amlodipine Tablets (Hua Yuan Pharmaceutical LLC, China) and Valsartan and Amlodipine Tablets (Ⅰ) (Novartis Pharma Schweiz AG, Switzerland)Condition: HealthyIntervention: Drug: Valsartan and Amlodipine Tablets Sponsor: Second Affiliated Hospital of Wenzhou Medical University Unknown status Wed, 11 Sep 2019 12:00:00 EDT Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled HypertensionCondition: HypertensionInterventions: Drug: Amlodipine; Drug: Olmesartan medoxomil; Drug: Amlodipine+valsartan; Drug: Hydrochlorothiazide Sponsor: Novartis Completed Fri, 31 Aug 2007 12:00:00 EDT Efficacy/Safety of Amlodipine Plus Losartan Versus Losartan in Patients With Essential HypertensionCondition: HypertensionInterventions: Drug: Amlodipine plus Losartan; Drug: Losartan Sponsor: Hanmi Pharmaceutical Company Limited Completed Thu, 16 Jul 2009 12:00:00 EDT
China Stroke Primary Prevention Trial for Subjects With Hypertension and MTHFR 677 TT Genotype (CSPPT2-TT)Condition: HypertensionInterventions: Drug: Amlodipine besylate tablets; Drug: Amlodipine besylate And Folic Acid Tablets; Drug: Folic Acid Tablets Sponsors: Shenzhen Ausa Pharmed Co.,Ltd; Shenzhen CCHRPP Biomedical Institute; Peking University First Hospital; Second Affiliated Hospital of Nanchang University; The First People's Hospital of Lianyungang; First Affiliated Hospital of Harbin Medical University; The First Affiliated Hospital of Shanxi Medical University Not yet recruiting Fri, 23 Jul 2021 12:00:00 EDT Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)Conditions: Hypertension; Angina Pectoris; Hypercholesterolemia; Familial HypercholesterolemiaIntervention: Drug: Amlodipine/Atorvastatin Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. Completed Wed, 21 Apr 2010 12:00:00 EDT Amlodipine for Myocardial Iron in ThalassemiaCondition: ThalassemiaInterventions: Drug: Standard Chelation; Drug: Amlodipine Sponsor: Aga Khan University Completed Wed, 19 Feb 2014 12:00:00 EST Combination of Fimasartan/Amlodipine/Rosuvastatin in Patients With Essential Hypertension and DyslipidemiaConditions: Essential Hypertension; DyslipidemiaInterventions: Drug: Fimasartan/Amlodipine, Rosuvastatin; Drug: Fimasartan/Amlodipine; Drug: Fimasartan, Rosuvastatin Sponsor: Boryung Pharmaceutical Co., Ltd Completed Wed, 17 May 2017 12:00:00 EDT Effectiveness of Valsartan/Amlodipine (EXforge®) and Nifedipine treAtment coMparison in Treating Chinese Hypertensive PatientsCondition: HypertensionInterventions: Drug: Valsartan/Amlodipine; Drug: Nifedipine Sponsor: Novartis Completed Thu, 22 Jul 2010 12:00:00 EDT Amlodipine Prevents Morning Blood Pressure Surge StudyCondition: HypertensionInterventions: Drug: Amlodipine (Norvasc®); Drug: Nifedipine GITS (Adalat® XL 30 Sponsor: Shanghai Jiao Tong University School of Medicine Completed Fri, 11 Dec 2009 12:00:00 EST Amlodipine Versus Valsartan for Improvement of Diastolic Dysfunction Associated With HypertensionCondition: HypertensionInterventions: Drug: Amlodipine; Drug: Valsartan Sponsors: Asan Medical Center; Yuhan Corporation Completed Fri, 25 Nov 2016 12:00:00 EST Study to Determine the Bioequivalence of Two Fixed Dose Combination (FDC) Tablet Formulations of Amlodipine and Losartan FDC5/50 and FDC5/100 Under Fasting ConditionsCondition: HypertensionInterventions: Drug: Reference Treatment: 5 mg amlodipine + 50 mg losartan; Drug: Reference Treatment:5 mg amlodipine + 100 mg losartan; Drug: FDC 5/50 amlodipine/ losartan; Drug: FDC 5/100 amlodipine /losartan Sponsor: GlaxoSmithKline Completed Mon, 25 Feb 2013 12:00:00 EST Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients Not Adequately Responding to Aliskiren AloneCondition: HypertensionInterventions: Drug: Aliskiren 300 mg; Drug: Aliskiren/Amlodipine 300/5 mg; Drug: Aliskiren/Amlodipine 300/10 mg; Drug: Placebo to Aliskiren; Drug: Placebo to Aliskiren/Amlodipine Sponsor: Novartis Completed Wed, 22 Oct 2008 12:00:00 EDT Efficacy and Safety of Combination Therapy of Aliskiren/Amlodipine or Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Stage II HypertensionCondition: Stage II HypertensionIntervention: Drug: Aliskiren/Amlodipine (150/5 mg/day, 300/10 mg/day) , Aliskiren/Amlodipine/Hydrochlorothiazide (300/10/12.5 mg/day, 300/10/25 mg/day) Sponsor: Novartis Completed Wed, 17 Feb 2010 12:00:00 EST
Telmisartan and Amlodipine Fixed Dose Combination [FDC] Trial for the Treatment of Severe HypertensionCondition: HypertensionInterventions: Drug: amlodipine; Drug: telmisartan; Drug: telmisartan and amlodipine Sponsor: Boehringer Ingelheim Completed Thu, 12 Mar 2009 12:00:00 EDT Anti Inflammatory Treatment of HypertensionCondition: HypertensionInterventions: Drug: Levamlodipine; Drug: Amlodipine Sponsors: Affiliated Hospital of North Sichuan Medical College; First Hospitals affiliated to the China PLA General Hospital Completed Fri, 05 Feb 2021 12:00:00 EST Evaluation of the Metabolic Effects of LCZ696 and Amlodipine in Obese Hypertensive SubjectsConditions: Hypertension; Concurrent ObesityInterventions: Drug: LCZ696; Drug: amlodipine; Drug: Placebo Sponsor: Novartis Pharmaceuticals Completed Fri, 29 Jun 2012 12:00:00 EDT Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipineConditions: Essential Hypertension; HyperlipidemiaInterventions: Drug: Telmisartan 80mg, S-amlodipine 5mg and Atorvastatin 40mg; Drug: Telmisartan 80mg and S-amlodipine 5mg Sponsor: Chong Kun Dang Pharmaceutical Completed Mon, 29 Apr 2013 12:00:00 EDT The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Adult Volunteers VolunteersCondition: Hypertension With DyslipidemiaInterventions: Drug: JLP-1401; Drug: Telmisartan/Amlodipine, Rosuvastatin Sponsor: Jeil Pharmaceutical Co., Ltd. Completed Tue, 16 Oct 2018 12:00:00 EDT An Assessment of Long Term Safety of the Combination of Aliskiren / Amlodipine in Patients With High Blood PressureCondition: HypertensionInterventions: Drug: Aliskiren; Drug: Amlodipine; Drug: Hydrochlorothiazide Sponsor: Novartis Completed Wed, 22 Nov 2006 12:00:00 EST To Demonstrate Non-inferiority of Combination of 5 mg Amlodipine/ 80 mg Valsartan to 160 mg Valsartan AloneConditions: Hypertension; High Blood PressureInterventions: Drug: Amlodipine 5mg/Valsartan 80 mg; Drug: Valsartan Sponsor: Novartis Completed Wed, 17 Feb 2010 12:00:00 EST Study of Efficacy and Safety of CVAA489 in Hypertensive PatientsCondition: Essential HypertensionIntervention: Drug: amlodipine/valsartan Sponsor: Novartis Pharmaceuticals Completed Fri, 14 Feb 2014 12:00:00 EST Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399)Condition: HypertensionInterventions: Drug: Losartan (+) amlodipine; Drug: Placebo to match losartan/amlodipine tablets; Drug: Amlodipine camsylate; Drug: Placebo to match amlodipine Sponsor: Merck Sharp & Dohme Corp. Completed Mon, 17 Jan 2011 12:00:00 EST The PK Characteristics of the Co-administration of Rosuvastatin and Telmisartan/Amlodipine and JLP-1401 in Healthy Male Volunteers VolunteersCondition: Hypertension With DyslipidemiaInterventions: Drug: JLP-1401; Drug: Telmisartan/Amlodipine, Rosuvastatin Sponsor: Jeil Pharmaceutical Co., Ltd. Completed Fri, 11 Aug 2017 12:00:00 EDT
Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and CandesartanCondition: HypertensionInterventions: Drug: Group I; Drug: Group II Sponsor: HK inno.N Corporation Unknown status Thu, 27 Jul 2017 12:00:00 EDT An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential HypertensionCondition: HypertensionInterventions: Drug: Amlodipine; Drug: TCV-116CCB; Drug: Amlodipine Placebo; Drug: TCV-116CCB Placebo Sponsor: Takeda Withdrawn Mon, 21 Nov 2016 12:00:00 EST Efficacy and Safety of LCZ696 200 mg + Amlodipine 5 mg in Comparison With Amlodipine 5 mg in Hypertensive Patients Not Responding to AmlodipineCondition: Essential HypertensionInterventions: Drug: LCZ696; Drug: Amlodipine; Drug: Placebo Sponsor: Novartis Pharmaceuticals Completed Mon, 13 Aug 2012 12:00:00 EDT Study to Evaluate the Bioavailability of the Test Formulation of Amlodipine 10 mg Tablets (Torrent Pharmaceuticals Limited) Compared to a 10 mg Dose of Norvasc® (Pfizer) in 18 Fed, Healthy Adult SubjectsCondition: HealthyInterventions: Drug: Amlodipine Besylate; Drug: Norvasc Sponsor: Torrent Pharmaceuticals Limited Completed Fri, 03 Jul 2009 12:00:00 EDT Short-term Effects of Perindopril-amlodipine Versus Perindopril-indapamide in Type 2 DiabetesConditions: Diabetes Mellitus, Type 2; HypertensionInterventions: Drug: Perindopril and Amlodipine; Drug: Perindopril-indapamide Sponsors: Yaounde Central Hospital; University of Yaounde 1 Completed Tue, 20 Nov 2018 12:00:00 EST Study to Evaluate the Bioavailability of the Test Formulation of Amlodipine 10 mg Tablets (Torrent Pharmaceuticals Limited) Compared to a 10 mg Dose of Norvasc® (Pfizer) in 22 Fasted, Healthy Adult SubjectsCondition: HealthyInterventions: Drug: Amlodipine besylate; Drug: Norvasc Sponsor: Torrent Pharmaceuticals Limited Completed Fri, 03 Jul 2009 12:00:00 EDT Efficacy and Safety of Levamlodipine Besylate Compared to Amlodipine Maleate in Patients With Essential HypertensionCondition: Essential HypertensionInterventions: Drug: Levamlodipine besylate; Drug: Amlodipine maleate Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. Completed Thu, 27 May 2010 12:00:00 EDT Additive Beneficial Effects of Atorvastatin Combined With Amlodipine In Treatment of HypertensionCondition: HypertensionIntervention: Drug: statin, amlodipine Sponsor: Gachon University Gil Medical Center Completed Tue, 26 Aug 2008 12:00:00 EDT Effect of Spirulina Compared to Amlodipine on Cardiac Iron Overload in Children With Beta ThalassemiaCondition: Beta Thalassemia MajorInterventions: Drug: Spirulina; Drug: Amlodipine Sponsor: Tanta University Completed Tue, 02 Feb 2016 12:00:00 EST Comparison of Sevikar® and the Combination of Perindopril/Amlodipine on Central Blood PressureCondition: HypertensionInterventions: Drug: Perindopril + amlodipine + if necessary, hydrochlorothiazide; Drug: olmesartan/amlodipine + hydrochlorothiazide, if necessary. Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company Completed Fri, 09 Apr 2010 12:00:00 EDT
Telmisartan+Amlodipine Fixed Dose Combination in HypertensionCondition: HypertensionIntervention: Drug: telmisartan+amlodipine fixed dose combination Sponsor: Boehringer Ingelheim Completed Fri, 17 Sep 2010 12:00:00 EDT CKD-828 S-Amlodipine Non-Responder TrialCondition: HypertensionInterventions: Drug: CKD-828 2.5/40mg; Drug: CKD-828 2.5/80mg; Drug: S-Amlodipine 2.5mg Sponsor: Chong Kun Dang Pharmaceutical Completed Thu, 29 Dec 2011 12:00:00 EST Fixed vs Free Dose of ACEi/CCB Combination TherapyCondition: HypertensionIntervention: Drug: Perindopril/Amlodipine Sponsor: Guido Iaccarino Completed Mon, 19 Dec 2016 12:00:00 EST Comparison of Aliskiren and Amlodipine on Insulin Resistance and Endothelial Dysfunction in Patients With Hypertension and Metabolic SyndromeConditions: High Blood Pressure; Metabolic Syndrome; Insulin Resistance; Endothelial DysfunctionInterventions: Drug: Aliskiren; Drug: Amlodipine; Drug: Placebo Aliskiren; Drug: Placebo Amlodipine Sponsor: Novartis Pharmaceuticals Completed Fri, 29 Dec 2006 12:00:00 EST A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential HypertensionCondition: Essential HypertensionInterventions: Drug: Amlodipine 5mg; Drug: Amlodipine 10mg; Drug: Candesartan Cilexetil 8mg; Drug: Candesartan cilexetil 16mg Sponsor: HK inno.N Corporation Unknown status Tue, 11 Feb 2014 12:00:00 EST Effects of Metoprolol and Amlodipine on Cardiac Remodeling, Arrhythmias and Blood Pressure Variation in Hypertensive Patients With Sleep Apnea SyndromeConditions: Sleep Apnea Syndrome; HypertensionInterventions: Drug: Amlodipine; Drug: metoprolol Sponsor: First Affiliated Hospital of Harbin Medical University Unknown status Fri, 03 Apr 2015 12:00:00 EDT Calcium Channel Blockade in Primary AldosteronismConditions: Primary Aldosteronism; Primary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)Intervention: Drug: Amlodipine Sponsors: Brigham and Women's Hospital; University of Michigan Recruiting Tue, 26 Nov 2019 12:00:00 EST Bioavailability Study Comparing 10 Mg Amlodipine Besylate Orally Disintegrating Tablet (ODT) And 10 Mg Amlodipine Besylate TabletsCondition: Healthy VolunteersInterventions: Drug: Amlodipine - reference; Drug: Amlodipine ODT - test Sponsors: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Aurobindo Pharma Ltd; Trident Life Sciences Ltd. Completed Mon, 07 Jun 2010 12:00:00 EDT Drug-drug Interaction Following Oral Administration of Telmisartan/Amlodipine and Atorvastatin in Healthy Adult VolunteersCondition: Hypertension With HyperlipidemiaIntervention: Drug: telmisartan/amlodipine and atorvastatin Sponsor: Jeil Pharmaceutical Co., Ltd. Completed Fri, 09 Mar 2018 12:00:00 EST Long Term Study Of Amlodipine 10mg With Hypertension For Whom Amlodipine 5mg Is InsufficientCondition: HypertensionIntervention: Drug: Amlodipine Sponsor: Pfizer Completed Tue, 06 Mar 2007 12:00:00 EST
Irbesartan Versus Amlodipine: The OBI StudyConditions: Obesity; HypertensionInterventions: Drug: Irbesartan; Drug: Amlodipine Sponsor: Aristotle University Of Thessaloniki Withdrawn Thu, 01 Oct 2009 12:00:00 EDT A Bioequivalence Study of Amlodipine / Valsartan From Amlodipine/Valsartan 10/160 Tablets (Pharmacare, Palestine) and Exforge Tablets (Novartis Pharma, USA)Condition: HealthyInterventions: Drug: Amlodipine/Valsartan; Drug: Exforge Sponsors: Genuine Research Center, Egypt; Pharmacare PLC, Palestine Completed Mon, 10 Aug 2015 12:00:00 EDT Safety and Pharmacokinetics Study of amlodipine10mg and candesartan32mgCondition: HypertensionInterventions: Drug: Candesartan32mg; Drug: Amlodipine10mg Sponsor: HanAll BioPharma Co., Ltd. Completed Thu, 07 Mar 2013 12:00:00 EST Bioequivalence Study of CJ-30059Condition: Healthy VolunteersInterventions: Drug: Candesartan cilexetil 16 mg and Amlodipine besylate 10mg (Reference); Drug: CJ-30059 (Test) Sponsor: HK inno.N Corporation Unknown status Wed, 25 Jun 2014 12:00:00 EDT Drug Interaction Study of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male SubjectsCondition: Drug-Drug InteractionIntervention: Drug: Fimasartan/Amlodipine combination drug, Hydrochlorothiazide Sponsor: Boryung Pharmaceutical Co., Ltd Completed Thu, 04 Jan 2018 12:00:00 EST TElmisartan and AMlodipine Single Pill sTudy With Patients Not on Goal With Mono rAas Therapy-switchCondition: HypertensionIntervention: Drug: telmisartan/amlodipine Sponsor: Boehringer Ingelheim Completed Wed, 02 Jun 2010 12:00:00 EDT Blood Pressure Lowering of Aliskiren Hydrochlorothiazide (HCTZ) Versus Amlodipine in Stage 2 Hypertension in African AmericansCondition: HypertensionInterventions: Drug: Aliskiren Hydrochlorothiazide (HCTZ): 8 weeks; Drug: Amlodipine: 8 weeks Sponsor: Novartis Pharmaceuticals Completed Fri, 22 Aug 2008 12:00:00 EDT Bioequivalency Study of Amlodipine Tablets Under Fed ConditionsConditions: Hypertension; Chronic Stable Angina; Vasospastic AnginaIntervention: Drug: Amlodipine Sponsor: Roxane Laboratories Completed Mon, 28 Jan 2008 12:00:00 EST Bioequivalency Study of Amlodipine Tablets Under Fasting ConditionsConditions: Hypertension; Chronic Stable Angina; Vasospastic AnginaIntervention: Drug: Amlodipine Sponsor: Roxane Laboratories Completed Mon, 28 Jan 2008 12:00:00 EST Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fed ConditionsCondition: HealthyInterventions: Drug: Amlodipine-benazepril 10 mg-20 mg capsules; Drug: Lotrel® 10 mg-20 mg capsule Sponsor: Teva Pharmaceuticals USA Completed Tue, 03 Feb 2009 12:00:00 EST
Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fasting ConditionsCondition: HealthyInterventions: Drug: Amlodipine-benazepril 10 mg-20 mg capsules; Drug: Lotrel® 10 mg-20 mg capsule Sponsor: Teva Pharmaceuticals USA Completed Tue, 03 Feb 2009 12:00:00 EST The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) MonotherapyCondition: HypertensionIntervention: Drug: valsartan and amlodipine Sponsor: Novartis Completed Fri, 25 Apr 2008 12:00:00 EDT Effects of Aliskiren and Amlodipine on the Renin-Angiotensin System (RAS) and Lipid/Carbohydrate Metabolism in Obese Patients With HypertensionConditions: Hypertension; Abdominal ObesityInterventions: Drug: Aliskiren; Drug: Amlodipine; Drug: Placebo of Aliskiren; Drug: Placebo of amlodipine Sponsor: Novartis Terminated Tue, 10 Jul 2007 12:00:00 EDT A Study of the Effects of Eplerenone and Amlodipine on Blood Pressure and Basal Metabolic Rate in Obese HypertensivesConditions: Obesity; HypertensionInterventions: Drug: eplerenone, amlodipine; Drug: eplerenone; Drug: amlodipine Sponsor: University of Mississippi Medical Center Terminated Mon, 19 Jan 2009 12:00:00 EST Efficacy/Safety of Valsartan Plus Amlodipine and Valsartan Alone in Patients With HypertensionCondition: HypertensionInterventions: Drug: Valsartan/amlodipine 80/5 mg; Drug: Valsartan 80 mg; Drug: Valsartan 160 mg Sponsor: Novartis Pharmaceuticals Completed Tue, 19 Dec 2006 12:00:00 EST Effects of Amlodipine/Benazepril in the Hypertensive African-American Population With Type 2 Diabetes MellitusCondition: HypertensionIntervention: Drug: Amlodipine/benazepril Sponsor: Novartis Completed Thu, 24 Aug 2006 12:00:00 EDT Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With DyslipidemiaConditions: Dyslipidemias; HypertensionInterventions: Drug: Rosuampin 10/5mg; Drug: Rosuampin 20/5mg; Drug: Amlodipine/Atorvastatin 5/20mg Sponsor: Yuhan Corporation Recruiting Wed, 15 May 2019 12:00:00 EDT Drug-drug-interaction Study of Candesartan, Amlodipine and AtorvastatinCondition: Healthy VolunteersIntervention: Drug: Candesartan, Amlodipine, Atorvastatin Sponsor: Midas Pharma GmbH Completed Tue, 28 Jan 2020 12:00:00 EST CKD-330 Drug-Drug Interaction Study (Candesartan)Condition: HypertensionInterventions: Drug: Candesartan 32mg; Drug: Candesartan 32mg/Amlodipine 10mg Sponsor: Chong Kun Dang Pharmaceutical Completed Mon, 17 Feb 2014 12:00:00 EST Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - BCondition: HypertensionInterventions: Drug: CKD-330 16/5mg - B; Drug: Candesartan 16mg and Amlodipine 5mg Sponsor: Chong Kun Dang Pharmaceutical Completed Thu, 23 Jun 2016 12:00:00 EDT
Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - ACondition: HypertensionInterventions: Drug: CKD-330 16/5mg - A; Drug: Candesartan 16mg and Amlodipine 5mg Sponsor: Chong Kun Dang Pharmaceutical Completed Thu, 16 Jun 2016 12:00:00 EDT Efficacy and Safety of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential HypertensionCondition: Essential HypertensionInterventions: Drug: Valsartan 160 mg capsules; Drug: Amlodipine 5 mg capsules; Drug: placebo Sponsor: Novartis Pharmaceuticals Completed Wed, 21 Feb 2007 12:00:00 EST Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential HypertensionCondition: Essential HypertensionInterventions: Drug: Candesartan Cilexetil 8mg; Drug: Candesartan Cilexetil 16mg; Drug: Amlodipine 5mg; Drug: Amlodipine 10mg Sponsor: Shin Poong Pharmaceutical Co. Ltd. Completed Wed, 26 Oct 2016 12:00:00 EDT Efficacy and Safety of Aliskiren/Ramipril/Amlodipine Compared With Ramipril/Amlodipine and Aliskiren/Amlodipine in Patients With Metabolic SyndromeCondition: Hypertension With Metabolic SyndromeInterventions: Drug: Amlodipine; Drug: Aliskiren; Drug: Ramipril Sponsor: Novartis Terminated Thu, 11 Oct 2007 12:00:00 EDT One Year Study to Evaluate the Safety of the Combination of Valsartan and Amlodipine in Patients With HypertensionCondition: HypertensionIntervention: Drug: valsartan+amlodipine Sponsor: Novartis Completed Mon, 11 Dec 2006 12:00:00 EST Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candesartan Monotherapy in Hypertensive Patients Inadequately Controlled by Candesartan MonotherapyCondition: HypertensionInterventions: Drug: Candesartan 16mg; Drug: Amlodipine 5mg; Drug: Amlodipine 10mg Sponsor: Chong Kun Dang Pharmaceutical Completed Mon, 11 Jan 2016 12:00:00 EST Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Valsartan AloneCondition: HypertensionIntervention: Drug: valsartan/amlodipine Sponsor: Novartis Completed Thu, 15 Sep 2005 12:00:00 EDT Drug Interaction Study of Avanafil and Enalapril or AmlodipineCondition: Erectile DysfunctionInterventions: Drug: avanafil and enalapril; Drug: avanafil and amlodipine Sponsor: VIVUS, Inc. Completed Wed, 05 May 2010 12:00:00 EDT A Study to Evaluate Methodologies for Measuring Swelling of the Leg and Ankle (MK-0000-106)(COMPLETED)Condition: HypertensionInterventions: Drug: Comparator: amlodipine besylate; Drug: Comparator: Placebo Sponsor: Merck Sharp & Dohme Corp. Completed Tue, 11 Nov 2008 12:00:00 EST Clinical Trial of Temisartan/Amlodipine & Rosuvastatin in Subjects With Hypertension and HyperlipidemiaConditions: Hypertension; HyperlipidemiaInterventions: Drug: Temisartan+Amlodipine+Rosuvastatin (Combination drug); Drug: Temisartan+Amlodipine; Drug: Temisartan+Rosuvastatin Sponsor: Yuhan Corporation Completed Wed, 01 Mar 2017 12:00:00 EST
Bioequivalence Study (Candesartan 8 mg and Amlodipine 5 mg)Condition: HypertensionInterventions: Drug: CKD-330 8/5mg; Drug: Candesartan 8mg and Amlodipine 5mg Sponsor: Chong Kun Dang Pharmaceutical Completed Thu, 10 Jul 2014 12:00:00 EDT Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential HypetensionCondition: Essential HypertensionIntervention: Drug: Irbesartan/Amlodipine Sponsor: Handok Inc. Recruiting Tue, 28 Jul 2020 12:00:00 EDT Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential HypertensionCondition: Essential HypertensionInterventions: Drug: Valsartan/amlodipine 160/5 mg; Drug: Valsartan 160 mg; Drug: Placebo Sponsor: Novartis Completed Mon, 26 Oct 2009 12:00:00 EDT Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Irbesartan 150 mg MonotherapyCondition: HypertensionInterventions: Drug: irbesartan/amlodipine; Drug: irbesartan Sponsor: Sanofi Completed Wed, 12 Aug 2009 12:00:00 EDT Clinical Trial to Compare the Safety and Pharmacokinetics of YHP1604 in Comparison to the Co-administration of Telmisartan/Amlodipine and RosuvastatinConditions: Hypertension; HyperlipidemiaInterventions: Drug: Temisartan/Amlodipine+Rosuvastatin; Drug: YHP1604 Sponsor: Yuhan Corporation Completed Mon, 17 Apr 2017 12:00:00 EDT Drug-drug-interaction Study of Ramipril, Amlodipine and AtorvastatinCondition: Healthy VolunteersIntervention: Drug: Ramipril, Amlodipine and Atorvastatin Sponsor: Midas Pharma GmbH Completed Mon, 10 Feb 2020 12:00:00 EST A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With HypertensionCondition: HYPERTENSIONIntervention: Drug: valsartan + amlodipine Sponsor: Novartis Completed Thu, 15 Sep 2005 12:00:00 EDT Efficacy and Safety of Valsartan/Amlodipine Combination in Hypertensive Patients Not Controlled With Amlodipine AloneCondition: HypertensionIntervention: Drug: valsartan/amlodipine Sponsor: Novartis Completed Thu, 15 Sep 2005 12:00:00 EDT Comparison of Tandospirone, Amlodipine and Their Combination in Adults With Hypertension and AnxietyConditions: Hypertension; AnxietyInterventions: Drug: Tandospirone + Amlodipine; Drug: Tandospirone placebo + Amlodipine; Drug: Tandospirone + Amlodipine placebo; Drug: Tandospirone placebo + Amlodipine placebo Sponsor: Chongqing Medical University Unknown status Wed, 12 Sep 2018 12:00:00 EDT Trial Comparing Metabolic Effects of Telmisartan and Amlodipine on Hypertensive Patients With Obesity and DiabetesConditions: Hypertension; Obesity; DiabetesInterventions: Drug: Temisartan; Drug: Amlodipine Sponsor: Third Military Medical University Completed Thu, 19 Feb 2009 12:00:00 EST
Efficacy and Safety of Amlodipine and Losartan in Patients With Essential HypertensionCondition: HypertensionInterventions: Drug: Amlodipine plus Losartan; Drug: Amlodipine; Drug: Losartan Sponsor: Hanmi Pharmaceutical Company Limited Completed Mon, 20 Jul 2009 12:00:00 EDT Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on AmlodipineCondition: Essential HypertensionInterventions: Drug: telmisartan plus hydrochlorothiazide; Device: Amlodipine Sponsor: Tokyo University Completed Tue, 31 Jul 2007 12:00:00 EDT CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin)Conditions: Hypertension; HyperlipidemiaInterventions: Drug: Telmisartan/S-Amlodipine; Drug: Rosuvastatin; Drug: Telmisartan/S-Amlodipine + Rosuvastatin Sponsor: Chong Kun Dang Pharmaceutical Completed Tue, 28 Jan 2014 12:00:00 EST A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Participants With Essential HypertensionCondition: Essential HypertensionInterventions: Drug: Aliskiren; Drug: Amlodipine; Drug: Hydrochlorothiazide Sponsor: Novartis Completed Mon, 28 Apr 2008 12:00:00 EDT Randomized, Open Labeled Clinical Trial to Compare the Effectiveness of Amlodipine/Valsartan vs Hydrochlorothiazide/Telmisartan on Glucose Tolerance in Patients With Hypertension With Metabolic SyndromeCondition: HypertensionInterventions: Drug: amlodipine/valsartan; Drug: hydrochlorothiazide/telmisartan Sponsor: Yonsei University Completed Wed, 27 Mar 2013 12:00:00 EDT A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/RosuvastatinCondition: Hypertension, HyperlipidemiaIntervention: Drug: Fimasartan/Amlodipine combination drug, Rosuvastatin Sponsor: Boryung Pharmaceutical Co., Ltd Completed Fri, 16 Dec 2016 12:00:00 EST Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Essential Hypertension PatientsConditions: Lower Leg Edema; Orthostatic HypertensionInterventions: Drug: Levacalm; Drug: Valsartan/amlodipine Sponsor: LG Life Sciences Unknown status Tue, 14 Apr 2015 12:00:00 EDT DMTA07 Combine With Amlodipine Treatment in Patients With HypertensionCondition: HypertensionInterventions: Drug: AM 5 + DM 0; Drug: AM 5 + DM 2.5; Drug: AM 5 + DM 7.5; Drug: AM 5 + DM 30 Sponsor: TSH Biopharm Corporation Limited Completed Thu, 07 Jun 2012 12:00:00 EDT Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Patients With Hypertension.Condition: HypertensionIntervention: Drug: valsartan+amlodipine combination, valsartan, amlodipine Sponsor: Novartis Completed Mon, 11 Dec 2006 12:00:00 EST The Pharmacokinetic Drug-drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male VolunteersCondition: Healthy Male VolunteerInterventions: Drug: Telmisartan; Drug: Amlodipine; Drug: Rosuvastatin Sponsor: Yuhan Corporation Completed Mon, 08 Sep 2014 12:00:00 EDT
To Compare the Pharmacokinetics of Fimasartan/Amlodipine Combination Tablet and Coadministration of Fimasartan and Amlodipine as Individual TabletsCondition: HypertensionInterventions: Drug: Fimasartan; Drug: Amlodipine; Drug: Fimasartan/Amlodipine combination Sponsors: Boryung Pharmaceutical Co., Ltd; Kyunghee university hospital A Drug Analytical Laboratory Completed Thu, 31 Jul 2014 12:00:00 EDT Once-daily Fixed Combination of Three Antihypertensive DrugsCondition: Arterial HypertensionInterventions: Drug: perindopril, indapamide , amlodipine; Drug: Tripliam (perindopril, indapamide, amlodipine) Sponsor: University of Roma La Sapienza Unknown status Wed, 16 Mar 2016 12:00:00 EDT Phase Ⅰ Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg Tablet and Novartis Exforge 10/160mg TabletCondition: HealthyIntervention: Drug: CJ Amlodipine/Valsartan 10/160mg Novartis Exforge 10/160mg Sponsor: HK inno.N Corporation Completed Wed, 28 Nov 2012 12:00:00 EST A Drug Interaction Study of Boceprevir in Combination With Amlodipine or Diltiazem in Healthy VolunteersConditions: Hepatitis C; HypertensionInterventions: Drug: Amlodipine; Drug: Diltiazem Sponsors: Ottawa Hospital Research Institute; Merck Sharp & Dohme Corp. Withdrawn Fri, 09 Mar 2012 12:00:00 EST Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg (T80/A5/H12.5 mg) Fixed-dose Combination (FDC) Tablet and T80/H12.5 mg Tab and A5 mg (Encap A2.5 mg Tab x2) Concomitant UseCondition: HealthyInterventions: Drug: Amlodipine 5mg capsule; Drug: T80/H12.5 mg FDC tablet; Drug: T80/A5/H12.5 mg FDC tablet Sponsor: Boehringer Ingelheim Completed Fri, 02 May 2014 12:00:00 EDT A Fixed Dose Combination Amlodipine + Enalapril Bioavailability StudyCondition: HypertensionInterventions: Drug: GSK2944404 FDC; Drug: Amlodipine 5 mg; Drug: Enalapril Maleate 20 mg Sponsor: GlaxoSmithKline Completed Tue, 02 Apr 2013 12:00:00 EDT Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular HypertrophyCondition: Hypertension; Hypertrophy, Left VentricularInterventions: Drug: Valsartan; Drug: Amlodipine; Drug: Hydrochlorothiazide; Drug: Losartan Sponsor: Novartis Completed Tue, 13 Mar 2007 12:00:00 EDT Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Amlodipine and Losartan in Health VolunteersCondition: HypertensionInterventions: Drug: Reference Treatment: 1 x 5mg amlodipine tablet and 1 x 100mg losartan tablet administered in fasted state; Drug: Fixed Dose Combination 1: 1 x 5mg amlodipine / 100mg losartan tablet administered in fasted state; Drug: Fixed Dose Combination 2: 1 x 5mg amlodipine / 100mg losartan tablet administered in fasted state Sponsor: GlaxoSmithKline Completed Tue, 24 Jul 2012 12:00:00 EDT Pharmacokinetic Drug Interactions Between Single and Concomitant Administrations of Amlodipine, Losartan, and Hydrochlorothiazide in Subjects With (Pre)HypertensionCondition: Essential HypertensionIntervention: Drug: multiple dose, crossover study between single and concomitant administrations of amlodipine, losartan, and hydrochlorothiazide Sponsor: Yonsei University Completed Fri, 10 Sep 2010 12:00:00 EDT A Study to Evaluate the Pharmacokinetic Drug Interaction After Oral Concurrent Administration of Fimasartan and Amlodipine in Healthy Male VolunteersCondition: Essential HypertensionInterventions: Drug: Fimasartan; Drug: Amlodipine Sponsor: Boryung Pharmaceutical Co., Ltd Completed Mon, 13 Jul 2009 12:00:00 EDT
Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately ControlledCondition: HypertensionIntervention: Drug: Telminuvo®Tab. 40/2.5mg Sponsor: Chong Kun Dang Pharmaceutical Unknown status Tue, 18 Aug 2015 12:00:00 EDT Clinical Trial to Investigate the Efficacy and Safety of DWJ1351Condition: HealthyInterventions: Drug: DWJ1351(FDC Amlodipine/Olmesartan/Rosuvastatin); Drug: Sevikar and Crestor Sponsor: Daewoong Pharmaceutical Co. LTD. Completed Tue, 27 Nov 2018 12:00:00 EST Bioequivalence of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female VolunteersCondition: HealthyInterventions: Drug: Telmisartan/Amlodipine FDC; Drug: Telmisartan; Drug: Amlodipine Sponsor: Boehringer Ingelheim Completed Thu, 17 Jul 2014 12:00:00 EDT Bioavailability of Telmisartan/Amlodipine Fixed Dose Combination in Healthy Male and Female VolunteersCondition: HealthyInterventions: Drug: Telmisartan/Amlodipine; Other: high fat, high caloric meal Sponsor: Boehringer Ingelheim Completed Thu, 09 Oct 2014 12:00:00 EDT Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male VolunteersCondition: HealthyInterventions: Drug: Telmisartan/amlodipine fixed-dose combination tablet; Drug: Telmisartan; Drug: Amlodipine Sponsor: Boehringer Ingelheim Completed Thu, 09 Oct 2014 12:00:00 EDT Influence of Amlodipine on the Mortality of Patients With End-Stage Renal FailureCondition: Kidney Failure, ChronicInterventions: Drug: Amlodipine; Drug: Placebo Sponsor: Charite University, Berlin, Germany Completed Fri, 29 Jul 2005 12:00:00 EDT Relative Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male VolunteersCondition: HealthyInterventions: Drug: Telmisartan/amlodipine fixed-dose combination (FDC) tablet; Drug: Telmisartan; Drug: Amlodipine Sponsor: Boehringer Ingelheim Completed Thu, 09 Oct 2014 12:00:00 EDT Influence of Food on the Bioavailability of Telmisartan/Amlodipine Fixed Dose Combination in Healthy Japanese Male VolunteersCondition: HealthyInterventions: Drug: Telmisartan/Amlodipine low dose; Drug: Telmisartan/Amlodipine high dose; Other: Japanese meal Sponsor: Boehringer Ingelheim Completed Fri, 10 Oct 2014 12:00:00 EDT Comparison of Valsartan With Amlodipine in Hypertensive Patients With Glucose IntoleranceConditions: Hypertension; Type 2 Diabetes MellitusInterventions: Drug: Valsartan; Drug: Amlodipine Sponsor: Nagoya University Completed Thu, 11 Aug 2005 12:00:00 EDT Amlodipine Diabetic Hypertension Efficacy Response TrialCondition: HypertensionIntervention: Drug: Amlodipine Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. Completed Mon, 12 Sep 2005 12:00:00 EDT
Direct Renin Inhibition Effects on Atherosclerotic BiomarkersConditions: Coronary Artery Disease; Type 2 Diabetes MellitusInterventions: Drug: Aliskiren; Drug: Amlodipine Sponsor: Texas Tech University Health Sciences Center Completed Thu, 08 Jan 2009 12:00:00 EST A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Amlodipine in Healthy Male SubjectsCondition: HypertensionInterventions: Drug: Fimasartan/Amlodipine; Drug: Fimasartan + Amlodipine Sponsor: Boryung Pharmaceutical Co., Ltd Completed Fri, 30 Sep 2016 12:00:00 EDT Diurnal Variation in Hypertensive Stroke PatientsConditions: Hypertension; StrokeIntervention: Drug: Amlodipine, Losartan Sponsor: Hanmi Pharmaceutical Company Limited Completed Fri, 12 Apr 2013 12:00:00 EDT Effects of Amlodipine in the Management of Chronic Heart FailureCondition: Chronic Heart FailureIntervention: Drug: Amlodipine Sponsor: Rennes University Hospital Terminated Fri, 09 Sep 2005 12:00:00 EDT A Study Comparing the Response of Patients With Hypertension to Amlodipine or Amlodipine Plus Benazepril.Condition: HypertensionIntervention: Drug: amlodipine/benazepril Sponsors: Novartis; Pfizer Completed Thu, 15 Sep 2005 12:00:00 EDT Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes MellitusConditions: Type 2 Diabetes; HypertensionIntervention: Drug: amlodipine, hydralazine, terazosin or hydrochlorothiazide Sponsor: Tulane University School of Medicine Completed Mon, 27 Jan 2014 12:00:00 EST The Pleiotropic Effects of Atorvastatin When Combined With Common Antihypertenisve Medications.Condition: HypertensionIntervention: Drug: Amlodipine and Hydrocholorothiazide Sponsor: University of New Mexico Terminated Fri, 11 Apr 2008 12:00:00 EDT Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin.Conditions: Essential Hypertension; HyperlipidemiaInterventions: Drug: Telmisartan 80mg, S-amlodipine 5mg and Atorvastatin 40mg; Drug: atorvastatin 40mg Sponsor: Chong Kun Dang Pharmaceutical Completed Mon, 29 Apr 2013 12:00:00 EDT Safety and Efficacy of Valsartan and Amlodipine Combined and Alone in Hypertensive PatientsCondition: HypertensionInterventions: Drug: valsartan+amlodipine combination; Drug: valsartan; Drug: amlodipine Sponsor: Novartis Completed Mon, 11 Dec 2006 12:00:00 EST Candesartan Cilexetil/Amlodipine Besilate Combination Tablets LD, HD Special Drug Use Surveillance "Hypertension: Long-Term Use"Condition: HypertensionIntervention: Drug: Candesartan cilexetil/Amlodipine besilate Sponsor: Takeda Completed Fri, 21 Feb 2014 12:00:00 EST
Efficacy of a Combination of Amlodipine/Valsartan on 24H Blood Pressure Control With One Nocturnal or Diurnal Intake a DayCondition: HypertensionInterventions: Drug: Amlodipine; Drug: Valsartan Sponsor: Novartis Pharmaceuticals Completed Wed, 18 Jun 2008 12:00:00 EDT Efficacy and Safety of Valsartan/Amlodipine Combination in Patients With Severe HypertensionCondition: HypertensionIntervention: Drug: valsartan/amlodipine Sponsor: Novartis Completed Thu, 15 Sep 2005 12:00:00 EDT Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With HyperlipidemiaCondition: Hypertension With HyperlipidemiaInterventions: Drug: Telmisartan/Amlodipine; Drug: Rosuvastatin; Drug: Telmisartan Sponsor: IlDong Pharmaceutical Co Ltd Completed Mon, 25 Jun 2018 12:00:00 EDT Pharmacokinetics of Different Formulations of Telmisartan, Amlodipine, and Hydrochlorothiazide (HCTZ) in Japanese Healthy Male VolunteersCondition: HealthyInterventions: Drug: Telmisartan/Amlodipine; Drug: Telmisartan/Amlodipine/HCTZ; Drug: Telmisartan/HCTZ Sponsor: Boehringer Ingelheim Completed Tue, 08 Jul 2014 12:00:00 EDT Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential HypertensionCondition: HypertensionInterventions: Drug: Amlodipine 5 mg; Drug: Valsartan 80 mg; Drug: Valsartan 40 mg; Drug: Placebo Sponsor: Novartis Pharmaceuticals Completed Tue, 17 Jun 2008 12:00:00 EDT Safety and Efficacy Study of a Triple Combination Therapy in Subjects With HypertensionCondition: HypertensionInterventions: Drug: Olmesartan medoxomil; Drug: Amlodipine; Drug: Hydrochlorothiazide Sponsor: Daiichi Sankyo, Inc. Completed Tue, 01 Apr 2008 12:00:00 EDT Efficacy and Safety of Valsartan Versus Amlodipine in Postmenopausal Women With HypertensionCondition: HypertensionInterventions: Drug: Valsartan 320 mg; Drug: Amlodipine 10 mg; Drug: Hydrochlorothiazide Sponsor: Novartis Completed Thu, 15 Sep 2005 12:00:00 EDT The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/AmlodipineConditions: Hypertension; HyperlipidemiaInterventions: Drug: Rosuvastatin; Drug: Telmisartan/Amlodipine; Drug: Rosuvastatin and Telmisartan/Amlodipine Sponsor: Jeil Pharmaceutical Co., Ltd. Completed Fri, 13 Mar 2015 12:00:00 EDT A Study to Evaluate the Drug-drug Interaction Between Telmisartan, Amlodipine and HydrochlorothiazideCondition: HealthyInterventions: Drug: Telmisartan 80mg; Drug: Amlodipine10mg; Drug: Hydrochlorothiazide Sponsor: IlDong Pharmaceutical Co Ltd Completed Tue, 26 Mar 2019 12:00:00 EDT Compare Efficacy and Safety of Telmisartan/Hydrochlorothiazide With Telmisartan/Hydrochlorothiazide Plus AmlodipineCondition: HypertensionInterventions: Drug: placebo; Drug: telmisartan + HCTZ; Drug: amlodipine Sponsor: Boehringer Ingelheim Completed Tue, 30 Jul 2013 12:00:00 EDT
Filtered Trial for Amlodipine Non-responderCondition: HypertensionInterventions: Drug: telmisartan+amlodipine; Drug: amlodipine Sponsor: Boehringer Ingelheim Completed Wed, 14 Nov 2007 12:00:00 EST Efficacy Study of PDE-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud PhenomenonCondition: Raynaud PhenomenonIntervention: Drug: Udenafil or Amlodipine Sponsors: Seoul National University Hospital; Dong-A Pharmaceutical Co., Ltd. Completed Thu, 20 Jan 2011 12:00:00 EST Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in HypertensionCondition: Essential HypertensionInterventions: Drug: olmesartan medoxomil + amlodipine + hydroclororthiazide + placebo; Drug: Olmesartan medoxomil + amlodipine + hydrochlorothiazide + placebo; Drug: olmesartan medoxomil + amlodipine + hydroclororthiazide; Drug: olmesartan medoxomil + amlodipine Sponsor: Daiichi Sankyo, Inc. Completed Thu, 18 Jun 2009 12:00:00 EDT Bioequivalence Study For 5 Mg Amlodipine Orally-Disintegrating TabletCondition: HealthyIntervention: Drug: Amlodipine Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. Completed Fri, 30 Oct 2009 12:00:00 EDT Left Atrial Mechanical Function Improvement After Atrial Fibrillation Catheter AblationCondition: Atrial FibrillationInterventions: Drug: Telmisartan 80 mg and amlodipine 5 mg; Drug: Placebo (for telmisartan and amlodipine) Sponsor: Research Institute for Complex Problems of Cardiovascular Diseases, Russia Completed Tue, 12 Apr 2016 12:00:00 EDT Safety, Tolerability and Pharmacokinetics of Single and Multiple Oral Doses of 40 mg Telmisartan/5 mg Amlodipine and 80 mg Telmisartan/5 mg Amlodipine in Healthy Male VolunteersCondition: HealthyInterventions: Drug: Telmisartan low; Drug: Telmisartan high; Drug: amlodipine Sponsor: Boehringer Ingelheim Completed Fri, 18 Jul 2014 12:00:00 EDT Effect of Calcium Channel Blocker on the Serum Fibrobalst Growth Factor-23 (FGF-23) Levels in Type-2 Diabetic Patients With Proteinuria PurposeCondition: We Searched for the Effects of Calcium Channel Blocker Amlodipine on the Clinical and Laboratory Parameters of Diabetic Patients With Proteinuria.Intervention: Drug: Amlodipine Sponsor: Gulhane School of Medicine Completed Fri, 30 Nov 2012 12:00:00 EST Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in HypertensionCondition: Essential HypertensionInterventions: Drug: Olmesartan medoxomil 40 mg - Amlodipine 10 mg; Drug: Olmesartan 40mg-Amlodipine 10mg-Hydrochlorothiazide 12.5mg; Drug: Olmesartan 40mg-Amlodipine 10mg-Hydrochlorothiazide 25mg; Drug: OLM 40mg-AML 10mg-Hydrochlorothiazide 12.5mg; Drug: OLM 40mg-AML 10mg-Hydrochlorothiazide 25mg Sponsor: Daiichi Sankyo, Inc. Completed Fri, 15 May 2009 12:00:00 EDT Efficacy & Safety Study of YH22162 vs Telmisartan/Amlodipine in Patients With Hypertension Inappropriately Controlled on Telmisartan/Amlodipine TreatmentCondition: HypertensionInterventions: Drug: telmisartan/amlodipine 40/5mg; Drug: YH22162 40/5/12.5 mg; Drug: telmisartan/amlodipine 80/5mg; Drug: YH22162 80/5/25 mg; Drug: telmisartan/amlodipine 40/5mg placebo; Drug: YH22162 40/5/12.5 mg placebo; Drug: telmisartan/amlodipine 80/5mg placebo; Drug: YH22162 80/5/25 mg placebo Sponsor: Yuhan Corporation Completed Wed, 02 Dec 2015 12:00:00 EST Telmisartan Versus Amlodipine in Patients With Mild-to-Moderate HypertensionCondition: HypertensionInterventions: Drug: Telmisartan; Device: Amlodipine; Drug: Placebo Sponsor: Boehringer Ingelheim Completed Fri, 27 Jun 2014 12:00:00 EDT
Phase I Study to Compare the Safety, Pharmacokinetic Profiles of CJ Amlodipine/Valsartan 10/160mg and Novartis Exforge 10/160mgCondition: HealthyInterventions: Drug: CJ Amlodipine/Valsartan 10/160mg; Drug: Novartis Exforge 10/160mg Sponsor: HK inno.N Corporation Completed Mon, 19 Dec 2011 12:00:00 EST Effectiveness of a Valsartan Based Versus an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current MonotherapyCondition: HypertensionInterventions: Drug: valsartan; Drug: amlodipine Sponsor: Novartis Completed Fri, 17 Mar 2006 12:00:00 EST Relative Bioavailability Study of One Amlodipine 10mg Tablet and One Rosuvastatin 20mg Tablet to Two Fixed Dose Combinations of Amlodipine (10mg) and Rosuvastatin (20mg) in Healthy Subjects Under Fasting ConditionsCondition: HypertensionInterventions: Drug: Amlodipine+Rosuvastatin; Drug: GSK3074477 FDC - 1; Drug: GSK3074477 FDC - 2 Sponsors: GlaxoSmithKline; SingHealth Investigational Medicine Unit, Singapore Completed Mon, 03 Mar 2014 12:00:00 EST Efficacy and Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential HypertensionCondition: Essential HypertensionInterventions: Drug: Aliskiren/Amlodipine 150/2.5 mg; Drug: Aliskiren/amlodipine 150/5 mg; Drug: Aliskiren 150 mg; Drug: Amlodipine 2.5 mg; Drug: Placebo of Aliskiren; Drug: Placebo of Amlodipine; Drug: Placebo of Aliskiren/amlodipine 150/2.5 mg; Drug: Placebo of Aliskiren/amlodipine 150/5 mg Sponsor: Novartis Completed Tue, 09 Nov 2010 12:00:00 EST Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive PatientsCondition: HypertensionInterventions: Drug: Valsartan plus Hydrochlorothiazide (80mg/12.5mg); Drug: Amlodipine (5mg) Sponsor: Novartis Completed Wed, 24 Jan 2007 12:00:00 EST Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mgCondition: HypertensionInterventions: Drug: Valsartan/amlodipine 80/5 mg tablets; Drug: Amlodipine 5 mg capsules; Drug: Amlodipine 10 mg capsules; Drug: Atenolol 50 mg tablets; Drug: Atenolol 100 mg tablets Sponsor: Novartis Pharmaceuticals Completed Mon, 02 Jun 2008 12:00:00 EDT A Study to Evaluate the Effects of Manidipine Versus Amlodipine and the Combination of Manidipine Plus Delapril Versus Amlodipine Plus Delapril on Intraglomerular Pressure in Hypertensive PatientsCondition: HypertensionInterventions: Drug: amlodipine 10 mg; Drug: manidipine 20 mg; Drug: amlodipine 5 mg + delapril 30 mg; Drug: manidipine 10 mg + delapril 30 mg Sponsors: University of Erlangen-Nürnberg Medical School; Chiesi Farmaceutici S.p.A. Completed Tue, 04 Mar 2008 12:00:00 EST Study of the Efficacy and Safety of LCZ696 Alone and in Combination With Amlodipine in Patients With HypertensionCondition: HypertensionInterventions: Drug: LCZ696; Drug: Amlodipine; Drug: LCZ696 and amlodipine combination; Drug: Placebo Sponsor: Novartis Pharmaceuticals Withdrawn Thu, 30 May 2013 12:00:00 EDT Levamlodipine Maleate or Amlodipine Besylate for Treatment of Hypertension: A Comparative Effectiveness ResearchCondition: Primary HypertensionIntervention: Sponsors: Peking University First Hospital; Ministry of Science and Technology of the People´s Republic of China; Southern Medical University, China; CSPC Ouyi Pharmaceutical Co., Ltd. Unknown status Wed, 01 May 2013 12:00:00 EDT Amlodipine And Olmesartan Medoxomil In Hypertensive Filipino PatientsCondition: HypertensionIntervention: Drug: Amlodipine + Olmesartan medoxomil Sponsor: Pfizer Terminated Mon, 13 Sep 2010 12:00:00 EDT
Effects of Amlodipine/Benazepril on Albuminuria in Hypertensive Patients With Type 2 Diabetes MellitusCondition: AlbuminuriaIntervention: Drug: amlodipine/benazepril Sponsor: Novartis Completed Mon, 29 Aug 2005 12:00:00 EDT Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant HypertensionCondition: HypertensionInterventions: Drug: fixed dose combination of telmisartan+amlodipine; Drug: amlodipine Sponsor: Boehringer Ingelheim Completed Sun, 04 Nov 2007 12:00:00 EDT Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk HypertensionConditions: Hypertension; Left Ventricular HypertrophyIntervention: Drug: amlodipine/benazepril Sponsor: Novartis Completed Wed, 31 Aug 2005 12:00:00 EDT Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant HypertensionCondition: HypertensionInterventions: Drug: fixed dose combination of telmisartan+amlodipine; Drug: amlodipine Sponsor: Boehringer Ingelheim Completed Thu, 15 Nov 2007 12:00:00 EST Phase I Study to Investigate the Effect on the Blood Pressure After Oral Administration of SK3530 and AmlodipineCondition: HypertensionIntervention: Drug: SK3530 100mg, Placebo, Amlodipine Sponsor: SK Chemicals Co., Ltd. Completed Fri, 29 Feb 2008 12:00:00 EST Irbesartan and Amlodipine Combination in Controlling Blood PressureCondition: HypertensionInterventions: Drug: IRBESARTAN (SR47436); Drug: Amlodipine; Drug: Irbesartan / Amlodipine; Drug: Placebo Sponsor: Sanofi Completed Fri, 31 Jul 2009 12:00:00 EDT BE Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tab - Fed ConditionsCondition: Healthy SubjectsInterventions: Drug: Torrent's Olmesartaan medoxomil, Amlodipine and Hydrochlorothiazide Tablets; Drug: Tribenzor of Daichi Sankyo Inc. USA Sponsor: Torrent Pharmaceuticals Limited Completed Fri, 11 Nov 2016 12:00:00 EST Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential HypertensionCondition: HypertensionInterventions: Drug: Placebo; Drug: Aliskiren 150 mg tablet; Drug: Aliskiren 300 mg tablet; Drug: Amlodipine 5 mg capsule; Drug: Amlodipine 10 mg capsule; Drug: Aliskiren/amlodipine 150/5 mg tablet; Drug: Aliskiren/amlodipine 150/10 mg tablet; Drug: Aliskiren/amlodipine 300/5 mg tablet; Drug: Aliskiren/amlodipine 300/10 mg tablet Sponsor: Novartis Pharmaceuticals Completed Fri, 22 Aug 2008 12:00:00 EDT Study of Efficacy and Safety of Irbesartan/Amlodipine 4 Fixed Combination Therapy in Hypertensive Patients Uncontrolled on Irbesartan or Amlodipine MonotherapyCondition: HypertensionInterventions: Drug: Irbesartan/Amlodipine (150/5mg); Drug: Irbesartan/Amlodipine (150/10mg); Drug: Irbesartan/Amlodipine (300/5mg); Drug: Irbesartan/Amlodipine (300/10mg) Sponsor: Sanofi Completed Thu, 21 Jun 2012 12:00:00 EDT Fed Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mgCondition: HealhtyInterventions: Drug: Amlodipine and Benazepril HCl Capsules 10 mg/20 mg; Drug: Lotrel® Capsules 10 mg/20 mg Sponsor: Mylan Pharmaceuticals Completed Tue, 01 Apr 2008 12:00:00 EDT
Fasting Study of Amlodipine and Benazepril HCl Capsules 10 mg/20 mg to Lotrel® Capsules 10 mg/20 mgCondition: HealthyInterventions: Drug: Amlodipine and Benazepril HCl Capsules 10 mg/20 mg; Drug: Lotrel® Capsules 10 mg/20 mg Sponsor: Mylan Pharmaceuticals Completed Tue, 01 Apr 2008 12:00:00 EDT Amlodipine Plus Botulinum Toxin for Focal DystoniaCondition: Focal DystoniaIntervention: Drug: Amlodipine plus Botulinum toxin Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) Completed Thu, 19 Apr 2001 12:00:00 EDT An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose CombinationCondition: HypertensionInterventions: Drug: telmisartan40/amlodipine5; Drug: telmisartan80/amlodipine5 Sponsor: Boehringer Ingelheim Completed Wed, 20 Feb 2008 12:00:00 EST CKD-828 Drug Interaction Study (Telmisartan)Condition: Healthy Male VolunteersInterventions: Drug: Telmisartan 80mg, S-amlodipine 5mg; Drug: Telmisartan 80mg Sponsors: Chong Kun Dang Pharmaceutical; Asan Medical Center Completed Thu, 19 May 2011 12:00:00 EDT Comparison in Japan T80/A5 (Telmisartan 80 mg and Amlodipine 5 mg) and T40/A5 (Telmisartan 40 mg and Amlodipine 5 mg)Condition: HypertensionInterventions: Drug: 40 mg telmisartan; Drug: 5 mg amlodipine; Drug: 80 mg telmisartan Sponsor: Boehringer Ingelheim Completed Mon, 31 Jan 2011 12:00:00 EST Bioequivalence of Levamlodipine Besylate Tablets in Healthy Chinese SubjectsCondition: Healthy SubjectsInterventions: Drug: Amlodipine 10 mg; Drug: Levamlodipine 5 mg Sponsor: The Affiliated Hospital of Qingdao University Completed Tue, 02 Jun 2020 12:00:00 EDT The Efficacy of a Combination of Telmisartan/S-Amlodipine Compared With Telmisartan MonotherapyCondition: HypertensionInterventions: Drug: Telminuvo®Tab. 40/2.5mg; Drug: Telmitrend®Tab. 80mg Sponsor: Chong Kun Dang Pharmaceutical Completed Thu, 04 Sep 2014 12:00:00 EDT A Study to Evaluate the Combination of Valsartan + Amlodipine in Hypertensive PatientsCondition: HypertensionIntervention: Drug: valsartan + amlodipine Sponsor: Novartis Completed Wed, 25 Oct 2006 12:00:00 EDT Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate DrugsCondition: HypertensionInterventions: Drug: Candesartan 8mg; Drug: Amlodipine 5mg; Drug: CKD-330 8/5mg Sponsor: Chong Kun Dang Pharmaceutical Completed Mon, 14 Sep 2015 12:00:00 EDT Study to Evaluate the Pharmacokinetic Interaction and Safety After Multiple Oral Doses of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male SubjectsCondition: HypertensionInterventions: Drug: Fimasartan; Drug: Amlodipine; Drug: Rosuvastatin Sponsors: Boryung Pharmaceutical Co., Ltd; Inje University Completed Wed, 25 Mar 2015 12:00:00 EDT
Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II HypertensionCondition: HypertensionIntervention: Drug: valsartan + amlodipine Sponsor: Novartis Completed Mon, 10 Jul 2006 12:00:00 EDT Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II HypertensionCondition: HypertensionIntervention: Drug: valsartan + amlodipine Sponsor: Novartis Completed Wed, 19 Jul 2006 12:00:00 EDT Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II HypertensionCondition: HypertensionInterventions: Drug: Amlodipine; Drug: Olmesartan medoxomil plus amlodipine Sponsor: Daiichi Sankyo, Inc. Completed Tue, 11 Sep 2007 12:00:00 EDT The Effect of Amlodipine and Lisinopril on Retinal Autoregulation in Type 1 DiabetesConditions: Type 1 Diabetes; Diabetic Retinopathy; Eye Diseases; Diabetes ComplicationsInterventions: Drug: Amlodipine; Drug: Lisinopril Sponsors: University of Aarhus; Velux Fonden Completed Thu, 15 Jun 2006 12:00:00 EDT Efficacy and Safety of the Combination of Valsartan Plus Amlodipine in Hypertensive Patients Not Adequately Responding to the Combination Therapy With Ramipril Plus FelodipineCondition: HypertensionIntervention: Drug: valsartan + amlodipine Sponsor: Novartis Completed Thu, 24 Aug 2006 12:00:00 EDT Amlodipine/Atorvastatin Combination to Reduce the Health Risk of High Blood Pressure and High Cholesterol LevelsConditions: Hypertension; HyperlipidemiaIntervention: Drug: Amlodipine/atorvastatin single pill Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. Completed Fri, 02 Sep 2005 12:00:00 EDT Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and DyslipidaemiaConditions: Hypertension; DyslipidemiaIntervention: Drug: Amlodipine/Atorvastatin Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. Completed Mon, 29 May 2006 12:00:00 EDT Effects of Fimasartan on Insulin Secretion in Type 2 Diabetic PatientsConditions: Diabetes Mellitus; HypertensionInterventions: Drug: Fimasartan; Drug: Amlodipine Sponsor: Seoul National University Hospital Completed Tue, 09 Dec 2014 12:00:00 EST Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in HypertensionCondition: HypertensionIntervention: Drug: Valsartan, hydrochlorothiazide and amlodipine Sponsor: Novartis Completed Fri, 17 Nov 2006 12:00:00 EST Telmisartan, Amlodipine and Flow Mediated DilationCondition: HypertensionInterventions: Drug: Telmisartan; Drug: Amlodipine; Drug: Olmesartan medoxomil; Drug: Hydrochlorothiazide Sponsor: Johannes Gutenberg University Mainz Unknown status Thu, 12 Aug 2010 12:00:00 EDT
Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential HypertensionCondition: Essential HypertensionInterventions: Drug: Valsartan + amlodipine 40/2.5 mg; Drug: Valsartan + amlodipine 40/5 mg; Drug: Valsartan + amlodipine 80/2.5 mg; Drug: Valsartan + amlodipine 80/5 mg; Drug: Valsartan 40 mg; Drug: Valsartan 80 mg; Drug: Amlodipine 2.5 mg; Drug: Amlodipine 5 mg; Drug: Placebo Sponsor: Novartis Pharmaceuticals Completed Tue, 23 Jan 2007 12:00:00 EST Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current MonotherapyCondition: HypertensionInterventions: Drug: valsartan; Drug: amlodipine Sponsor: Novartis Completed Wed, 12 Jul 2006 12:00:00 EDT The Efficacy And Safety Of Lacidipine And Amlodipine Once-Daily Treatment In Hypertensive Adult PatientsConditions: Uncomplicated Hypertension; Hypertension; EssentialInterventions: Drug: Lacidipine 4 or 6 mg (oral); Drug: Amlodipine 5 or 10 mg(oral) Sponsor: GlaxoSmithKline Completed Tue, 20 Jun 2006 12:00:00 EDT Open Label Study Telmisartan and Amlodipine in HypertensionCondition: HypertensionInterventions: Drug: telmisartan/amlodipine 40/5 mg fixed combination; Drug: telmisartan/amlodipine 80/5 mg fixed combination Sponsor: Boehringer Ingelheim Completed Wed, 13 Feb 2008 12:00:00 EST Efficacy and Safety of Lacidipine and Amlodipine on Blood Pressure in Korean ISH Patients Aged 60 to 80 YearsCondition: HypertensionIntervention: Drug: Lacidipine & Amlodipine Sponsors: Korea University Guro Hospital; GlaxoSmithKline Completed Tue, 17 Apr 2007 12:00:00 EDT Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients HypertensionCondition: HypertensionInterventions: Drug: Valsartan/HCTZ; Drug: amlodipine; Drug: HCTZ Sponsor: Novartis Completed Wed, 24 Jan 2007 12:00:00 EST Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and DiabetesConditions: Hypertension; Stage 2 Hypertension; DiabetesInterventions: Drug: Valturna; Drug: Amlodipine; Drug: Chlorthalidone; Drug: Placebo of Valturna Tablet; Drug: Placebo Capsule Sponsor: Novartis Pharmaceuticals Terminated Wed, 08 Jun 2011 12:00:00 EDT Effects of Amlodipine and Other Blood Pressure Lowering Agents on Microvascular FunctionCondition: Cerebral Small Vessel DiseasesInterventions: Drug: Amlodipine; Drug: Losartan; Drug: Atenolol Sponsors: Ludwig-Maximilians - University of Munich; University of Edinburgh; Maastricht University Medical Center; UMC Utrecht; University of Oxford Recruiting Fri, 17 Mar 2017 12:00:00 EDT 26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in HypertensionCondition: HypertensionInterventions: Drug: fixed-dose combination of telmisartan 40mg+amlodipine 10mg; Drug: fixed-dose combination of telmisartan 80mg+amlodipine10mg Sponsor: Boehringer Ingelheim Completed Tue, 26 Feb 2008 12:00:00 EST Open Label Study To Assess The Effectiveness Of Amlodipine-Atorvastatin Combination In Hypertension And Dyslipidemia.Conditions: Hypertension; HyperlipidemiaIntervention: Drug: Amlodipine/atorvastatin single pill Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. Completed Thu, 15 Sep 2005 12:00:00 EDT
Drug-drug Interaction Study (Telmisartan, Amlodipine, Chlorthalidone)Condition: HypertensionInterventions: Drug: Telmisartan; Drug: Amlodipine; Drug: Chlorthalidone Sponsor: Yuhan Corporation Completed Mon, 02 Jun 2014 12:00:00 EDT Olmesartan and an add-on Treatment in Patients With Mild to Moderate HypertensionCondition: Essential HypertensionIntervention: Drug: olmesartan medoxomil + hydrochlorothiazide, if necessary + amlodipine, if necessary Sponsor: Sankyo Pharma Gmbh Completed Wed, 05 Apr 2006 12:00:00 EDT Personalised Electronic Record Supported Optimisation When Alone for Patients With Hypertension- Pilot Study for Remote Medical Management of Hypertension During the COVID-19 PandemicCondition: HypertensionIntervention: Drug: Amlodipine Sponsors: Queen Mary University of London; Closed Loop Medicine Ltd; Innovate UK Recruiting Tue, 22 Sep 2020 12:00:00 EDT BLOCKade of Calcium Channels and Beta Adrenergic Receptors for the Treatment of Hypertension in HFpEFConditions: Heart Failure With Preserved Ejection Fraction; HypertensionInterventions: Drug: Amlodipine Besylate; Drug: Metoprolol Succinate Sponsors: University of Pennsylvania; Julio Chirinos, MD, PhD; Raymond Townsend, MD Recruiting Wed, 17 Jun 2020 12:00:00 EDT Pharmacokinetic Drug Interaction Study Following Co-administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With HypertensionCondition: HypertensionInterventions: Drug: Valsartan/hydrochlorothiazide (HCTZ); Drug: Valsartan/amlodipine; Drug: Amlodipine/hydrochlorothiazide(HCTZ); Drug: Valsartan/amlodipine/hydrochlorothiazide(HCTZ) Sponsor: Novartis Completed Tue, 23 Oct 2007 12:00:00 EDT A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and HyperlipidemiaConditions: Hypertension; HyperlipidemiasInterventions: Drug: Amlodipine/Olmesartan 10/40mg (Combination drug), Rosuvastatin 20mg; Drug: Olmesartan 40 mg, Rosuvastatin 20mg; Drug: Amlodipine/Olmesartan 10/40mg (Combination drug) Sponsor: Daewoong Pharmaceutical Co. LTD. Unknown status Wed, 04 Jan 2017 12:00:00 EST Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by Serial Volumetric IVUS Analysis(ALPS-J)Conditions: Hypertension; Coronary AtherosclerosisIntervention: Drug: Calcium channel blockers (amlodipine, azelnidipine) Sponsors: Juntendo University; Japan Heart Foundation Completed Wed, 22 Feb 2006 12:00:00 EST Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose CombinationConditions: Adherence to Medication Regime; Hypertensive DiseaseIntervention: Drug: Perindopril/Indapamide/Amlodipine fixed dose combination Sponsor: Servier Hellas Pharmaceuticals Ltd. Completed Wed, 13 Jan 2016 12:00:00 EST Double Blind Atorvastatin Amlodipine StudyCondition: AnginaInterventions: Drug: amlodipine; Drug: atorvastatin Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. Completed Mon, 12 Sep 2005 12:00:00 EDT Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/RosuvastatinCondition: Dyslipidemia With HypertensionInterventions: Drug: Group I (Telmisartan 80 mg, Amlodipine 10 mg, Rosuvastatin 20 mg); Drug: Group II (Telmisartan 80 mg, Amodipine 10 mg, Rosuvastatin placebo); Drug: Group III (Telmisartan 80 mg, Amlodipine placebo, Rosuvastatin 20 mg) Sponsor: Jeil Pharmaceutical Co., Ltd. Completed Thu, 23 Mar 2017 12:00:00 EDT
The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/RosuvastatinConditions: Hypertension; DyslipidemiasInterventions: Drug: NEWSTATIN TS; Drug: CADUET Sponsor: Hyo-Soo Kim Unknown status Fri, 01 Mar 2019 12:00:00 EST CKD-828 (80/5mg) Pharmacokinetic StudyCondition: HypertensionInterventions: Drug: CKD-828; Drug: Telmisartan; Drug: S-amlodipine Sponsor: Chong Kun Dang Pharmaceutical Completed Fri, 26 Sep 2014 12:00:00 EDT MR Antagonist and LSD1Conditions: Hypertension; Mineralocorticoid ExcessInterventions: Drug: Eplerenone; Drug: Amlodipine Sponsor: Brigham and Women's Hospital Not yet recruiting Mon, 12 Apr 2021 12:00:00 EDT Telmisartan 80mg Non-responder TrialCondition: HypertensionInterventions: Drug: Telmisartan and amlodipine; Drug: Telmisartan Sponsor: Boehringer Ingelheim Completed Mon, 18 Oct 2010 12:00:00 EDT Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And DyslipidemiaConditions: Hypertension; HyperlipidemiaInterventions: Drug: atorvastatin; Drug: amlodipine Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. Completed Thu, 15 Sep 2005 12:00:00 EDT Efficacy and Safety of a Therapy Change From Candesartan 32 mg to Fixed Combination of Olmesartan 40 mg/Amlodipine 10 mgCondition: HypertensionInterventions: Drug: Candesartan cilexetil; Drug: Olmesartan medoxomil; Drug: Olmesartan/amlodipine Sponsor: Institut für Pharmakologie und Präventive Medizin Completed Mon, 04 Jun 2012 12:00:00 EDT Clinical Efficacy of Telmisartan in Reducing Cardiac Remodeling Among Obese Patients With HypertensionCondition: HypertensionInterventions: Drug: telmisartan; Drug: amlodipine Sponsor: First Affiliated Hospital Xi'an Jiaotong University Recruiting Tue, 21 May 2019 12:00:00 EDT CKD-828 (80/5mg) Pharmacokinetic StudyCondition: HypertensionInterventions: Drug: CKD-828; Drug: Telmisartan; Drug: S-amlodipine Sponsor: Chong Kun Dang Pharmaceutical Completed Mon, 09 Feb 2015 12:00:00 EST Sympathetic Mechanisms in the Cardiovascular and Metabolic Alterations of ObesityCondition: Obesity-Associated Insulin ResistanceInterventions: Drug: Moxonidine 0.2 MG; Drug: Amlodipine 5 MG Sponsors: Italo Biaggioni; National Heart, Lung, and Blood Institute (NHLBI) Recruiting Wed, 01 Apr 2020 12:00:00 EDT Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy in Real-world Japanese Therapeutic PracticeCondition: HypertensionInterventions: Drug: subjects treated with telmisartan/hydrochlorothiazide; Drug: Subjects treated with Telmisartan and amlodipine; Drug: subjects treated with Telmisartan+hydrochlorothiazide double-pill combination group; Drug: subjects treated with telmisartan+amlodipine double pill Sponsor: Boehringer Ingelheim Not yet recruiting Sun, 02 Jul 2017 12:00:00 EDT
Efficacy and Safety of Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Moderate-severe HypertensionCondition: HypertensionInterventions: Drug: Aliskiren; Drug: Amlodipine; Drug: Hydrochlorothiazide (HCTZ); Drug: Placebo Sponsor: Novartis Completed Fri, 03 Oct 2008 12:00:00 EDT Mechanism of Masked Hypertension - InterventionCondition: Masked HypertensionInterventions: Drug: Carvedilol; Drug: Amlodipine Sponsor: University of Alabama at Birmingham Not yet recruiting Wed, 09 Oct 2019 12:00:00 EDT Azilsartan Circadian and Sleep PressureCondition: HypertensionInterventions: Drug: Azilsartan; Drug: Amlodipine Sponsors: Sogo Rinsho Médéfi Co., Ltd.; Takeda Completed Mon, 07 Jan 2013 12:00:00 EST Pharmacokinetic Interactions Between Amlodipine Besylate/Valsartan and Atorvastatin in Healthy Male SubjectsCondition: HealthyIntervention: Drug: combination administration Sponsor: HK inno.N Corporation Completed Mon, 24 Feb 2014 12:00:00 EST Amlodipine as add-on to Olmesartan in HypertensionCondition: Essential HypertensionInterventions: Drug: olmesartan medoxomil; Drug: amlodipine Sponsor: Sankyo Pharma Gmbh Completed Thu, 22 Sep 2005 12:00:00 EDT An Eight-week Randomized,Double-blind Study to Evaluate the Efficacy and Safety of Fixed-dose Combinations of T80+A5 Versus A5 Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With A5 MonotherapyCondition: HypertensionInterventions: Drug: Telmisartan80mg+Amlodipine5mg; Drug: amlodipine 5mg; Drug: Telmisartan80mg+Amlodipine 5mg Sponsor: Boehringer Ingelheim Completed Thu, 15 Apr 2010 12:00:00 EDT PK Study of YH22189 FDC Compared to Combination of Telmisartan/Amlodipine and RosuvastatinConditions: Hypertension; HyperlipidemiaInterventions: Drug: YH22189; Drug: Twynsta 80/10mg; Drug: Crestor 20mg Sponsor: Yuhan Corporation Terminated Wed, 18 Nov 2015 12:00:00 EST Caduet vs Usual Care in Subjects With Hypertension and Additional Risk FactorsConditions: Hypertension; HypercholesterolemiaIntervention: Drug: Amlodipine besylate/atorvastatin calcium single pill combination Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. Completed Tue, 05 Dec 2006 12:00:00 EST Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe HypertensionCondition: HypertensionInterventions: Drug: Olmesartan medoxomil; Drug: Amlodipine Sponsor: Daiichi Sankyo, Inc. Completed Fri, 16 Sep 2005 12:00:00 EDT Effect of Antihypertensive Agents on Diastolic Function in Patients With Sleep ApneaConditions: Hypertension; Sleep ApneaInterventions: Drug: Chlorthalidone plus amiloride; Drug: Amlodipine Sponsor: Hospital de Clinicas de Porto Alegre Completed Mon, 12 Sep 2016 12:00:00 EDT
ARB and CCB Longest Combination Treatment on Ambulatory and Home BP in Hypertension With Atrial Fibrillation -Multicenter Study on Time of Dosing (ACROBAT)Condition: Hypertension and Atrial FibrillationInterventions: Drug: Telmisartan-amlodipine tablet administration group (morning); Drug: Telmisartan-amlodipine tablet administration group (bedtime) Sponsor: Acrobat Trial Group Unknown status Wed, 12 Dec 2012 12:00:00 EST MR Antagonist and STRIATINConditions: Hypertension; Genetics HypertensionIntervention: Drug: Eplerenone vs Amlodipine Sponsor: Brigham and Women's Hospital Recruiting Tue, 25 Sep 2018 12:00:00 EDT Add-on to Micamlo BP TrialCondition: HypertensionInterventions: Drug: Telmisartan + amlodipine; Drug: hydrochlorothiazide; Drug: Placebo Sponsor: Boehringer Ingelheim Completed Sun, 03 Nov 2013 12:00:00 EDT A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive PatientsConditions: Hypertension; ObesityInterventions: Drug: Telmisartan plus Metformin; Drug: Telmisartan; Drug: Candesartan; Drug: Candesartan plus Metformin; Drug: Amlodipine; Drug: Amlodipine plus Metformin Sponsor: Third Military Medical University Completed Tue, 02 Oct 2007 12:00:00 EDT A Study to Evaluate the Combination of Valsartan and Amlodipine in Hypertensive Patients Not Controlled on MonotherapyCondition: HypertensionInterventions: Drug: valsartan; Drug: hydrochlorothiazide; Drug: amlodipine Sponsor: Novartis Completed Thu, 18 May 2006 12:00:00 EDT Effect of Two Doses of Olmesartan Medoxomil and Amlodipine on Vascular Markers in Hypertensive Patients With Metabolic SyndromeConditions: Metabolic Syndrome; HypertensionInterventions: Drug: Olmesartan medoxomil tablets low dose; Drug: Olmesartan medoxomil tablets high dose; Drug: Amlodipine Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company Completed Fri, 01 May 2009 12:00:00 EDT 8-week Study to Evaluate Safety and Efficacy of Various Combinations of Valsartan, HCTZ, and Amlodipine in Patients With Moderate to Severe HypertensionCondition: HypertensionInterventions: Drug: Valsartan + amlodipine; Drug: Valsartan + HCTZ; Drug: Amlodipine + HCTZ; Drug: Valsartan + amlodipine + HCTZ Sponsor: Novartis Completed Thu, 18 May 2006 12:00:00 EDT High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine in the Treatment of High-Risk Hypertensive PatientsCondition: HypertensionInterventions: Drug: Quinapril 40 mg; Drug: Quinapril 10 mg and amlodipine 5 mg Sponsors: Montreal Heart Institute; Pfizer Terminated Wed, 12 Apr 2006 12:00:00 EDT Efficacy and Safety of TELMINUVO to Stage 2 HypertensionCondition: HypertensionInterventions: Drug: TELMINUVO Tab. (80/2.5mg); Drug: TELMINUVO Tab. (80/5mg); Drug: S-amlodipine 2.5mg; Drug: S-amlodipine 5mg Sponsor: Chong Kun Dang Pharmaceutical Unknown status Thu, 14 Nov 2013 12:00:00 EST Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential HypertensionCondition: Essential HypertensionIntervention: Drug: olmesartan medoxomil + hydrochlorothiazide, if necessary + amlodipine, if necessary Sponsor: Daiichi Sankyo, Inc. Completed Thu, 30 Apr 2009 12:00:00 EDT
Cozaar XQ Re-examination Study (MK-0954-349)Condition: HypertensionIntervention: Drug: amlodipine/losartan Sponsor: Merck Sharp & Dohme Corp. Completed Fri, 01 Jan 2010 12:00:00 EST Management of Hypertension Utilizing Trained Community Health Worker in Rural Municipalities of NepalCondition: Hypertension,EssentialInterventions: Drug: Amlodipine; Behavioral: Lifestyle counselling Sponsors: Johns Hopkins Bloomberg School of Public Health; Nepal Development Society Recruiting Thu, 20 Aug 2020 12:00:00 EDT Study to Evaluate the Safety and Efficacy of CJ-30061 in Hypertensive Patients With HyperlipidemiaConditions: Hypertension; HyperlipidemiaInterventions: Drug: Amlodipine 10mg+Valsartan 160mg+Atorvastatin 40mg; Drug: Amlodipine 10mg+Valsartan 160mg; Drug: Valsartan 160mg+Atorvastatin 40mg Sponsor: HK inno.N Corporation Unknown status Tue, 21 Aug 2018 12:00:00 EDT Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive PatientsCondition: HypertensionInterventions: Drug: losartan/hydrochlorothiazide; Drug: amlodipine/hydrochlorothiazide Sponsor: Shanghai Jiao Tong University School of Medicine Recruiting Fri, 10 May 2019 12:00:00 EDT A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/RosuvastatinConditions: Hypertension; HyperlipidemiaInterventions: Drug: Fimasartan/Amlodipine/Rosuvastatin; Drug: Fimasartan/Amlodipine; Drug: Rosuvastatin Sponsor: Boryung Pharmaceutical Co., Ltd Completed Wed, 07 Oct 2015 12:00:00 EDT Effect of Amlodipine Monotherapy or Combined With Terazosin on Lower Urinary Tract Symptoms and HypertensionConditions: Lower Urinary Tract Symptoms; HypertensionInterventions: Drug: amlodipine; Drug: terazosin; Drug: amlodipine plus terazosin Sponsors: Anhui Medical University; The University of Science and Technology of China; Peking University First Hospital Completed Fri, 06 Jun 2008 12:00:00 EDT Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of HypertensionCondition: HypertensionInterventions: Drug: Amlodipine 5 mg; Drug: Placebo; Drug: Telmisartan 20 mg; Drug: Telmisartan 40 mg; Drug: Amlodipine 10 mg; Drug: Telmisartan 80 mg; Drug: Amlodipine 2.5 mg Sponsor: Boehringer Ingelheim Completed Wed, 25 Jan 2006 12:00:00 EST Endogenous Renin-Angiotensin-Aldosterone System and Glucose MetabolismCondition: Metabolic SyndromeInterventions: Other: Low Salt diet plus Placebo tablet; Other: Low Sodium diet plus Salt tablet; Drug: Epleronone; Drug: Amlodipine Sponsor: Vanderbilt University Medical Center Completed Mon, 13 Jan 2014 12:00:00 EST Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=27)Condition: Healthy Male SubjectsInterventions: Drug: Exforge tab. 10/160mg; Drug: Lodivixx tab. 5/160mg Sponsor: Hanlim Pharm. Co., Ltd. Completed Mon, 27 Aug 2018 12:00:00 EDT A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And AtorvastatinConditions: Hypertension; HypercholesterolemiaInterventions: Drug: Amlodipine 2.5mg/Atorvastatin 5mg; Drug: Amlodipine 2.5mg/Atorvastatin 10mg; Drug: Amlodipine 5mg/Atorvastatin 5mg; Drug: Amlodipine 5mg/Atorvastatin 10mg Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. Completed Tue, 18 Sep 2007 12:00:00 EDT
Amlodipine vs Nitrates Study in Patients With Chronic Stable AnginaCondition: Myocardial IschemiaInterventions: Drug: Amlodipine; Drug: iso- 5 - mononitrate; Procedure: Blood tests; Procedure: Exercise Stress Test Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. Completed Fri, 02 Sep 2005 12:00:00 EDT Twynsta Study With Lifestyle Modifications in Korean Patients With HypertensionCondition: HypertensionInterventions: Drug: Telmisartan; Drug: amlodipine Sponsor: Boehringer Ingelheim Completed Wed, 16 Mar 2011 12:00:00 EDT The Effects of Renin Angiotensin System Blockage (RAS), Calcium Channel Blocker and Combined Drugs on TWEAK, PTX3 and FMD Levels in Diabetic Proteinuric Patients With HypertensionConditions: Diabetes; Hypertension; ProteinuriaInterventions: Drug: Amlodipine; Drug: Valsartan Sponsor: Gulhane School of Medicine Completed Tue, 16 Jun 2009 12:00:00 EDT Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab (Olmesartan 20 mg/Amlodipine 5 mg/Rosuvastatin 5 or 10 mg) in Hypertension Patients With Low-Intermediate Risk for Cardiovascular DiseaseConditions: Hypertension; DyslipidemiasInterventions: Drug: OLOMAX 20/5/5mg; Drug: OLOMAX 20/5/10mg; Drug: Olmesartan 20 mg/Amlodipine 5 mg Sponsor: Daewoong Pharmaceutical Co. LTD. Unknown status Wed, 09 Oct 2019 12:00:00 EDT Perindopril and Telmisartan for the Treatment of Nonalcoholic Fatty Liver DiseaseCondition: Nonalcoholic Fatty Liver Disease (NAFLD)Interventions: Drug: Perindopril; Drug: Telmisartan; Drug: Amlodipine Sponsor: Nanfang Hospital of Southern Medical University Unknown status Mon, 11 Aug 2014 12:00:00 EDT Phase IV, 9 Weeks Comparison Between MICARDIS 80 mg and Amlodipine 10 mg on Biological PPAR Gamma ActivitiesConditions: Hypertension; Metabolic Syndrome XInterventions: Drug: Micardis; Drug: Amlodipine; Procedure: Abdominal biopsy Sponsor: Boehringer Ingelheim Completed Fri, 21 Oct 2005 12:00:00 EDT An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2))Condition: ProteinuriaInterventions: Drug: Losartan Potassium; Other: Comparator: Placebo (Losartan); Drug: Comparator: amlodipine besylate; Other: Comparator: Placebo (amlodipine besylate); Other: Placebo (Losartan); Drug: Enalapril Maleate Sponsor: Merck Sharp & Dohme Corp. Completed Wed, 05 Dec 2007 12:00:00 EST N-of-1 Trials for Blood Pressure Medications in AdultsConditions: Hypertension; High Blood PressureInterventions: Drug: Losartan; Drug: Amlodipine; Drug: Hydrochlorothiazide Sponsor: Columbia University Completed Wed, 20 Apr 2016 12:00:00 EDT Long Term Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential HypertensionCondition: Essential HypertensionIntervention: Drug: Ali/Amlo 150/2.5 mg Sponsor: Novartis Pharmaceuticals Completed Wed, 10 Nov 2010 12:00:00 EST A Study to Investigate Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and RosuvastatinConditions: Hypertension; HyperlipidemiaInterventions: Drug: Twynsta 80/5mg; Drug: Crestor 20mg Sponsor: Yuhan Corporation Completed Tue, 01 Nov 2016 12:00:00 EDT
Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED)Condition: HypertensionInterventions: Drug: MK0954, losartan potassium/Duration of Treatment: 18 weeks; Drug: Comparator: losartan, HCTZ, amlodipine, atenolol/Duration of Treatment: 18 weeks Sponsor: Merck Sharp & Dohme Corp. Completed Thu, 01 Sep 2005 12:00:00 EDT Efficacy of Olmesartan on Cerebral Glucose Metabolism, Vascular Inflammation and Adipose TissueCondition: Efficacy of Olmesartan on Cerebral Glucose Metabolism in Essential HypertensionInterventions: Drug: Olmesartan; Drug: Amlodipine Sponsor: Kurume University Unknown status Mon, 19 Dec 2016 12:00:00 EST A Comparison of Telmisartan + Hydrochlorothiazide With Amlodipine + Hydrochlorothiazide in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension (ATHOS Study)Condition: HypertensionInterventions: Drug: Telmisartan 80 mg + hydrochlorothiazide 12.5 mg; Drug: Amlodipine 10 mg + hydrochlorothiazide 12.5 mg Sponsor: Boehringer Ingelheim Completed Tue, 18 Oct 2005 12:00:00 EDT A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra RiskConditions: Dyslipidemia; HypertensionInterventions: Drug: Amlodipine besylate; Drug: Amlodipine besylate/atorvastatin calcium single pill combination Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. Completed Fri, 15 Dec 2006 12:00:00 EST Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes-----renal SubstudyConditions: Diabetes Mellitus, Type 2; Blood PressureInterventions: Drug: Allisartan Isoproxil; Drug: Amlodipine Sponsor: Guangdong Provincial People's Hospital Not yet recruiting Tue, 27 Jul 2021 12:00:00 EDT Effect of Atorvastatin on Carotid Intima Media ThicknessConditions: Essential Hypertension; HypercholesterolemiaIntervention: Drug: Perindopril/Amlodipine and Perindopril/Amlodipine/Atorvastatin treatment Sponsors: Yerevan State Medical University; Servier Not yet recruiting Fri, 13 Mar 2020 12:00:00 EDT Safety and Efficacy of Aliskiren + Hydrochlorothiazide (± Amlodipine 5 mg) in Patients With Moderate HypertensionCondition: HypertensionInterventions: Drug: Candesartan+HCTZ - Phase 1; Drug: Aliskiren+HCTZ - Phase 2; Drug: Aliskiren+HCTZ+amlodipine - Phase 3 Sponsor: Novartis Completed Mon, 23 Mar 2009 12:00:00 EDT DP-R212 Pharmacokinetic StudyConditions: Hypertension; HyperlipidemiasInterventions: Drug: Amlodipine; Drug: Rosuvastatin Sponsor: Alvogen Korea Unknown status Fri, 03 Jun 2016 12:00:00 EDT Efficacy and Safety of CKD-828 to Stage 2 HypertensionCondition: HypertensionInterventions: Drug: CKD-828 2.5/40mg; Drug: CKD-828 5/40mg; Drug: CKD-828 5/80mg; Drug: S-amlodipine 2.5mg; Drug: S-amlodipine 5mg Sponsor: Chong Kun Dang Pharmaceutical Completed Fri, 06 Jul 2012 12:00:00 EDT Fixed Combination for Lipid and Blood Pressure ControlConditions: Arterial Hypertension; Dyslipidemias; Blood Pressure; Lipid Metabolism DisordersIntervention: Drug: Atorvastatin, Amlodipine, Perindopril Sponsors: Charles University, Czech Republic; University Hospital Olomouc; University Hospital Pilsen; General Teaching Hospital, Prague; St. Anne; Brno University Hospital; Na Homolce Hospital Withdrawn Thu, 09 Feb 2017 12:00:00 EST
Hypertension Control Based on Home Blood PressureCondition: HypertensionIntervention: Drug: Amlodipine, Losartan Sponsors: Ministry of Health, Labour and Welfare, Japan; Japan Cardiovascular Research Foundation Unknown status Tue, 20 Sep 2005 12:00:00 EDT Kanagawa Combination Anti-hypertensive Therapy (K-CAT)Condition: HypertensionIntervention: Drug: Losartan/amlodipine or losartan/hydrochlorothiazide Sponsor: Yokohama City University Medical Center Completed Wed, 27 Jun 2007 12:00:00 EDT The Role of Aldosterone on Augmented Exercise Pressor Reflex in HypertensionCondition: HypertensionInterventions: Drug: Eplerenone; Drug: Amlodipine; Procedure: Microneurography; Procedure: Rhythmic handgrip exercise; Procedure: Sustained hand grip; Procedure: Forearm blood flow; Procedure: Arm cycling exercise; Procedure: Cold Pressor test Sponsor: University of Texas Southwestern Medical Center Recruiting Wed, 27 Nov 2013 12:00:00 EST Angiotensin Receptor Blocker Combined With Calcium Antagonist Evaluation of Safety and Lowering of Systolic Blood Pressure StudyCondition: HypertensionInterventions: Drug: Perindopril; Drug: Perindopril/amlodipine; Drug: Olmesartan/amlodipine Sponsors: Monash University; Schering-Plough Withdrawn Thu, 18 Mar 2010 12:00:00 EDT Olmesartan as an add-on to Amlodipine in HypertensionCondition: Essential HypertensionInterventions: Drug: olmesartan medoxomil; Drug: amlodipine; Drug: hydrochlorothiazide Sponsor: Sankyo Pharma Gmbh Completed Thu, 22 Sep 2005 12:00:00 EDT A Regulatory Requirement Post-Marketing Surveillance Study to Monitor the Safety and Efficacy of Twynsta (Telmisartan + Amlodipine SPC, q.d.) in Korean Hypertensive Patients Requiring Combination TherapyCondition: HypertensionIntervention: Drug: Twynsta tablet Sponsor: Boehringer Ingelheim Completed Thu, 18 Nov 2010 12:00:00 EST Low-dose Combination of Three Antihypertensive DrugsCondition: Arterial HypertensionInterventions: Drug: Tripliam (perindopril, indapamide, amlodipine); Drug: Reaptan (perindopril, amlodipine) Sponsor: University of Roma La Sapienza Unknown status Wed, 16 Mar 2016 12:00:00 EDT Ambulatory vs Office BP Management Usual Care for Diagnosing and Managing Hypertension: A Pilot StudyCondition: HypertensionInterventions: Drug: Amlodipine; Drug: Chlorthalidone; Drug: Losartan Sponsors: Anthony J Viera, MD, MPH; North Carolina Translational and Clinical Sciences Institute Completed Wed, 23 Apr 2014 12:00:00 EDT Newer Versus Older Antihypertensive Agents in African Hypertensive Patients (NOAAH) TrialCondition: Blood PressureInterventions: Drug: amlodipine 5/10 mg per day plus valsartan 160 mg/day; Drug: hydrochlorothiazide 6.25 mg/day plus bisoprolol 5/10 mg/day Sponsors: KU Leuven; University of Kinshasa; Yaounde Central Hospital; University of Yaounde; University of Libreville; Institute of Cardiology Abidjan; University of Ilorin Teaching Hospital; University of Nigeria, Enugu Campus; Hospital Aristide Le Dantec, Dakar, Senegal Completed Fri, 11 Dec 2009 12:00:00 EST Study of DWJ1351 in Healthy Male VolunteersCondition: HealthyInterventions: Drug: DWJ1351; Drug: Co-administration of Sevikar (Olmesartan/Amlodipine) and Crestor (Rosuvastatin) Sponsor: Daewoong Pharmaceutical Co. LTD. Unknown status Thu, 28 Jan 2016 12:00:00 EST
MK-0954E Study in Participants With Hypertension (MK-0954E-357)Condition: HypertensionInterventions: Drug: losartan potassium + hydrochlorothiazide + amlodipine besylate (MK-0954E); Drug: Losartan potassium; Drug: Amlodipine besylate; Drug: Placebo to MK-0954E; Drug: Placebo to losartan potassium; Drug: Placebo to amlodipine besylate Sponsor: Merck Sharp & Dohme Corp. Completed Thu, 24 Feb 2011 12:00:00 EST Study to Evaluate the Safety and Efficacy of CJ-30060 in Hypertensive Patients With HyperlipidemiaCondition: Hypertension With HyperlipidemiaInterventions: Drug: Amlodipine 10 mg + Valsartan 160 mg + Rosuvastatin 20 mg; Drug: Amlodipine 10 mg + Valsartan 160 mg; Drug: Valsartan 160 mg + Rosuvastatin 20 mg Sponsor: HK inno.N Corporation Completed Thu, 24 May 2018 12:00:00 EDT Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of HypertensionCondition: HypertensionInterventions: Drug: Telmisartan 10 mg/amlodipine 1.25 mg/indapamide 0.625 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: Placebo Sponsor: George Medicines PTY Limited Recruiting Wed, 19 Aug 2020 12:00:00 EDT Management of Newly Diagnosed and Uncontrolled Hypertension With Fixed-Dose Combination of Perindopril/Amlodipine and Perindopril/Indapamide/AmlodipineCondition: HypertensionInterventions: Drug: Amlessa®; Drug: Co-Amlessa® Sponsors: KRKA; Clinres Farmacija d.o.o.; University Medical Centre Ljubljana Completed Tue, 13 Nov 2018 12:00:00 EST Vascular Augmentation of Late-life Unremitted Depression (VALUeD)Condition: DepressionInterventions: Drug: Amlodipine; Drug: Placebo Sponsors: Gateshead Health NHS Foundation Trust; Newcastle-upon-Tyne Hospitals NHS Trust; National Institute for Health Research, United Kingdom Unknown status Mon, 19 Mar 2012 12:00:00 EDT Co-Administration of MK-4618 With Antihypertensive Agents (MK-4618-010)Condition: HypertensionInterventions: Drug: MK-4618; Drug: Placebo for MK-4618; Drug: Metoprolol; Drug: Amlodipine Sponsor: Merck Sharp & Dohme Corp. Completed Tue, 19 Apr 2011 12:00:00 EDT Sympathoinhibition as a Preferred Second Line Treatment of Obesity Related HypertensionConditions: Obesity; HypertensionInterventions: Drug: Moxonidine 0.4 MG; Drug: Amlodipine 5mg Sponsors: Royal Perth Hospital; The University of Western Australia Recruiting Fri, 17 Jul 2020 12:00:00 EDT Bioequivalence Study of Amlodipine / Losartan/ Hydrochlorothiazide of PHARMALINE, Lebanon Under Fastion ConditionsCondition: FastingIntervention: Drug: Amlodipin, losartan, HCTZ Sponsor: Pharmaceutical Research Unit, Jordan Completed Thu, 25 Oct 2012 12:00:00 EDT Bioequivalence Study of Torrent's Olmesartan Medoxomil, Amlodipine and Hydrochloride Tablets Under Fasting Conditions.Condition: Healthy SubjectsInterventions: Drug: Torrent's Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets; Drug: Tribenzor Tablets of Daichi Sankyo Inc, USA Sponsor: Torrent Pharmaceuticals Limited Completed Fri, 11 Nov 2016 12:00:00 EST A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual ComponentsCondition: Primary HypertensionInterventions: Drug: Metoprolol XL 50mg + Amlodipine 5mg; Drug: Metoprolol XL 25 mg + Amlodipine 2.5mg; Drug: Metoprolol XL 50mg; Drug: Metoprolol XL 25 mg; Drug: Amlodipine 5mg Sponsors: AstraZeneca; St. John's Research Institute Completed Thu, 08 Jan 2009 12:00:00 EST
Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic HypertensionCondition: HypertensionInterventions: Drug: Benazepril/amlodipine 20/5 mg - Dose Level 1 from Day 1 to Month 1; Drug: Benazepril/amlodipine 40/5 mg - Dose Level 2 from Month 1 to Month 2; Drug: Benazepril/amlodipine 40/10 mg - Dose Level 3 from Month 2 to Month 3 and thereafter; Drug: Benazepril/hydrochlorothiazide 20/12.5 mg - Dose Level 1 from Day 1 to Month 1; Drug: Benazepril/hydrochlorothiazide 40/12.5 mg - Dose Level 2 from Month 1 to Month 2; Drug: Benazepril/hydrochlorothiazide 40/25 mg - Dose Level 3 from Month 2 to Month 3 and thereafter Sponsor: Novartis Terminated Thu, 15 Sep 2005 12:00:00 EDT Enalapril Folic Acid Tablets Combined With CCB or Diuretic to Prevent Stroke in Patients With Type H HypertensionCondition: HypertensionInterventions: Drug: Enalapril Folic Acid Tablets Combined With amlodipine; Drug: Enalapril Folic Acid Tablets Combined With hydrochlorothiazide Sponsors: Second Affiliated Hospital, School of Medicine, Zhejiang University; National Clinical Research Center, Southern Medical University; Ningbo Yinzhou Community Health Service Center Completed Wed, 07 Jul 2021 12:00:00 EDT Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male Subjects (N=60)Condition: Healthy Male SubjectsInterventions: Drug: Exforge tab. 10/160mg; Drug: Lodivixx tab. 5/160mg Sponsor: Hanlim Pharm. Co., Ltd. Completed Thu, 28 Mar 2013 12:00:00 EDT Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive PatientsCondition: Essential HypertensionIntervention: Drug: Amlodipine, Telmisartan, Amiloride Compound , Simvastatin Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital Unknown status Wed, 11 Nov 2009 12:00:00 EST Clinical Trial to Assess the Pharmacokinetic Characteristics of Lodivixx Tab. 5/160mg in Healthy Male SubjectsCondition: Healthy Male SubjectsInterventions: Drug: Exforge tab. 10/160mg; Drug: Lodivixx tab. 5/160mg Sponsor: Hanlim Pharm. Co., Ltd. Completed Mon, 30 Jul 2012 12:00:00 EDT Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive AdultsCondition: HypertensionInterventions: Drug: HCTZ + Amlodipine; Drug: Valsartan/HCTZ Sponsor: Novartis Pharmaceuticals Completed Mon, 26 Feb 2007 12:00:00 EST Intermittent Hypoxia 2: Cardiovascular and MetabolismConditions: Hypoxia; Sleep Apnea; Obstructive Sleep ApneaInterventions: Drug: Placebo; Drug: Valsartan; Drug: Amlodipine Sponsors: University Hospital, Grenoble; Institut National de la Santé Et de la Recherche Médicale, France Terminated Mon, 10 Feb 2014 12:00:00 EST Thiazide Diuretics for Hypertension in Kidney Transplant Recipients Using TacrolimusConditions: Hypertension; Kidney TransplantationInterventions: Drug: Chlorthalidone; Drug: Amlodipine Sponsor: Erasmus Medical Center Completed Thu, 31 Dec 2015 12:00:00 EST Aliskiren Study of Safety and Efficacy in Senior HypertensivesCondition: HypertensionInterventions: Drug: Aliskiren; Drug: Amlodipine; Drug: Ramipril; Drug: Hydrochlorothiazide Sponsor: Novartis Pharmaceuticals Withdrawn Wed, 14 Aug 2013 12:00:00 EDT ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With MicroalbuminuriaConditions: Hypertension; Diabetes Mellitus, Type 2; AlbuminuriaInterventions: Drug: Amlodipine+Benazepril; Drug: Valsartan+Hydrochlorothiazide Sponsor: TSH Biopharm Corporation Limited Completed Fri, 17 Jun 2011 12:00:00 EDT
High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and HypertensionConditions: ASCVD; Impaired Fasting Glucose; HypertensionInterventions: Drug: Duowell®; Drug: Monorova® + Amlopin® Sponsor: Yuhan Corporation Completed Thu, 22 Mar 2018 12:00:00 EDT Comparison of Effects Between Amlodipine and Hydrochlorothiazide in Combination With Losartan on 24-hr Central Blood Pressure in Hypertensive PatientsCondition: HypertensionInterventions: Drug: Losartan 50mg/amlodipine 5mg; Drug: Losartan 100mg/amlodipine 5mg; Drug: Losartan 50mg/Hydrochlorothiazide 12.5mg; Drug: Losartan 100mg/Hydrochlorothiazide 25mg Sponsors: Chong-Jin Kim; Hanmi Pharmaceutical Company Limited Completed Wed, 19 Nov 2014 12:00:00 EST Comparison of Fimasartan Versus Amlodipine Therapy on Carotid PlaquE InflammationConditions: Inflammation Plaque, Atherosclerotic; Coronary Disease; Renin-Angiotensin SystemIntervention: Drug: 6-month treatment Sponsors: CHEOL WHAN LEE, M.D., Ph.D; Boryung Pharmaceutical Co., Ltd Completed Wed, 04 Mar 2015 12:00:00 EST CKD-828 Primary Hypertension Trial(Dose-selection)Condition: HypertensionInterventions: Drug: S-Amlodipine, Telmisartan; Drug: S-Amlodipine; Drug: Telmisartan; Drug: Placebo Sponsor: Chong Kun Dang Pharmaceutical Completed Fri, 21 May 2010 12:00:00 EDT Reduced Contractile Reserve: a Therapeutic Target in Heart Failure With Preserved Ejection Fraction(HFpEF)Conditions: Heart Failure With Preserved Ejection Fraction; Pulmonary Disease; Left Ventricular Hypertrophy/HypertensionInterventions: Drug: Dobutamine; Drug: Amlodipine Sponsors: University of Wisconsin, Madison; National Heart, Lung, and Blood Institute (NHLBI) Completed Tue, 17 May 2011 12:00:00 EDT A Dose Selection Trial of CKD-330 in Patients With Essential HypertensionCondition: Essential HypertensionInterventions: Drug: Candesartan 8mg; Drug: Candesartan 16mg; Drug: Amlodipine 5mg; Drug: Amlodipine 10mg Sponsor: Chong Kun Dang Pharmaceutical Unknown status Fri, 01 Aug 2014 12:00:00 EDT Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and DyslipidemiaConditions: Hypertension; DyslipidemiaInterventions: Drug: Telmisartan + Amlodipine + Rosuvastatin; Drug: Telmisartan + Amlodipine; Drug: Telmisartan + Rosuvastatin Sponsor: Daewon Pharmaceutical Co., Ltd. Completed Fri, 07 Jul 2017 12:00:00 EDT Intervention for High-normal Blood Pressure in Adults With Type 2 DiabetesConditions: Diabetes Mellitus, Type 2; Stroke; Blood Pressure; Prehypertension; Cardiovascular Risk FactorInterventions: Drug: Allisartan Isoproxil; Drug: Amlodipine 5mg; Other: Standard treatment by current guideline Sponsor: Jiyan Chen Recruiting Tue, 29 Aug 2017 12:00:00 EDT Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/AmlodipineConditions: Hypercholesterolemia; HypertensionInterventions: Drug: Ezetimibe/Rosuvastatin; Drug: Telmisartan; Drug: Telmisartan/Amlodipine 80 Mg-5 Mg ORAL TABLET Sponsor: Addpharma Inc. Completed Fri, 08 Nov 2019 12:00:00 EST PHARES Study: Management of Resistant HypertensionCondition: HypertensionIntervention: Drug: irbesartan, amlodipine and hydrochlorothiazide Sponsor: Assistance Publique - Hôpitaux de Paris Completed Fri, 23 Sep 2005 12:00:00 EDT
Antiproteinuric Efficacy of Losartan Potassium in Patients With Non-Diabetic Proteinuric Renal Diseases (0954-213)Condition: Renal DisorderInterventions: Drug: MK0954, losartan potassium/Duration of Treatment: 20 weeks; Drug: Comparator: amlodipine / Duration of Treatment: 20 weeks Sponsor: Merck Sharp & Dohme Corp. Completed Thu, 01 Sep 2005 12:00:00 EDT Spironolactone Versus Indapamide in Obese and Hypertensive PatientsCondition: HypertensionInterventions: Drug: Spironolactone; Drug: Indapamide; Drug: Amlodipine Sponsors: Peking University Third Hospital; University of Michigan; Peking University Unknown status Mon, 13 Aug 2018 12:00:00 EDT Effect of RAS Blockers on CKD Progression in Elderly Patients With Non Proteinuric Nephropathies (PROERCAN01)Conditions: Renal Insufficiency, Chronic; ProteinuriaInterventions: Drug: Lisinopril; Drug: Amlodipine Sponsor: Hospital General Universitario Gregorio Marañon Recruiting Thu, 22 Jun 2017 12:00:00 EDT Determining the Optimal Dose of AD-209 in Patients With Essential HypertensionCondition: Hypertension,EssentialInterventions: Drug: AD209; Drug: Amlodipine low; Drug: Amlodipine high; Drug: Telmisartan Sponsor: Addpharma Inc. Completed Mon, 06 Jan 2020 12:00:00 EST Effects Of Losartan On Myocardial Structure In Diabetic Hypertensive Patients With Left VentricularConditions: Essential Hypertension; Diabetes MellitusInterventions: Drug: Losartan; Drug: Amlodipine Sponsor: University of Pavia Unknown status Wed, 16 Apr 2008 12:00:00 EDT Effect of Nocturnal Administration of Anti-hypertensive Medications in NoN-dippersCondition: HypertensionIntervention: Drug: Valsaltan, amlodipine Sponsor: Yonsei University Completed Wed, 24 Mar 2010 12:00:00 EDT A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605Condition: HypertensionInterventions: Drug: HCP1401; Drug: HCP0605 Sponsor: Hanmi Pharmaceutical Company Limited Completed Tue, 27 Sep 2016 12:00:00 EDT The Effects of Antihypertensive Agents on Central Blood Pressure in Healthy Participants and Participants With Hypertension (MK-0000-166) (COMPLETED)Condition: HypertensionInterventions: Drug: Placebo; Drug: Comparator: Amlodipine; Drug: Comparator: ISMN ER Sponsor: Merck Sharp & Dohme Corp. Completed Tue, 25 May 2010 12:00:00 EDT A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Amlodipine in Hypertensive Non Responders PatientsCondition: HypertensionIntervention: Drug: aliskiren Sponsor: Novartis Completed Thu, 22 Sep 2005 12:00:00 EDT A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of AmlodipineCondition: HypertensionIntervention: Drug: Aliskiren Sponsor: Novartis Completed Wed, 22 Feb 2006 12:00:00 EST
Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate HypertensionCondition: Essential Hypertension ( Mild to Moderate)Interventions: Drug: Aliskiren; Drug: Hydrochlorothiazide; Drug: Amlodipine Sponsor: Novartis Completed Fri, 03 Oct 2008 12:00:00 EDT Combination of OLMesartan and CCB or Low Dose Diuretics in High Risk Elderly Hypertensive Patients Study (COLM-Study)Conditions: Hypertension; Cardiovascular Disease; DiabetesInterventions: Drug: olmesartan medoxomil / amlodipine or azelnidipine; Drug: olmesartan medoxomil / low dose thiazide type drug Sponsors: COLM Study Research Organization; Japan Heart Foundation Completed Mon, 02 Apr 2007 12:00:00 EDT A Clinical Study to Compare Combination of Aliskiren+ HCTZ to Irbesartan+ HCTZ or Amlodipine+ HCTZ or HCTZ Alone in Obese Hypertensive Not Responsive to HCTZ 25 mgCondition: HypertensionIntervention: Drug: aliskiren Sponsor: Novartis Completed Thu, 22 Sep 2005 12:00:00 EDT Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male VolunteersCondition: Hypertension and DyslipidemiaInterventions: Drug: Telmisartan; Drug: Amlodipine; Drug: Rosuvastatin Sponsor: Daewon Pharmaceutical Co., Ltd. Completed Fri, 14 Oct 2016 12:00:00 EDT Effect of Antihypertensive Agents Over Sleep ApneaConditions: Hypertension; Obstructive Sleep ApneaInterventions: Drug: Diuretics; Drug: Calcium Channel Blockers Sponsor: Hospital de Clinicas de Porto Alegre Completed Thu, 11 Jul 2013 12:00:00 EDT Blood Pressure Variability and the Prognosis of Ischemic Stroke With Intracranial Artery StenosisConditions: Blood Pressure Variability; Intracranial Artery StenosisInterventions: Drug: Amlodipine; Drug: ACEI / ARB; Drug: Aspirin or Clopidogrel; Drug: Atorvastatin Sponsor: RenJi Hospital Unknown status Wed, 15 Aug 2012 12:00:00 EDT Assessment of Renin Inhibition on Insulin Sensitivity, Diastolic Function and Aortic ComplianceConditions: Insulin Sensitivity; Aortic Compliance; Diastolic FunctionInterventions: Drug: Aliskiren; Drug: Valsartan and Aliskiren; Drug: Amlodipine Sponsor: Brigham and Women's Hospital Terminated Thu, 02 Dec 2010 12:00:00 EST Changes in Endothelial Function and Biomarkers in African Americans (AA) With Metabolic SyndromeCondition: HypertensionInterventions: Drug: amlodipine and olmesartan; Drug: losartan and HCTZ Sponsor: InVasc Therapeutics, Inc. Unknown status Thu, 06 Jan 2011 12:00:00 EST The Use of TrIple Fixed-dose Combination in the Treatment of Arterial HypertensionCondition: Arterial HypertensionIntervention: Drug: amlodipine / indapamide / perindopril arginine FDC Sponsor: Servier Russia Completed Mon, 29 Oct 2018 12:00:00 EDT Sevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan/ AmlodipineCondition: HypertensionInterventions: Drug: Candesartan cilexetil; Drug: Olmesartan/Amlodipin Sponsor: Institut für Pharmakologie und Präventive Medizin Completed Thu, 07 Jun 2012 12:00:00 EDT
Aggressive Medical Treatment Evaluation for Asymptomatic Carotid Artery StenosisConditions: Carotid Artery Stenosis; Atherosclerosis; StrokeInterventions: Procedure: Carotid Endarterectomy; Drug: atorvastatin, aspirin, losartan, amlodipine Sponsor: Russian Cardiology Research and Production Center Terminated Tue, 09 Dec 2008 12:00:00 EST Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential HypertensionCondition: HypertensionInterventions: Drug: AGSAVI; Drug: AGLS Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd Not yet recruiting Tue, 29 Dec 2020 12:00:00 EST Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL)Condition: HypertensionIntervention: Drug: Amlodipine 10 mg or Losartan 100 mg + Amlodipine 5 mg Sponsors: Ullevaal University Hospital; Merck Sharp & Dohme Corp. Completed Wed, 12 Oct 2005 12:00:00 EDT Blood Pressure Reduction in Heart FailureConditions: Heart Failure; Cardiac Failure; Congestive Heart FailureInterventions: Drug: Hydralazine/amlodipine; Drug: Placebo Sponsors: University of Sao Paulo; Conselho Nacional de Desenvolvimento Científico e Tecnológico Completed Tue, 07 Dec 2010 12:00:00 EST Evaluate the Efficacy and Safety of Pletaal (Cilostazol) in Subjects With Vasospastic AnginaCondition: Variant AnginaIntervention: Drug: Placebo Sponsor: Korea Otsuka Pharmaceutical Co., Ltd. Completed Mon, 03 Oct 2011 12:00:00 EDT Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451Condition: Hypertension, DyslipidemiaInterventions: Drug: Amlodipine/Olmesartan 10/40mg (Combination drug), Ezetimibe/Rosuvastatin 10/20mg(Combination drug); Drug: Olmesartan 40mg, Ezetimibe/Rosuvastatin 10/20mg(Combination drug); Drug: Amlodipine/Olmesartan 10/40mg (Combination drug) Sponsor: Daewoong Pharmaceutical Co. LTD. Recruiting Wed, 13 Nov 2019 12:00:00 EST Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients Not Controlled by AmlodipineConditions: Hypertension; Diabetes MellitusInterventions: Drug: Benazepril; Drug: Losartan Sponsor: Hospital Universitario Pedro Ernesto Completed Wed, 23 May 2012 12:00:00 EDT Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.Condition: Grade I or II Essential HypertensionInterventions: Drug: TAK-536CCB; Drug: TAK-536CCB + Hydrochlorothiazide; Drug: Hydrochlorothiazide Sponsor: Takeda Completed Wed, 26 Feb 2014 12:00:00 EST Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial FibrillationConditions: Atrial Fibrillation; HypertensionInterventions: Drug: Amlodipine/Atorvastatin 5 Mg-20 Mg ORAL TABLET; Drug: Amlodipine/Atorvastatin 5 Mg-10 Mg ORAL TABLET; Drug: Allisartan Isoproxil Sponsor: Shanghai Jiao Tong University School of Medicine Recruiting Tue, 01 Oct 2019 12:00:00 EDT Clinical Utility of Caduet in Achieving Blood Pressure and Lipid Endpoints in a Specific Patient PopulationConditions: Hypertension; DyslipidemiaIntervention: Drug: Amlodipine/Atorvastatin Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. Completed Thu, 08 Sep 2005 12:00:00 EDT
Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Combination Therapy in Patients With Hypertension Not Controlled With Olmesartan Medoxomil and Hydrochlorothiazide Combination TherapyCondition: Essential HypertensionInterventions: Drug: CS8635 20/5/12.5mg and placebo; Drug: Olmetec® Plus 20/12.5mg and placebo Sponsor: Daiichi Sankyo Korea Co., Ltd., a Daiichi Sankyo Company Completed Wed, 24 Apr 2013 12:00:00 EDT DP-R212 Pharmacokinetic Study Phase ICondition: HealthyInterventions: Drug: DP-R212; Drug: Amlodipine; Drug: Rosuvastatin Sponsor: Alvogen Korea Unknown status Mon, 27 Jun 2016 12:00:00 EDT Comparative Study of Valsartan and Amlodipine Versus Amlodipine Alone in HypertensionCondition: HypertensionIntervention: Drug: valsartan Sponsor: Novartis Completed Mon, 05 Jun 2006 12:00:00 EDT Valsartan and Amlodipine Compared to Losartan and Amlodipine in Hypertensive PatientsCondition: Essential HypertensionInterventions: Drug: valsartan/amlodpine; Drug: losartan/amlodpine Sponsor: University of Pavia Unknown status Wed, 16 Jul 2008 12:00:00 EDT Efficacy and Tolerability of Combination Antihypertensive Drug in Non-Responders to ARB monoTHerapy Using 24h ABPMCondition: HypertensionIntervention: Drug: SEVIKAR Sponsors: Sang Hyun Ihm, MD PhD; Daiichi Sankyo Korea Co., Ltd.; Daewoong Pharmaceutical Co. LTD. Completed Thu, 25 Oct 2012 12:00:00 EDT The SCCS Polypill Pilot TrialConditions: Hypertension; HyperlipidemiaIntervention: Drug: Polypill (atorvastatin, amlodipine, losartan, and hydrochlorothiazide) Sponsor: Vanderbilt University Completed Thu, 30 Oct 2014 12:00:00 EDT INTERVENCION TrialCondition: Blood Pressure, HighInterventions: Drug: Hydrochlorothiazide; Drug: Amlodipine; Drug: Telmisartan Sponsor: Prevencion Unknown status Thu, 26 Feb 2015 12:00:00 EST Losartan and Simvastatin in Hypertensive Obeses With Liver SteatosisCondition: HypertensionInterventions: Drug: Losartan + Simvastatin; Drug: Amlodipine + Simvastatin Sponsor: University of Pavia Unknown status Wed, 30 Apr 2008 12:00:00 EDT Vascular Improvement With Olmesartan Medoxomil StudyCondition: HypertensionInterventions: Drug: olmesartan medoxomil + hydrochlorothiazide + amlodipine + hydralazine if necessary to control blood pressure; Drug: atenolol+ hydrochlorothiazide + amlodipine + hydralazine if necessary to control blood pressure Sponsor: Daiichi Sankyo, Inc. Completed Wed, 15 Oct 2008 12:00:00 EDT Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of HypertensionCondition: HypertensionInterventions: Drug: Telmisartan 20 mg/amlodipine 2.5 mg/indapamide 1.25 mg; Drug: telmisartan 40 mg/amlodipine 5 mg/indapamide 2.5 mg; Drug: Telmisartan 20 mg/amlodipine 2.5 mg .; Drug: telmisartan 40 mg/amlodipine 5 mg; Drug: Telmisartan 20 mg/indapamide 1.25 mg; Drug: telmisartan 40 mg/indapamide 2.5 mg; Drug: Amlodipine 2.5 mg/indapamide 1.25 mg; Drug: amlodipine 5 mg/indapamide 2.5 mg Sponsor: George Medicines PTY Limited Recruiting Wed, 19 Aug 2020 12:00:00 EDT
Essential HypertensionCondition: Essential HypertensionInterventions: Drug: ACT-280778; Drug: Placebo; Drug: Amlodipine Sponsor: Idorsia Pharmaceuticals Ltd. Completed Wed, 22 Dec 2010 12:00:00 EST Real Life Experience With Caduet In Patients With Cardiovascular Risk FactorsCondition: Hypertension and Cardiovascular Risk FactorsIntervention: Drug: CADUET (AMLODIPINE 5 mg/ATORVASTATIN 10 mg or 20 mg) Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. Terminated Mon, 24 Dec 2007 12:00:00 EST Comparison of Three Combination Therapies in Lowering Blood Pressure in Black AfricansCondition: HypertensionInterventions: Drug: Perindopril plus Amlodipine; Drug: Perindopril plus Hydrochlorothiazide; Drug: Amlodipine plus Hydrochlorothiazide Sponsors: University of Abuja; Imperial College London; University of Cape Town; Hôpital Edouard Herriot; University of Nairobi; University College Hospital, Ibadan; Hospital General De Douala; Mulago Hospital, Uganda Completed Tue, 19 Apr 2016 12:00:00 EDT CKD-828(80/2.5mg) Pharmacokinetic Study_2ndCondition: HypertensionInterventions: Drug: CKD-828(FDC); Drug: Combination Therapy Sponsor: Chong Kun Dang Pharmaceutical Completed Thu, 12 May 2011 12:00:00 EDT CKD-828 (40/5mg) Pharmacokinetic StudyCondition: HypertensionInterventions: Drug: CKD-828; Drug: Combination Therapy Sponsor: Chong Kun Dang Pharmaceutical Completed Fri, 22 Apr 2011 12:00:00 EDT CKD-828(80/2.5mg) Pharmacokinetic StudyCondition: HypertensionInterventions: Drug: CKD-828(FDC); Drug: Combination Therapy Sponsor: Chong Kun Dang Pharmaceutical Completed Tue, 23 Nov 2010 12:00:00 EST Recurrent Stroke Prevention Clinical Outcome StudyConditions: Hypertension; Stroke; Blood PressureIntervention: Drug: Losartan, Losartan and HCTZ, Amlodipine , Spironolactone Sponsor: Biomedis International Ltd. Unknown status Fri, 10 Sep 2010 12:00:00 EDT The Efficacy and Safety Study of Anti-hypertension Combination Drug in Patients Uncontrolled With Monotherapy.Condition: HypertensionInterventions: Drug: Amosartan® tab; Drug: Cozaar® plus pro tab Sponsor: Hanmi Pharmaceutical Company Limited Completed Wed, 10 Apr 2013 12:00:00 EDT Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial Magnetic Resonance Imaging Sub-studyConditions: Stroke; Cerebral Small Vessel Diseases; Intracerebral Hemorrhage; Vascular Dementia; HypertensionInterventions: Drug: telmisartan 20 mg + amlodipine 2.5mg + indapamide 1.25mg; Drug: Placebo oral capsule Sponsors: The George Institute; University of Sydney Terminated Fri, 21 Dec 2018 12:00:00 EST Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts TrialConditions: Intracerebral Haemorrhage (ICH); HypertensionInterventions: Drug: telmisartan 20mg, amlodipine 2.5mg, and indapamide 1.25mg; Drug: Placebo Sponsors: The George Institute; The University of New South Wales Recruiting Fri, 04 Mar 2016 12:00:00 EST
Randomized Controlled Trial of Renal Denervation for Resistant HypertensionCondition: HypertensionInterventions: Device: Radiofrequency ablation catheter; Drug: Amlodipine, losartan potassium and hydrochlorothiazide Sponsor: Shanghai WiseGain Medical Devices Co., Ltd. Unknown status Wed, 14 Sep 2016 12:00:00 EDT Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-StudyConditions: Cognitive Decline; Intracerebral Hemorrhage; Dementia, Vascular; Cerebral Small Vessel Diseases; Hypertension; Stroke HemorrhagicInterventions: Drug: telmisartan 20mg + amlodipine 2.5mg +indapamide 1.25mg; Drug: Placebo oral capsule Sponsors: The George Institute; University of Sydney Terminated Mon, 24 Dec 2018 12:00:00 EST AARDVARK (Aortic Aneurysmal Regression of Dilation: Value of ACE-Inhibition on RisK)Condition: Abdominal Aortic AneurysmInterventions: Drug: perindopril arginine; Drug: amlodipine 5mgs; Drug: placebo Sponsors: Imperial College London; National Institute for Health Research, United Kingdom Completed Thu, 06 May 2010 12:00:00 EDT Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy VolunteersCondition: HypertensionIntervention: Drug: Telmisartan 80mg + Amlodipine 5mg + Chlorthalidone 25mg Sponsor: Yuhan Corporation Completed Fri, 07 Sep 2018 12:00:00 EDT Efficacy and Safety of Nebivolol Versus Metoprolol in Hypertensive Subject Taking AmlodipineCondition: JNC 7 Stage 1 or 2 HypertensionInterventions: Drug: Nebivolol I; Drug: Nebivolol II; Other: Baseline Washout Phase Sponsor: Trinity Hypertension & Metabolic Research Institute Completed Fri, 17 Aug 2018 12:00:00 EDT STITCH2 (Simplified Therapeutic Intervention to Control Hypertension and Hypercholesterolemia)Conditions: Hypertension; HypercholesterolemiaIntervention: Other: Treatment algorithm:caduet, Amlodipine, ACEI-ARB combo dose, a-blocker, b-blocker or spironolactone, dyslipidemic therapy with ezetamide Sponsors: University of Western Ontario, Canada; Pfizer Completed Mon, 17 Mar 2008 12:00:00 EDT Safety and Tolerability of Valsartan in Children 6 to 17 Years of AgeConditions: Hypertension; Chronic Kidney DiseaseInterventions: Drug: Valsartan; Drug: amlodipine; Drug: Hydrochlorothiazide Sponsor: Novartis Pharmaceuticals Completed Fri, 03 Jun 2011 12:00:00 EDT Genetics of Hypertension Associated Treatments (GenHAT)Conditions: Cardiovascular Diseases; Heart Diseases; Hypertension; Coronary Disease; Myocardial InfarctionInterventions: Drug: Chlorthalidone; Drug: Lisinopril; Drug: Amlodipine; Drug: Doxazosin Sponsors: Donna Arnett, 257-5678; University of Minnesota; National Heart, Lung, and Blood Institute (NHLBI) Completed Tue, 26 Sep 2000 12:00:00 EDT Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential HypertensionCondition: HypertensionInterventions: Drug: Nifedipine (Adalat, BAYA1040); Drug: Amlodipine (Norvasc); Drug: Diovan Sponsor: Bayer Completed Thu, 26 Jan 2012 12:00:00 EST Renin Profiling in Selection of Initial Antihypertensive DrugCondition: HypertensionInterventions: Drug: olmesartan, hydrochlorothiazide, amlodipine; Drug: hydrochlorothiazide (HCTZ) or olmesartan Sponsors: The Louis & Rachel Rudin Foundation; Daiichi Sankyo, Inc. Completed Tue, 03 Feb 2009 12:00:00 EST
Feasibility Study of the Intensive Systolic Blood Pressure ControlConditions: Hypertension; HyperhomocysteinemiaInterventions: Drug: Standard BP control; Drug: Moderate BP control; Drug: Intensive BP control Sponsors: Second Affiliated Hospital of Nanchang University; Peking University First Hospital Unknown status Wed, 29 Jun 2016 12:00:00 EDT A Dose Escalation Study of a Combination Antihypertensive Drug in the Treatment of Various Groups of Patients Who do Not Respond to Single Drug Treatment of Their High Blood PressureCondition: HypertensionInterventions: Drug: amlodipine and olmesartan medoxomil tablets; Drug: hydrochlorothiazide tablets Sponsors: Daiichi Sankyo, Inc.; Integrium Completed Fri, 14 Nov 2008 12:00:00 EST Study to Evaluate the Effect on Improvement of LVH by the Control of BP in Hypertension Patients With AV DiseaseConditions: Aortic Stenosis; Aortic Regurgitation; Hypertension; LVM; Left Ventricular HypertrophyInterventions: Drug: Amlodipine 5mg; Drug: Losartan; Drug: Losartan and Amlodipine; Drug: Amlodipine/Losartan/Chlorthalidone; Drug: current treatment Sponsor: Hanmi Pharmaceutical Company Limited Recruiting Tue, 11 Sep 2018 12:00:00 EDT ALiskiren or Losartan Effects on bioMARKers of Myocardial RemodelingConditions: Hypertension; Left Ventricle HypertrophyInterventions: Drug: Aliskiren; Drug: Losartan; Drug: Amlodipine; Drug: Hydrochlorothiazide (HCTZ) Sponsor: Novartis Pharmaceuticals Completed Thu, 05 Aug 2010 12:00:00 EDT Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.Condition: HypertensionIntervention: Drug: valsartan/hydrochlorothiazide Sponsor: Novartis Completed Thu, 15 Sep 2005 12:00:00 EDT Lowering Blood Pressure in Primary Care in ViennaCondition: HypertensionIntervention: Drug: Olmesartan medoxomil, amlodipine, hydrochlorothiazide Sponsors: Wilhelminenspital Vienna; Association for the Promotion of Research in Atherosclerosis, Thrombosis and Vascular Biology; Ludwig Boltzmann Foundation for Cardiovascular Research Completed Tue, 03 Mar 2015 12:00:00 EST A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the ElderlyCondition: HypertensionInterventions: Drug: Aliskiren; Drug: Ramipril; Drug: Hydrochlorothiazide; Drug: Amlodipine Sponsor: Novartis Pharmaceuticals Completed Thu, 24 Aug 2006 12:00:00 EDT Effect of Renin-angiotensin System Blockers on Glomerular Filtration Rate in Patients With Hypertension, Type 2 Diabetes With NormoalbuminuriaConditions: Diabetes; Hypertensive DiseaseInterventions: Drug: Renin-angiotensin system blockers; Drug: non-renin angiotensin system blockers Sponsor: Hospital Authority, Hong Kong Unknown status Wed, 28 Dec 2011 12:00:00 EST Bioequivalence Study of CJ-30061 in Healthy Male VolunteersConditions: Hypertension; HyperlipidemiaInterventions: Drug: CJ-30061; Drug: Exforge® 5/160mg & Lipitor® 20mg Sponsor: HK inno.N Corporation Completed Wed, 05 Sep 2018 12:00:00 EDT Filtered Trial for Telmisartan 40mg Non-responderCondition: HypertensionInterventions: Drug: telmisartan+amlodipine; Drug: telmisartan Sponsor: Boehringer Ingelheim Completed Tue, 30 Oct 2007 12:00:00 EDT
The Comparison Between Spironolactone and Indapamide Monotherapy or in Combination With Amlodipine to Reduce the Risk of Heart FailureCondition: HypertensionInterventions: Drug: Spironolactone; Drug: Indapamide Sponsor: Shanghai Jiao Tong University School of Medicine Recruiting Thu, 02 Jul 2020 12:00:00 EDT Evaluating a Pharmacokinetic Drug Interaction Between Amlodipine/Losartan and RosuvastatinCondition: HealthyInterventions: Drug: amosartan; Drug: rosuvastatin; Drug: amosartan and rosuvastatin Sponsor: Hanmi Pharmaceutical Company Limited Unknown status Fri, 16 May 2014 12:00:00 EDT Bioequivalence Study of Telmisartan Between T80/A5/H12.5 mg FDC Tablet and T80/A5 mg Tab and H12.5 mg Tab Concomitant UseCondition: HealthyInterventions: Drug: T80/A5 mg FDC tablet; Drug: H12.5 mg tablet; Drug: T80/A5/H12.5 ng FDC tablet; Drug: H12.5 mf tablet; Drug: T80/A5/H12.5 mg FDC tablet Sponsor: Boehringer Ingelheim Completed Wed, 23 Apr 2014 12:00:00 EDT Comparison of Optimal Hypertension RegimensCondition: HypertensionInterventions: Drug: Amlodipine; Drug: Lisinopril; Drug: Amiloride; Drug: Chlortalidone Sponsors: Cambridge University Hospitals NHS Foundation Trust; Medical Research Council Recruiting Thu, 28 Jul 2016 12:00:00 EDT A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential HypertensionCondition: Essential HypertensionInterventions: Drug: LCZ696; Drug: Amlodipine; Drug: Hydrochlorothiazide (HCTZ) Sponsor: Novartis Pharmaceuticals Completed Wed, 08 Dec 2010 12:00:00 EST OlmeSartan and Calcium Antagonists Randomized (OSCAR) StudyConditions: Hypertension; Cardiovascular DiseasesInterventions: Drug: Olmesartan medoxomil; Drug: Calcium channel blockers (amlodipine, azelnidipine) Sponsors: OSCAR Study; Japan Heart Foundation Completed Wed, 24 Aug 2005 12:00:00 EDT Pharmacokinetics Study of CJ-30060 After Single Dose Administration in Health Male VolunteersConditions: Hypertension; HyperlipidemiasInterventions: Drug: CJ-30060; Drug: Exforge tab 5/160mg, Crestor tab 10mg Sponsor: HK inno.N Corporation Completed Wed, 04 Jan 2017 12:00:00 EST Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314)Condition: Essential HypertensionIntervention: Drug: MK0954A; hydrochlorothiazide (+) losartan potassium / Duration of Treatment: 12 weeks Sponsor: Merck Sharp & Dohme Corp. Completed Mon, 12 Sep 2005 12:00:00 EDT Ranolazine SR in Patients With Chronic Angina Who Remain Symptomatic Despite Maximal Treatment With AmlodipineCondition: AnginaIntervention: Drug: Ranolazine Sponsor: Gilead Sciences Completed Fri, 10 Sep 2004 12:00:00 EDT A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly PeopleCondition: Cardiovascular EventsInterventions: Drug: Aliskiren; Drug: Amlodipine; Drug: Hydrochlorothiazide (HCTZ); Drug: Placebo for Aliskiren; Drug: Placebo for Amlodipine; Drug: Placebo for Hydrochlorothiazide (HCTZ) Sponsor: Novartis Pharmaceuticals Terminated Tue, 14 Dec 2010 12:00:00 EST
Diva - The Effects Of 12 Weeks Of Treatment With High Dose Valsartan (320 Mg) To Amlodipine On Endothelial Function In Hypertensive Subjects With The Metabolic SyndromeConditions: Hypertension; Metabolic SyndromeIntervention: Drug: VALSARTAN Sponsor: Novartis Completed Tue, 18 Oct 2005 12:00:00 EDT A Randomized, Open Label, Single Dose, 2-Way Cross-over Clinical Trial to Compare the Safety and Pharmacokinetic Characteristics of Exforge® and G-0081 in Healthy Male VolunteersCondition: Healthy Male VolunteerInterventions: Drug: Exforge®; Drug: G-0081 Sponsor: Dong-A Pharmaceutical Co., Ltd. Completed Fri, 25 Jan 2013 12:00:00 EST A Clinical Study to Compare Long-term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazidebased Treatment Regimen With Optional Addition of AmlodipineCondition: HypertensionIntervention: Drug: aliskiren Sponsor: Novartis Completed Thu, 22 Sep 2005 12:00:00 EDT Bioequivalence Study of Telmisartan Between Telmisartan 80 mg/Amlodipine 5 mg FDC Tablet and Telmisartan 80 mg Tab and Amlodipine 5 mg Tab Concomitant UseCondition: HealthyInterventions: Drug: Telmisartan/Amlodipin FDC; Drug: Telmisartan; Drug: Amlodipin Sponsor: Boehringer Ingelheim Completed Fri, 29 Apr 2011 12:00:00 EDT Fixed-Free HTN TrialCondition: HypertensionInterventions: Drug: Losartan and amlodipine and hydrochlorothiazide; Drug: Standard of care Sponsor: Hotel Dieu de France Hospital Unknown status Thu, 05 Jul 2018 12:00:00 EDT Pharmacokinetic Interaction Between HGP0904, HGP0608 and HGP1405Condition: Hypertension(HTN)Interventions: Drug: HGP0904; Drug: HGP0608; Drug: HGP1405 Sponsors: Hanmi Pharmaceutical Company Limited; Seoul National University Bundang Hospital Completed Fri, 13 Mar 2015 12:00:00 EDT Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus HydrochlorothiazideCondition: HypertensionInterventions: Drug: Valsartan plus Hydrochlorothiazide; Drug: Candesartan plus Hydrochlorothiazide; Drug: Amlodipine Sponsor: Novartis Completed Fri, 04 Aug 2006 12:00:00 EDT A Phase 2 Study to Assess Dose-response Relationship of HCP1803 in Patients With Essential HypertensionCondition: HypertensionInterventions: Drug: HCP1803; Drug: Amlodipine; Drug: Losartan; Drug: Placebo Sponsor: Hanmi Pharmaceutical Company Limited Unknown status Mon, 01 Apr 2019 12:00:00 EDT L-NMMA Plus Taxane Chemotherapy in Refractory Locally Advanced or Metastatic Triple Negative Breast Cancer PatientsCondition: Metastatic Triple Negative Breast CancerInterventions: Drug: L-NMMA; Drug: Docetaxel; Drug: Amlodipine; Drug: Pegfilgrastim; Drug: Enteric-coated aspirin Sponsors: Polly A. Niravath, MD; The Methodist Hospital Research Institute Completed Fri, 15 Jul 2016 12:00:00 EDT PK Study of YH22162 FDC Compared to Combination of Twynsta and HygrotonCondition: HypertensionInterventions: Drug: YH22162; Drug: Telmisartan/Amlodipine 80/5 mg (FDC); Drug: Chlorthalidone 25mg Sponsor: Yuhan Corporation Completed Tue, 14 Jul 2015 12:00:00 EDT
RAS Peptide Profiles in Patients With Arterial HypertensionCondition: Essential HypertensionInterventions: Drug: Perindopril; Drug: Olmesartan; Drug: Amlodipine; Drug: Hydrochlorothiazide Sponsor: University Hospital Inselspital, Berne Completed Wed, 20 May 2015 12:00:00 EDT Series of N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents With Essential HypertensionCondition: Essential HypertensionInterventions: Drug: Lisinopril; Drug: Amlodipine; Drug: Hydrochlorothiazide Sponsor: The University of Texas Health Science Center, Houston Completed Thu, 09 Apr 2015 12:00:00 EDT Combination of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male SubjectsCondition: PharmacokineticsInterventions: Drug: Treatment T; Drug: Treatment R Sponsor: Boryung Pharmaceutical Co., Ltd Completed Tue, 14 Aug 2018 12:00:00 EDT African American Study of Kidney Disease and HypertensionConditions: Hypertensive Nephrosclerosis; Chronic Renal InsufficiencyInterventions: Other: MAP goal less than or equal to 92 mm Hg; Other: MAP goal 102-107 mm Hg; Drug: Ramipril; Drug: Amlodipine; Drug: Metoprolol Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); The Cleveland Clinic Completed Mon, 27 Apr 2020 12:00:00 EDT Tarka® vs. Lotrel® in Hypertensive, Diabetic Subjects With Renal Disease (TANDEM)Conditions: Hypertension; Diabetes; ProteinuriaInterventions: Drug: trandolapril/verapamil; Drug: Lotrel (amlodipine/benazepril) Sponsor: Abbott Completed Mon, 10 Oct 2005 12:00:00 EDT Pathophysiological Mechanisms of Hypertensive LVH:Optimising RegressionConditions: Hypertension; Left Ventricular HypertrophyInterventions: Drug: Bendroflumethiazide 2.5mg OD; Amlodipine 10mg OD; Drug: Valsartan 160mg OD; Moxonidine 400mcg OD Sponsors: University of Leeds; The Leeds Teaching Hospitals NHS Trust Completed Mon, 20 Aug 2007 12:00:00 EDT A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With HypertensionCondition: HypertensionInterventions: Drug: sacubitril/valsartan (LCZ696); Drug: olmesartan; Other: placebo to sacubitril/valsartan (LCZ696); Other: placebo to olmesartan; Drug: Amlodipine (Optional) Sponsor: Novartis Pharmaceuticals Completed Thu, 06 Jun 2013 12:00:00 EDT The Precision Hypertension Care StudyCondition: HypertensionInterventions: Drug: Zestril®; Drug: Atacand®; Drug: Norvasc®; Drug: Hydrochlorthiazide®; Drug: Treatment X; Drug: Treatment Y; Drug: Placebo Sponsor: Uppsala University Completed Tue, 17 May 2016 12:00:00 EDT Study to Evaluate the Safety and PK of LODIENT Tablet 80/2.5mg in Healthy Adult VolunteersCondition: HypertensionInterventions: Drug: Twynsta; Drug: LodineT Sponsor: Hanlim Pharm. Co., Ltd. Completed Wed, 16 Dec 2020 12:00:00 EST Valsartan Intensified Primary Care Reduction of Blood Pressure StudyCondition: HypertensionInterventions: Drug: Valsartan and hydrochlorothiazide (HCTZ) - monotherapy; Drug: Valsartan and amlodipine; Drug: Usual care; Drug: Valsartan; Drug: Valsartan and hydrochlorothiazide (HCTZ) - combination arm Sponsors: Novartis Pharmaceuticals; Baker Heart and Diabetes Institute Completed Fri, 15 May 2009 12:00:00 EDT
CKD-828 Telmisartan Non-Responder TrialCondition: HypertensionInterventions: Drug: CKD-828 40/2.5mg; Drug: CKD-828 40/5mg; Drug: Telmisartan 80mg Sponsor: Chong Kun Dang Pharmaceutical Completed Wed, 31 Aug 2011 12:00:00 EDT Gut Microbiomes in Patients With Metabolic SyndromeCondition: Metabolic SyndromeInterventions: Drug: Metformin; Behavioral: lifestyle modification; Drug: Simvastatin 10mg; Drug: Amlodipine 5mg Sponsor: Chinese University of Hong Kong Recruiting Thu, 05 Apr 2018 12:00:00 EDT A Phase 3 Study to Compare the Efficacy and Safety of Co-administered HGP0608, HGP0904 and HCP1306 Versus HCP1701 in Patients With Hypertension and DyslipidemiaConditions: Hypertension; DyslipidemiasInterventions: Drug: HCP1701; Drug: Losartan; Drug: Amlodipine; Drug: Rosuvastatin and Ezetimibe Sponsor: Hanmi Pharmaceutical Company Limited Completed Fri, 30 Aug 2019 12:00:00 EDT Black Education and Treatment of Hypertension (BEAT HTN)Condition: HypertensionInterventions: Drug: Hydrochlorothiazide; Drug: Lisinopril; Drug: Lisinopril and Hydrochlorothiazide; Drug: Nifedipine XL; Drug: Metoprolol tartrate; Drug: Atenolol; Drug: Valsartan; Drug: Doxazosin; Drug: Clonidine; Drug: Hydralazine; Drug: Metoprolol succinate; Drug: Amlodipine Sponsor: Creighton University Completed Mon, 21 Apr 2008 12:00:00 EDT Drug-drug Interactions Between Antiretroviral Drugs and Cardiovascular Drugs in Elderly PatientsConditions: HIV Infections; Drug Interactions; Cardiovascular DiseasesIntervention: Drug: Co-administration of darunavir with a cardiovascular drug Sponsor: Centre Hospitalier Universitaire Vaudois Completed Fri, 04 May 2018 12:00:00 EDT N-of-1 Trials In Children With HypertensionCondition: Pediatric HypertensionInterventions: Other: NICHE method; Other: Usual care; Drug: Amlodipine; Drug: Lisinopril; Drug: Hydrochlorothiazide; Drug: Losartan Sponsor: The University of Texas Health Science Center, Houston Completed Fri, 09 Mar 2018 12:00:00 EST Bioequivalence Study of CJ-30060 in Healthy VolunteersCondition: Healthy SubjectsInterventions: Drug: Exforge® tab 5/160mg, Crestor® tab 10mg; Drug: CJ-30060 5/160/10mg Sponsor: HK inno.N Corporation Unknown status Wed, 28 Nov 2018 12:00:00 EST Bioequivalence Study of CJ-30060 in Healthy Male VolunteersCondition: Healthy Male SubjectsInterventions: Drug: Exforge® tab 10/160mg, Crestor® tab 20mg; Drug: CJ-30060 10/160/20mg Sponsor: HK inno.N Corporation Completed Tue, 21 Aug 2018 12:00:00 EDT Pharmacokinetic Interactions and Safety Between Exforge Tab. and Crestor Tab. in Healthy Male SubjectsCondition: HealthyIntervention: Drug: administration of exforge 10/160mg for 3days. Next 7days administration of exforge 10/160mg and crestor 20mg. Sponsor: HK inno.N Corporation Completed Tue, 11 Feb 2014 12:00:00 EST Interactions Between HIV Protease Inhibitors and Calcium Channel BlockersConditions: HIV Infections; Cardiovascular Diseases; HypertensionInterventions: Drug: Indinavir sulfate; Drug: Ritonavir; Drug: Amlodipine; Drug: Diltiazem HCl Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Completed Thu, 20 Jun 2002 12:00:00 EDT
Phase 4 Study of the Efficacy of Losartan Based Therapy in Hypertensives With and Without DiabetesConditions: Diabetes Mellitus; HypertensionInterventions: Drug: Losartan 50Mg Tab; Drug: Losartan/Hydrochlorothiazide 50 Mg-12.5 Mg ORAL TABLET; Drug: Losartan/Hydrochlorothiazide 100 Mg-25 Mg ORAL TABLET; Drug: Amlodipine 5mg Sponsors: The University of The West Indies; Caribbean College of Family Physicians Withdrawn Fri, 07 Jun 2019 12:00:00 EDT Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With HypertensionCondition: HypertensionInterventions: Drug: LCZ696; Drug: Olmesartan; Drug: LCZ696 matching placebo; Drug: Olmesartan matching placebo; Drug: amlodipine; Drug: hydrochlorothiazide Sponsor: Novartis Pharmaceuticals Completed Tue, 25 Sep 2012 12:00:00 EDT Effect of Active Telephone Calls in the Compliance of Hypertensive Patients With TreatmentCondition: Blood PressureInterventions: Behavioral: phone call; Drug: amlodipine (calcium chanel blocker) and losartan (at1 antagonist); Drug: atenolol (beta blocker) and hydrochlorothiazide (diuretic) Sponsor: University of Sao Paulo Unknown status Tue, 23 Dec 2008 12:00:00 EST A Study on Molecular Genetics of Drug Responsiveness in Essential HypertensionConditions: Hypertension; PharmacogeneticsInterventions: Drug: Amlodipine; Drug: Bisoprolol; Drug: Hydrochlorothiazide; Drug: Losartan; Drug: Placebo Sponsor: Helsinki University Central Hospital Completed Fri, 08 Sep 2017 12:00:00 EDT Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)Condition: HypertensionInterventions: Drug: Standard Care; Drug: Intensive Treatment Sponsors: University of Texas Southwestern Medical Center; Texas Health Resources; Michigan State University Recruiting Mon, 27 Nov 2017 12:00:00 EST The Efficacy and Safety of OROSARTAN® Versus CODIOVAN® in Patients With Essential Hypertension Uncontrolled With MonotherapyCondition: HypertensionInterventions: Drug: OROSARTAN® 5/160mg; Drug: CODIOVAN® 160/12.5mg Sponsor: Dong-A ST Co., Ltd. Completed Mon, 04 May 2015 12:00:00 EDT Intensive Vasodilator Therapy in Patients With Essential HypertensionConditions: Essential Hypertension; High Blood PressureInterventions: Drug: Amlodipine; Drug: Ramipril; Drug: Lercanidipine; Drug: Losartan Sponsors: Aarhus University Hospital; University of Aarhus Completed Thu, 12 Aug 2010 12:00:00 EDT Pharmacodynamic Effects of Atorvastatin vs. Rosuvastatin on Platelet ReactivityCondition: Coronary Artery DiseaseInterventions: Drug: Atorvastatin; Drug: Rosuvastatin Sponsor: University of Roma La Sapienza Unknown status Fri, 30 Mar 2012 12:00:00 EDT Antihypertensive Pharmacological Therapy With Mineralocorticoid Receptor Antagonists in Obese Hypertensive PatientsConditions: Hypertension; ObesityInterventions: Drug: Eplerenone (-based therapy) arm; Drug: Valsartan (-based therapy) arm Sponsor: Hippocration General Hospital Unknown status Mon, 26 Mar 2018 12:00:00 EDT Anglo-Scandinavian Cardiac Outcomes Trial: Post Trial Follow-Up StudyConditions: Hypertension; Diabetes; Death From Cardiovascular Disease; Myocardial Infarction; StrokeIntervention: Sponsors: Imperial College London; Pfizer Completed Mon, 26 Dec 2011 12:00:00 EST
Treatment of Resistant Hypertension by Prevention of T-Cell Co-StimulationCondition: HypertensionInterventions: Drug: Abatacept; Drug: Placebo Sponsors: Vanderbilt University Medical Center; Bristol-Myers Squibb Terminated Fri, 05 Sep 2014 12:00:00 EDT Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel BlockerCondition: HypertensionInterventions: Drug: Olmesartan medoxomil; Drug: Hydroclorothiazide; Drug: Benazepril; Drug: Amlodipine Sponsor: Daiichi Sankyo, Inc. Completed Fri, 16 Sep 2005 12:00:00 EDT Pharmacokinetics and Drug Interaction Study Between Amlodipine,Olmesartan and Rosuvastatin in Healthy Adult VolunteersCondition: HealthyInterventions: Drug: Sevikar(amlodipne/olmesartan); Drug: crestor(Rosuvastatin) Sponsor: Daewoong Pharmaceutical Co. LTD. Completed Mon, 17 Mar 2014 12:00:00 EDT Risk Reduction for Alzheimer's DiseaseConditions: Cognitively Normal Older Adults; Hypertension; Subjective Cognitive Decline; Family History of Alzheimer's DiseaseInterventions: Drug: Angiotensin II receptor blocker (ARB, losartan) and calcium channel blocker (CCB, amlodipine); Behavioral: Aerobic Exercise Training; Other: Usual Care; Behavioral: Stretching Exercise Sponsors: University of Texas Southwestern Medical Center; Texas Health Resources; University of Kansas Medical Center; Washington University School of Medicine; Pennington Biomedical Research Center; Michigan State University Active, not recruiting Mon, 26 Sep 2016 12:00:00 EDT To Evaluate Real-world Safety, Effectiveness and Appropriate Use of Micatrio® Combination Tablets Treatment in Patients With HypertensionCondition: HypertensionIntervention: Drug: T80/A5/H12.5 FDC Sponsor: Boehringer Ingelheim Completed Fri, 13 Jan 2017 12:00:00 EST A Phase III Long-term Study of TAK-536TCH in Participants With Essential HypertensionCondition: Essential HypertensionInterventions: Drug: TAK-536TCH tablet; Drug: TAK-536CCB tablet; Drug: HCTZ 12.5 mg tablet Sponsor: Takeda Completed Wed, 29 Oct 2014 12:00:00 EDT Clinical Trial in Patients With Hypertension and Left Ventricular DysfunctionConditions: Hypertension; Cardiac Arrhythmias; Diabetes Mellitus; Renal Insufficiency; Sleep ApneaIntervention: Sponsor: Elpen Pharmaceutical Co. Inc. Completed Thu, 29 May 2014 12:00:00 EDT A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab in Hypertensive Patients Inadequately Controlled by Candesartan MonotherapyCondition: HypertensionInterventions: Drug: Cantabell Tab; Drug: Candemore Plus Tab Sponsor: Chong Kun Dang Pharmaceutical Completed Thu, 20 Aug 2020 12:00:00 EDT A Randomized, Open-label, Single Dose, Two-way Crossover Clinical Trial to Compare the Safety, Pharmacokinetic Profiles of UI15AML055MT and Amosartan® Tablet 5/50 mg After a Single Oral Administration in Healthy Male VolunteersCondition: HealthyInterventions: Drug: UI15AML055MT; Drug: Amosartan 5/50 Sponsor: Korea United Pharm. Inc. Completed Wed, 18 Jun 2014 12:00:00 EDT Safety and Pharmacokinetics of Besylsartan Tablet in Healthy Male SubjectCondition: HypertensionInterventions: Drug: Besylsartan; Drug: Amosartan Sponsor: Huons Co., Ltd. Completed Wed, 22 Jul 2015 12:00:00 EDT
Evaluation of the Long-Term Safety and Tolerability of Metoprolol Versus Nebivolol in Patients With HypertensionCondition: HypertensionInterventions: Drug: Nebivolol; Drug: Metoprolol Sponsor: Mylan Bertek Pharmaceuticals Completed Fri, 02 Sep 2005 12:00:00 EDT Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With HypertensionCondition: HypertensionIntervention: Drug: Daglutril Sponsor: Solvay Pharmaceuticals Completed Mon, 12 Sep 2005 12:00:00 EDT Effect of Chronic ACE and DPP4 Inhibition on Blood PressureConditions: Type 2 Diabetes Mellitus; HypertensionInterventions: Drug: Placebo; Drug: Sitagliptin; Drug: Aprepitant; Other: Mixed Meal Test (MMT) Sponsor: Vanderbilt University Completed Mon, 05 May 2014 12:00:00 EDT Caduet and TLC Intervention in Metabolic SyndromeCondition: Metabolic SyndromeInterventions: Behavioral: Therapeutic Lifestyle Change; Drug: Caduet Pill; Drug: Placebo Sponsors: The University of Texas Medical Branch, Galveston; Pfizer; University of Texas Southwestern Medical Center Completed Fri, 20 Apr 2018 12:00:00 EDT Pharmacokinetic/Pharmacodynamic & Safety Study of G3041 and SEVIKAR® Tablet in Healthy Adult VolunteersCondition: Healthy Adult VolunteersInterventions: Drug: G3041; Drug: SEVIKAR® Sponsors: Dong-A Pharmaceutical Co., Ltd.; Dong-A ST Co., Ltd. Unknown status Mon, 10 Feb 2014 12:00:00 EST Statin Neuroprotection and Carotid Endarterectomy: Safety, Feasibility and OutcomesConditions: Carotid Artery Stenosis; StrokesInterventions: Drug: Statin; Drug: Atorvastatin; Other: Placebo Sponsor: Columbia University Recruiting Fri, 29 Jul 2016 12:00:00 EDT Clinical Trial to Evaluate the Bioavailability and Safety of AGSAV301Condition: HypertensionInterventions: Drug: AGSAV301; Drug: Exforge 10/160 Sponsors: Ahn-Gook Pharmaceuticals Co.,Ltd; Asan Medical Center Completed Wed, 22 Feb 2012 12:00:00 EST Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese PatientsConditions: Hypertension; Hypercholesterolemia; Angina PectorisIntervention: Drug: Caduet Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. Completed Fri, 27 Aug 2010 12:00:00 EDT Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AFCondition: Atrial FibrillationIntervention: Drug: Aggressive Blood Pressure control Sponsors: Nova Scotia Health Authority; Nova Scotia Health Research Foundation Completed Wed, 21 Feb 2007 12:00:00 EST Antihypertensive Treatment in Masked Hypertension for Target Organ ProtectionCondition: Masked HypertensionInterventions: Drug: Allisartan Isoproxil; Drug: Placebo Sponsor: Yan Li Active, not recruiting Thu, 08 Sep 2016 12:00:00 EDT
Caduet in an Untreated Subject PopulationConditions: Hypertension; DyslipidemiaIntervention: Drug: Caduet Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. Completed Fri, 02 Jun 2006 12:00:00 EDT A Pilot Study of Plasma Renin Activity Guided vs Generic Combination Therapy for HypertensionConditions: Hypertension; Plasma Renin ActivityInterventions: Drug: Hydrochlorothiazide; Drug: Lisinopril; Drug: Amlodipine; Drug: metoprolol; Drug: lisinopril/hydrochlorothiazide Sponsors: University of North Carolina, Chapel Hill; Cornell University; Wake Forest University Health Sciences Completed Tue, 07 Aug 2012 12:00:00 EDT Rituximab Combined With MSCs in the Treatment of PNS (3-4 Stage of CKD)Conditions: Renal Insufficiency, Chronic; Nephrotic SyndromeInterventions: Drug: Rituximab; Drug: conventional therapy; Drug: Mesenchymal stem cells Sponsor: Zhujiang Hospital Unknown status Thu, 17 Nov 2016 12:00:00 EST Safety and Pharmacokinetic Comparison of Exforge® and G-0081 in Healthy Male VolunteersCondition: HealthyInterventions: Drug: Test formulation; Drug: Reference formulation Sponsor: Severance Hospital Completed Thu, 04 Apr 2013 12:00:00 EDT Blood Pressure Lowering of Aliskiren HCTZ Compared to HCTZ in Stage 2 Systolic Hypertension in Older PopulationCondition: HypertensionInterventions: Drug: Aliskiren; Drug: Hydrochlorothiazide Sponsor: Novartis Completed Fri, 26 Sep 2008 12:00:00 EDT Strategy of Blood Pressure Intervention in the Elderly Hypertensive PatientsCondition: Primary HypertensionInterventions: Drug: Intensive BP control; Drug: Standard BP control Sponsor: Chinese Academy of Medical Sciences, Fuwai Hospital Active, not recruiting Tue, 10 Jan 2017 12:00:00 EST Coronavirus (COVID-19) ACEi/ARB InvestigationConditions: Hypertension; COVID-19Interventions: Drug: Thiazide or Thiazide-like diuretics; Drug: Calcium Channel Blockers; Drug: ACE inhibitor; Drug: Angiotensin receptor blocker Sponsor: National University of Ireland, Galway, Ireland Suspended Wed, 01 Apr 2020 12:00:00 EDT The Renin-Angiotensin-Aldosterone System in Adiposity, Blood Pressure and Glucose in African AmericansConditions: PreDiabetes; Impaired Glucose Tolerance; Obesity; Blood PressureInterventions: Drug: Sacubitril-Valsartan Tab 97-103 MG; Drug: Valsartan 160mg; Drug: Placebo Oral Tablet Sponsors: Ohio State University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Recruiting Mon, 06 May 2019 12:00:00 EDT ACEI/CCB Versus ACEI/DIU Combination Antihypertensive Therapy in Chinese Hypertensive Patients (ACvAD)Condition: HypertensionInterventions: Drug: ACEI/CCB; Drug: ACEI/DIU Sponsor: Shanghai Jiao Tong University School of Medicine Active, not recruiting Tue, 25 Sep 2018 12:00:00 EDT Italian Study on the Cardiovascular Effects of Systolic Blood Pressure Control - CARDIOSIS StudyCondition: HypertensionInterventions: Drug: Triatec 10 mg; Drug: Triatec HCT 5; Drug: Lasix 25; Drug: Micardis 80 mg; Drug: Micardis plus 80/12.5; Drug: Catapresan TTS 2; Drug: Norvasc 10 mg; Drug: Triatec 5 mg; Drug: Pluscor Sponsor: Heart Care Foundation Completed Mon, 15 Jan 2007 12:00:00 EST
Non-invasive Haemodynamic Assessment in HypertensionCondition: Arterial HypertensionInterventions: Drug: lisinopril; Drug: Telmisartan; Drug: Nebivolol; Drug: Indapamide/hydrochlorothiazide; Drug: Amlodipine Sponsor: Military Institute of Medicine, Poland Completed Wed, 27 Nov 2013 12:00:00 EST Safety and Efficacy of Daily Use of Micamlo® Combination Tablets AP in Patients With HypertensionCondition: HypertensionIntervention: Drug: Micamlo Sponsor: Boehringer Ingelheim Completed Fri, 13 May 2011 12:00:00 EDT Medication Adherence and "True" Resistance in Patients With Resistant HypertensionConditions: Hypertensive Disease; Hypertension, Resistant to Conventional TherapyIntervention: Sponsor: Charite University, Berlin, Germany Unknown status Thu, 01 May 2014 12:00:00 EDT Blood Pressure Lowering Effects of Amosartan Regarding Proviso iN Patients With High Blood PressureCondition: HypertensionIntervention: Drug: Amosartan Sponsor: Seoul National University Bundang Hospital Completed Mon, 21 Aug 2017 12:00:00 EDT Adrenal Artery Ablation for Primary AldosteronismConditions: Primary Aldosteronism; HypertensionInterventions: Procedure: Endovascular chemical Ablation of Adrenal Gland; Drug: Sequenced antihypertensvie drugs with titrated dosage Sponsor: Third Military Medical University Unknown status Fri, 31 Aug 2018 12:00:00 EDT Nephropathy In Type 2 Diabetes and Cardio-renal EventsCondition: Diabetic NephropathyInterventions: Drug: SoC therapy; Drug: irbesartan; Drug: ramipril; Drug: hydrochlorothiazide; Drug: furosemide; Drug: amlodipine; Drug: atenolol; Drug: doxazosin; Drug: clonidine; Drug: insulin; Drug: simvastatin; Drug: fibrate; Drug: erythropoietin; Drug: aspirin Sponsor: University of Campania "Luigi Vanvitelli" Completed Thu, 27 Sep 2007 12:00:00 EDT Standard Medical Management in Secondary Prevention of Ischemic Stroke in ChinaCondition: StrokeInterventions: Drug: Aspirin / Clopidogrel, Atorvastatin / Simvastatin; Drug: Asprin / Clopidogrel, Atorvastatin / Simvastatin Sponsor: Peking Union Medical College Hospital Completed Wed, 23 Apr 2008 12:00:00 EDT Treatment of Mild Hypertension Study (TOMHS)Conditions: Cardiovascular Diseases; Heart Diseases; Hypertension; Vascular DiseasesInterventions: Behavioral: diet, sodium-restricted; Behavioral: diet, reducing; Behavioral: exercise; Behavioral: alcohol restriction; Drug: chlorthalidone; Drug: acebutolol; Drug: doxazosin; Drug: amlodipine; Drug: enalapril Sponsors: University of Minnesota; National Heart, Lung, and Blood Institute (NHLBI) Completed Thu, 28 Oct 1999 12:00:00 EDT Role of ARNi in Ventricular Remodeling in Hypertensive LVHCondition: Hypertensive Heart DiseaseInterventions: Drug: Entresto; Drug: Valsartan Sponsors: National Heart Centre Singapore; National Medical Research Council (NMRC), Singapore Recruiting Tue, 12 Jun 2018 12:00:00 EDT An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With HypertensionCondition: HypertensionInterventions: Drug: Azilsartan Medoxomil; Drug: Losartan; Drug: Placebo for Azilsartan Medoxomil; Drug: Placebo for Losartan; Drug: antihypertension medication Sponsor: Arbor Pharmaceuticals, Inc. Completed Wed, 10 Sep 2014 12:00:00 EDT
Efficacy and Safety of Stent Implantation in Symptomatic Extra- and Intracranial Artery StenosisConditions: Stroke; Transient Ischemic Attack; Atherosclerosis; Stenosis; StentsInterventions: Device: Stent implantation (Wingspan, Coroflex, and TiTAN2); Drug: Standard medical treatment Sponsor: Peking Union Medical College Hospital Completed Thu, 05 Jun 2008 12:00:00 EDT Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated HypertensionCondition: HypertensionInterventions: Drug: clinical hypertension specialist-no specific med. Any anti-hypertension meds.; Drug: renin guided therapeutics-no specific med. Any anti-hypertensive med. Sponsors: Medical University of South Carolina; New York Presbyterian Hospital Completed Mon, 26 May 2008 12:00:00 EDT Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for HypertensionCondition: HypertensionInterventions: Drug: QUARTET LDQT; Drug: Candesartan Sponsors: Northwestern University; ACCESS Community Health Network; University of Sydney Recruiting Tue, 21 Aug 2018 12:00:00 EDT Evaluating the Effect of Aliskiren Versus HCTZ on Coronary Flow Reserve in Hypertensive Type II DiabeticsConditions: Hypertension; Diabetes Type 2Interventions: Drug: Aliskiren; Drug: Hydrochlorothiazide Sponsors: William Beaumont Hospitals; Novartis Pharmaceuticals Withdrawn Wed, 14 Oct 2009 12:00:00 EDT CAndesartan vs LIsinopril Effects on the BRainConditions: Hypertension; Mild Cognitive ImpairmentInterventions: Drug: Candesartan; Drug: Lisinopril Sponsors: Emory University; National Institute on Aging (NIA) Completed Thu, 14 Nov 2013 12:00:00 EST Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)Conditions: Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus; Heart Diseases; Hypercholesterolemia; Hypertension; Myocardial Infarction; Myocardial Ischemia; Heart FailureInterventions: Drug: Inhibitors, ACE; Drug: amlodipine; Drug: lisinopril; Drug: doxazosin; Drug: chlorthalidone; Drug: pravastatin; Behavioral: diet, fat-restricted Sponsor: National Heart, Lung, and Blood Institute (NHLBI) Completed Thu, 28 Oct 1999 12:00:00 EDT Default BP Medication IntensificationCondition: HypertensionIntervention: Other: default intensification Sponsors: Cedars-Sinai Medical Center; University of California, Los Angeles Terminated Mon, 25 Nov 2013 12:00:00 EST Estimation of the Long Term Effectiveness of Routine Use of Cardiac Shock Wave TherapyCondition: Coronary Heart Disease (CHD)Interventions: Other: Treatment of CHD risk factors; Drug: Aspirin, Isosorbide mononitrate, Atenolol, Enalapril.; Procedure: PCA; Procedure: CABG; Device: Cardiospec; Drug: Aspirin, Isosorbide mononitrate, Atenolol, Enalapril Sponsor: City Hospital No 40, Saint Petersburg, Russia Withdrawn Fri, 29 Jun 2012 12:00:00 EDT To Evaluate the Pharmacokinetic/Pharmacodynamic Interactions and Safety Between ID1801 and ID1803 in Healthy Male AdultsConditions: Hypertension; DyslipidemiasInterventions: Combination Product: ID1803; Combination Product: ID1801; Combination Product: ID1803+ID1801 Sponsor: IlDong Pharmaceutical Co Ltd Not yet recruiting Wed, 04 Dec 2019 12:00:00 EST Transforming Hypertension Treatment in Nigeria Using a Type II Hybrid, Interrupted Time Series DesignCondition: HypertensionIntervention: Other: Evidence-based hypertension treatment Sponsors: Northwestern University; National Heart, Lung, and Blood Institute (NHLBI); University of Abuja Teaching Hospital; Resolve to Save Lives Recruiting Fri, 08 Nov 2019 12:00:00 EST
The Study of Novel Dual Renin Angiotensin Aldosterone System (RAAS) Blockade; Valsartan/Aliskiren in African American Patients With Hypertension and the Metabolic SyndromeConditions: Hypertension; Metabolic SyndromeIntervention: Drug: Aliskerin/Valsartan and Rampiril Sponsors: University of Michigan; Novartis Pharmaceuticals Withdrawn Mon, 12 Sep 2011 12:00:00 EDT Regression of Fatty Heart by Valsartan TherapyConditions: Metabolic Syndrome; LipotoxicityInterventions: Drug: Valsartan; Drug: Hydrochlorothiazide Sponsors: University of Texas Southwestern Medical Center; Novartis Pharmaceuticals Withdrawn Wed, 03 Sep 2008 12:00:00 EDT Surgery of Subclinical Cortisol Secreting Adrenal IncidentalomasCondition: Adrenal IncidentalomasInterventions: Procedure: Laparoscopic surgical removal of the adrenal tumor; Drug: Standardized medical treatment of hypertension by SAHR Sponsor: University Hospital, Bordeaux Active, not recruiting Mon, 16 Feb 2015 12:00:00 EST Treating Nocturnal Hypertension and Nocturia in African American MenCondition: High Blood PressureInterventions: Drug: Thiazide Treatment Group; Drug: Intensified Thiazide Treatment Group; Drug: Combination Medication Treatment Group Sponsor: Cedars-Sinai Medical Center Withdrawn Tue, 24 Oct 2017 12:00:00 EDT European Blood Pressure Intensive Control After StrokeConditions: Ischemic Stroke; Transient Ischemic AttackIntervention: Drug: anti-hypertensive Sponsors: University College Dublin; St Vincent's University Hospital, Ireland; Cork University Hospital; Tallaght University Hospital; University of Limerick; University of Calgary; Universitaire Ziekenhuizen Leuven; Attikon Hospital; Hospital Universitario La Paz; HRB Stroke Trials Network Ireland; National University of Ireland, Galway, Ireland; Mater Misericordiae University Hospital; University of Oslo; Newcastle University; University Hospital Waterford Not yet recruiting Mon, 30 Nov 2020 12:00:00 EST Adrenal Artery Ablation for Uncontrolled HypertensionCondition: Uncontrolled HypertensionInterventions: Procedure: Selective endovascular chemical ablation of adrenal gland; Drug: Traditional triple antihypertensive treatment Sponsor: Third Military Medical University Unknown status Thu, 06 Sep 2018 12:00:00 EDT Matão Controlling Hypertension (MatCH Study): Rationale and DesignConditions: Hypertension; Blood PressureInterventions: Drug: Captopril 25Mg, Hydrochlorothiazide 25Mg Oral Tablet,; Drug: Atenolol; Drug: Losartan potassium 50mg; Drug: Clonidine Sponsor: Centro Neurológico de Pesquisa e Reabiitação, Brazil Unknown status Wed, 10 May 2017 12:00:00 EDT Nutraceuticals and Drug Treatment in Frail Older AdultsCondition: FrailtyIntervention: Other: Nutraceuticals Sponsor: University of Campania "Luigi Vanvitelli" Recruiting Thu, 15 Jul 2021 12:00:00 EDT Glycemic And Blood Pressure Control In Type 2 Diabetes, In A Primary Care Unit: A Staged Management StrategyConditions: Diabetes Mellitus; Arterial HypertensionInterventions: Drug: Metformin; Drug: Glybenclamide; Drug: NPH insulin; Drug: Hydrochlorothiazide; Drug: Propranolol; Drug: Captopril; Drug: Amlodipine Sponsors: Hospital de Clinicas de Porto Alegre; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Brazil Unknown status Thu, 09 Jul 2009 12:00:00 EDT The Effects of Doxazosin and Nifedipine on Blood Pressure Variability and Uric Acid in Plasma in Hypertensive PatientsCondition: HypertensionInterventions: Drug: Doxazosin; Drug: Nifedipine Sponsor: First Affiliated Hospital of Harbin Medical University Unknown status Wed, 30 Sep 2015 12:00:00 EDT
The Effects of Nifedipine and Metoprolol on Blood Pressure Variability in Northern ChineseCondition: HypertensionInterventions: Drug: metoprolol; Drug: Nifedipine Sponsor: First Affiliated Hospital of Harbin Medical University Unknown status Mon, 03 Aug 2015 12:00:00 EDT Interaction Between Antihypertensives and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)Condition: HypertensionInterventions: Drug: acetaminophen; Drug: ibuprofen; Drug: piroxicam Sponsors: University Hospital of Split; Dr Ivancica Pavlicevic Family Practice Office Completed Fri, 07 Mar 2008 12:00:00 EST Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive PatientsConditions: Hypertension; Type 2 Diabetes MellitusInterventions: Drug: Nebivolol; Drug: Metoprolol ER; Drug: HCTZ Sponsor: Forest Laboratories Completed Fri, 29 Aug 2008 12:00:00 EDT Renal Artery Stenting in Patients With Documented Resistant Hypertension and Atherosclerotic Renal Artery Stenosis (ANDORRA)Conditions: Hypertension; Hypertension Resistant to Conventional Therapy; Angiographically Proven Grade III Unilateral or Bilateral Atherosclerotic Renal Artery Stenosis (ARAS) Greater Than or Equal to 60 PercentInterventions: Device: Renal artery Angioplasty plus stenting.; Drug: Anti hypertensive, statin and antiplatelet medication. Sponsors: Assistance Publique - Hôpitaux de Paris; Ministry of Health, France Terminated Thu, 03 Sep 2015 12:00:00 EDT A Study to Compare the Pharmacokinetics, Safety and Tolerability Between Fixed-Dose Combination and Co-Administration of HGP0904, HGP0608 and HCP1306 Tablets in Healthy Male Subjects.Condition: HealthyInterventions: Drug: HCP1701; Drug: HCP1306; Drug: HGP0904; Drug: HGP0608 Sponsor: Hanmi Pharmaceutical Company Limited Completed Thu, 26 Mar 2020 12:00:00 EDT A Study to Evaluate the Pharmacokinetic and Pharmacodynamic Interactions Between HGP0904, HGP0608, and HCP1306 in Healthy Male Subjects.Condition: HealthyInterventions: Drug: HCP1306; Drug: HGP0904; Drug: HGP0608 Sponsor: Hanmi Pharmaceutical Company Limited Completed Mon, 09 Sep 2019 12:00:00 EDT Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) StudyCondition: Stage D Heart FailureInterventions: Drug: Sacubitril-Valsartan; Drug: Usual care (standard-of-care) arm Sponsor: The Cleveland Clinic Recruiting Tue, 10 Dec 2019 12:00:00 EST Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk AssessmentConditions: Essential Hypertension; Cardiovascular Disease; Stroke; Chronic Kidney DiseaseInterventions: Drug: Any antihypertensive medication alone or in combination; Device: Ambulatory blood pressure monitoring Sponsors: University of Vigo; Servicio Gallego de Salud Completed Tue, 26 Aug 2008 12:00:00 EDT Optimization of Blood Pressure Management After Acute Ischemic Stroke and Its Prognostic SignificanceConditions: Ischemic Stroke; HypertensionInterventions: Behavioral: Behavioral intensification; Drug: Pharmacological intensification based on olmesartan; Device: Bluetooth-equipped sphygmomanometer Sponsors: Seoul National University Bundang Hospital; Daiichi Sankyo Korea Co., Ltd. Completed Wed, 18 Jan 2017 12:00:00 EST Resistant Arterial Hypertension Cohort StudyConditions: Hypertension; Essential Hypertension; Resistant HypertensionInterventions: Drug: chlorthalidone; Behavioral: motivational intervention for non-compliant individuals; Drug: standardized anti-hypertensive treatment Sponsor: University Hospital, Geneva Completed Tue, 09 Mar 2010 12:00:00 EST
Action to Control Cardiovascular Risk in Diabetes (ACCORD)Conditions: Atherosclerosis; Cardiovascular Diseases; Hypercholesterolemia; Hypertension; Diabetes Mellitus, Type 2; Diabetes Mellitus; Coronary DiseaseInterventions: Drug: Anti-hyperglycemic Agents; Drug: Anti-hypertensive Agents; Drug: Blinded fenofibrate or placebo plus simvastatin Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute on Aging (NIA); National Eye Institute (NEI); Centers for Disease Control and Prevention Completed Thu, 28 Oct 1999 12:00:00 EDT ACEI or ARB and COVID-19 Severity and Mortality in US VeteransConditions: Hypertension; COVIDInterventions: Drug: ACEI/ARB; Drug: Non-ACEI/ARB; Drug: ACEI; Drug: ARB Sponsors: University of Utah; VA Salt Lake City Health Care System; University of Pennsylvania; Wake Forest University Health Sciences; University of Florida; Johns Hopkins Bloomberg School of Public Health; Boston University; Northwestern University; Edith Nourse Rogers Memorial Veterans Hospital; Columbia University; MedStar Georgetown University Hospital Completed Mon, 13 Jul 2020 12:00:00 EDT Assessment of Immediate Postoperative Delirium (IPD) in Adult Patients: Incidence and Etiologic FactorsConditions: Delirium; Anesthesia; Adverse EffectInterventions: Procedure: Types of Anesthesia; Procedure: Access of Surgery; Other: Comorbidities; Drug: Preoperative Medication; Diagnostic Test: Routine blood test Sponsor: Sultan Qaboos University Completed Thu, 30 May 2019 12:00:00 EDT Analyzing How Genetics May Affect Response to High Blood Pressure MedicationsConditions: Hypertension; Coronary Disease; Cerebrovascular AccidentIntervention: Sponsors: University of Alabama at Birmingham; National Heart, Lung, and Blood Institute (NHLBI); University of Texas; University of Minnesota Completed Mon, 26 Nov 2007 12:00:00 EST |